Embryonic lipid metabolism and the actions of the teratogen valproic acid. by Clarke, David Oakley.
EMBRYONIC LIPID METABOLISM AND THE ACTIONS OF 
THE TERATOGEN VALPROIC ACID
by
David Oakley Clarke, B.Sc., M.Sc.
A thesis submitted to the Department of 
Biochemistry, University of Surrey, for 
the degree of Doctor of Philosophy.
MRC Experimental Embryology & Teratology Unit 
Medical Research Council Laboratories 
Carshalton, Surrey.
May 1988
ProQuest Number: 10798331
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10798331
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
11
ABSTRACT
Lipid metabolism and the actions of valproic acid, a human teratogen, 
have been studied in the organogenesis-stage rat conceptus, using whole 
embryo culture techniques.
All major lipid classes, particularly phospholipids, cholesterol and 
triacylglycerols, were synthesized de novo from acetate by the 
conceptus. Oleic acid and glucose were also incorporated into complex 
lipids. The pattern of lipid biosynthesis was dependent on the develop­
mental istage of the conceptus. Despite this lipid biosynthetic activity, 
cholesterol uptake experiments suggested that the rat conceptus derives 
most of its required lipid from exogenous sources.
Valproic acid stimulated de novo synthesis of cholesterol, and 
concomitantly reduced cholesterol esterification, in the yolk sac during 
an eight hour exposure. These effects were also induced by butyric acid, 
which produces valproic acid-like dysmorphologies in vitro, but not by 
the non-teratogen valpromide. Some observations suggested that the 
initial action was inhibition of cholesterol uptake at the yolk sac.
Subsequent studies disproved this hypothesis and also suggested that the
increased levels of newly synthesized cholesterol were not responsible, 
per se, for the valproic acid teratogenicity.
The specific actions of valproic acid on yolk sac cholesterol
synthesis and esterification were, nevertheless, dose-dependent in 
culture, and were also induced in conceptuses exposed to valproic acid 
in utero. This contrasts with several other major biochemical pathways, 
previously studied in the conceptus, which are not affected by valproic 
acid. It is likely, therefore, that these changes in lipid metabolism 
are related to the initial teratogenic insult of valproic acid.
" " He who will know the paths of nature will observe 
more easily their deviations; on the other hand, he who 
will know the deviations will describe more precisely the
paths; " .........................................
...........  while the statement applies in its
generality to all nature, it expresses especially neatly 
the relationships that prevail between normal 
embryogenesis and teratogenesis."
Camille Dareste (1891), commenting on a statement by 
Francis Bacon (1620, in his work "Novum organum").
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Chapter 1 
GENERAL INTRODUCTION
2The aims of the studies presented in this thesis were to provide a 
better understanding of some of the major lipid pathways in the organo- 
genesis-stage mammalian conceptus, and to examine the actions of the 
human teratogen valproic acid on these pathways. While little is 
presently known about lipid metabolism in the embryo, particularly during 
this stage of development, much more is, however, known about
carbohydrate or 'energy' metabolism. The current knowledge of embryonic
lipid and other pathways is described in the present chapter. In
addition, the visceral yolk sac has important nutritional functions
during this period and these are also described.
During organogenesis, the embryo is especially sensitive to chemical 
insult. Mechanisms by which teratogens potentially disturb intermediary 
metabolism are of particular importance in the present studies and are 
briefly described. The whole-embryo culture technique, used for the 
majority of studies presented subsequently, has become very popular for 
studying both normal and abnormal embryonic metabolism, and some of its 
applications are discussed. Finally, following a summary of the present 
knowledge pertaining to valproic acid, particularly its actions on adult 
metabolic pathways and its effects on the embryo, a rational for the 
studies in this thesis is presented.
1.1 Lipids: composition, metabolism and biological functions
Lipids are water-insoluble organic biomolecules containing long-chain 
hydrocarbon groups and are extractable from cells and tissues by non- 
-polar solvents, e.g. chloroform, ether or benzene.
Several different classes of lipids occur in the mammalian system, 
each deriving their distinctive properties from their hydrocarbon 
structure and therefore fulfilling specialized and important biological 
functions. Their main roles are as structural components of membranes
3and as storage and transport forms of metabolic fuels, while some lipids 
serve as physiologically active 'hormones' or function as cell-surface 
components in cell recognition. Lipids are synthesized from simple 
molecules such as acetyl-CoA and/or may be obtained and modified from 
dietary sources.
The following sections offer brief descriptions of the structures, 
metabolism (mainly syntheses) and functions of the common lipids, 
concentrating particularly on those which have been studied in the work 
presented in later chapters. More concise descriptions are found in 
general and specialized biochemistry texts (Stryer, 1981 and Gurr & 
James, 1980, for example). Finally, an overview of lipid metabolism and 
its relationships with other biosynthetic and energy providing pathways 
is presented.
1.1.1 Fatty acids and their neutral esters
Fatty acids are long-chain hydrocarbons with a terminal carboxyl 
group, ionized under physiological conditions (fig. 1.1). They usually 
have an even number of carbon atoms (14-24) , are unbranched and may be 
saturated or unsaturated. The most common fatty acids are palmitate and 
palmitoleate (Cie), and stearate and oleate (Cia).
Their synthesis is from the simple two-carbon precursor acetyl-CoA 
and proceeds in the cytosol via carboxylation to malonate and then by the 
multienzyme complex fatty acid synthetase. All the carbon atoms of even 
chain fatty acids are derived from acetyl-CoA, which in turn is generally 
obtained from mitochondrial oxidation of fuel molecules.
0
// Figure 1.1
General structure of 
long-chain fatty acids
H3C-(CH2)n-CH2-C
\
OH
4Fatty acids have two physiological roles: (i) they are the building 
blocks for membrane phospholipids and glycolipids (see 1.1.2), and (ii) 
they are fuel molecules, stored in highly concentrated form as triacyl- 
glycerols, uncharged esters of glycerol (fig. 1.2). Triacylglycerols are 
stored in adipose cells and are transported there in the form of plasma 
lipoproteins, either chylomicrons (transport dietary triacylglycerols) or 
VLDL (very low density lipoproteins; transport triacylglycerols synthe­
sized in the endoplasmic reticulum of hepatic cells). When energy is 
required from this efficient fuel reservoir, triacylglycerols are 
hydrolyzed by lipase action, under hormonal control, and the liberated 
fatty acids transported as albumin complexes back to the liver where they 
are oxidized.
Figure 1.2
General structure of a triacylglycerol.
(Ra,b,c represent the long-chain acyl 
groups of fatty acid components. The 
glycerol backbone is in bold type.)
The most common route of fatty acid catabolism is via ^-oxidation 
in hepatic mitochondria. For entry into this organelle, as well as for 
most of the metabolic reactions in which fatty acids take part, the fatty 
acids are first activated by linkage to coenzyme A, achieved by acyl-CoA 
synthetases. Three enzymes with slightly overlapping specificities are 
involved: acetate thiokinase (EC 6.2.1.1) activates acetate and propio­
nate; medium chain fatty acid thiokinase (EC 6.2.1.2) activates acids 
with chain lengths C4-Ci2 , but also phenyl substituted, branched chain 
and other modified acids; and long chain fatty acid thiokinase (EC 
6.2.1.3) activates acids Cs-Cis. Two less common routes of fatty acid 
catabolism are a- and w-oxidation. Their functions are uncertain 
but, unlike p-oxidation, these pathways occur in the microsomal fraction
0 CH2-O-C-Ra
I I 
Rb-C-O-CH 0
i ii
CHs-O-C-Rc
5and do not require 'activated' fatty acid substrates.
Some fatty acids are 'essential' and cannot be synthesized but are 
obtained in the diet. These are linoleic and T-linolenic acids, necessa­
ry precursors of prostaglandins, a group of hormone-like lipids having 
potent and diverse physiological regulatory actions. Other neutral 
esters of fatty acids include mono- and diacylglycerols which are present 
in small amounts as intermediates in the synthesis or hydrolysis of 
triacylglycerols. 1,2-Diacylglycerol also has a key role in phospholipid 
synthesis (see 1.1.2). In addition, small amounts of fatty acids may be 
reduced to saturated or unsaturated fatty alcohols which occur in free 
form or esterified as alkyl ether acylglycerols, much less abundant than 
triacylglycerols, or as plasmalogens (see 1.1.2). Thus in general only 
very low levels of free or 'non-esterified' fatty acids (NEFA) occur 
naturally, high levels usually reflecting cell damage. The exception is 
during their transportation in the body fluids as NEFA-albumin complexes.
1.1.2 Phospholipids and glycolipids
Fatty acids are also esterified as phospholipids and glycolipids, 
two lipid classes which together with cholesterol (see 1.1.3) are 
important components of biological membranes.
Phosholipids These lipids represent the major lipid components of 
membranes giving rise to the lipid bilayer. This serves as a permea­
bility barrier, establishing cellular compartments and providing a 
'solvent* for integral membrane proteins, as well as other lipids, having 
specialized communicative functions. Fatty acids and phosphoric acid
are esterified with an alcohol, either glycerol (phosphoglycerides) or 
sphingosine (phosphosphingolipids), as illustrated in figure 1.3.
Figure 1.3
General structures of (i) phosphoglycerides, with diacylglycerol 
backbone in bold type, and (ii) phosphosphingolipids, with sphingosine 
component in bold type. X represents the alcohol moiety, 
e.g. choline: {OH-jCfo-CIfc-NMCHsh.
Phosphoglycerides are by far the most abundant and the simplest, 
phosphatidate, is a key intermediate in the biosynthesis of more complex 
lipids of this class as well as triacylglycerols (see fig. 1.5). There 
are several pathways of phosphoglyceride synthesis which occur in the 
endoplasmic reticulum of mammalian cells. The starting point is glycerol 
3-phosphate which is formed mainly from dihydroxyacetone phosphate (DHAP; 
a glycolytic intermediate), but also from glycerol. Glycerol 3-phosphate 
is acylated twice to phosphatidate which in turn is activated to cytidine 
diphosphodiacylglycerol (CDP-DG), or converted to 1,2-diacylglycerol 
(1,2-DG). Phosphatidylethanolamine is synthesized by reaction of 
cytidine triphosphate activated alcohol (i.e. CDP-ethanolamine) with 
1,2-diacylglycerol. Phosphatidylcholine, the most abundant phospho­
glyceride, may be formed by an analogous reaction as well as via direct 
trimethylation of phosphatidylethanolamine. Plasmalogens, abundant in 
the membranes of muscles and nerve cells, are also synthesized from 
CDP-ethanolamine but in reaction with alkyl-diacylglycerol. Phospha- 
tidylserine is formed by enzymatic exchange of the alcohol moiety of 
phosphatidylethanolamine with serine; phosphatidylserine may undergo 
decarboxylation back to phosphatidylethanolamine. Phosphatidylinositol 
is synthesized by direct reaction of the alcohol inositol with CDP-DG,
7while phosphatidylglycerol, the precursor of cardiolipin (important in
\
mitochondrial membrane structure) is formed indirectly from the active 
phosphatidate. Sphingomyelin, a phosphosphingolipid, is synthesized via 
acylation of sphingosine to ceramide which reacts with CDP-choline.
Membrane phosphoglycerides are hydrolyzed by the action of specific 
phospholipases liberating fatty acids such as arachidonic acid, the 
precursor of prostaglandins. However, lysophosphoglycerides, low level 
intermediates in phosphoglyceride metabolism formed by the removal of one 
fatty acid molecule from phosphoglyceride, can be toxic to membranes if 
they reach high concentrations.
Glycolipids Like sphingomyelin, glycolipids have a sphingosine backbone 
and are derived via ceramide. However, ceramide reacts with uridine
diphosphate glucose (UDP-glucose) or UDP-galactose to form glycosyl
ceramides (cerebrosides) which may be linked via one or more sugar 
residues and one or more molecules of sialic acid to form gangliosides.
Although glycolipids occur in highest concentration in nervous tissue,
they are also present in much smaller amounts in non-neuronal tissues. 
They are only minor constituents of membranes but are important in
neurotransmission, cell-cell recognition and tissue immunity.
1.1.3 Cholesterol and other steroids
Cholesterol (fig 1.4) is the most abundant steroid (sub-classed as
a sterol) in animal tissues. Like the phospholipids it is a major
component of biological membranes, especially the plasma membrane which 
is particularly rich in this sterol (other organelles typically have 
lesser amounts). Together with the fatty acyl chains of membrane 
phospholipids, cholesterol is a key regulator of membrane fluidity. The 
relative amounts of cholesterol and phospholipids within membranes,
therefore, are important for the appropriate functioning of plasma and 
sub-cellular membranes. Cholesterol is also the direct precursor of 
the steroid hormones: progestens, androgens, oestrogens, glucocorticoids 
and mineralocorticoids. These are responsible for the regulation of many 
physiological functions, some of which are particularly relevant to the 
maintenance of pregnancy and normal embryonic development. In addition, 
vitamin D3 and the bile acids are derived from cholesterol.
CH3
/
CH2-CH2-CH 
\
CH3
The primary source of cholesterol is via de novo synthesis in the 
liver, although a smaller proportion is derived from the diet and 
a little is also synthesized in the intestine. Acetyl-CoA is the 
sole substrate for de novo synthesis providing all twenty seven carbon 
atoms (Cornforth et al., 1957). The committed step in the pathway is the 
conversion of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA; formed by 
the condensation of acetyl-CoA and acetoacetyl-CoA) to mevalonate. This 
step is rate-limiting and controlled by HMG-CoA reductase (EC 1.1.1.34). 
Mevalonate is converted to the five carbon intermediate isopentenyl pyro­
phosphate, an important building block for the synthesis of squalene, the 
intermediate in cholesterol biosynthesis, and other isoprenoids such as 
coenzyme Q10 (ubiquinone) and dolichol, which functions in cell surface 
glycoprotein and lipopolysaccharide synthesis. The final stages of
Figure 1.4
Structure of cholesterol.
(Long-chain fatty acids H3C CH2
esterify cholesterol at \ /
the 3-hydroxyl group.) CH
CH3 1
CH3
HO
9cholesterol biosynthesis begin with the cyclization of squalene to its 
epoxide and then to lanosterol. Reduction and demethylation of 
lanosterol results in the formation of cholesterol.
The rate of hepatic cholesterol biosynthesis is under dietary 
control. Exogenous cholesterol, transported to the liver as chylomicron 
remnants (formed by the removal of triacylglycerols) suppresses the 
activity of HMG-CoA reductase, while high fat (fatty acid/glycerol) or 
low cholesterol levels in the plasma stimulate it. In general, however, 
cells outside the liver and intestine obtain cholesterol from the plasma 
rather than synthesizing it de novo. Specifically their primary source 
is the cholesterol ester contained in low-density lipoproteins (LDL) 
formed by modification of VLDL in the plasma. Briefly, VLDL triacyl­
glycerols are removed by lipoprotein lipase (EC 3.1.1.34) action in 
capillaries to form intermediate-density lipoprotein (IDL) and the 
phospholipid and cholesterol constituents are transferred to high-density 
lipoprotein (HDL). The cholesterol of HDL is esterified by the action of 
plasma lecithin-cholesterol acyltransferase (LCAT; EC 2.3.1.43) with 
fatty acids derived from phosphatidylcholine, the major plasma phospho­
lipid, and the newly synthesized cholesterol ester is transferred back to 
IDL which undergoes lipolysis and removal of remaining triacylglycerols 
to form LDL (see review by Brown et al., 1981).
Studies with cultured human fibroblasts by Brown and Goldstein (1976, 
1979; review articles) have provided an insight into the mechanisms of 
LDL uptake and the regulation of cholesterol metabolism in extrahepatic 
tissues. LDL binds to specific cell surface receptors and the LDL- 
-receptor complex is internalized as endocytotic vesicles which rapidly 
fuse with lysosomes. The protein of LDL is hydrolyzed to amino acids, 
and the cholesteryl esters are hydrolyzed by a lysosomal acid lipase. 
The free cholesterol liberated into the cytosol plays a central role in
10
mediating feedback control, thus stabilizing cellular cholesterol 
content. This is achieved by suppression of HMG-CoA reductase, therefore 
limiting cholesterol synthesis, activation of acyl-CoA:cholesterol 
acyltransferase (ACAT; EC 2.3.1.26) allowing excess cholesterol to be 
re-esterified for storage, and inhibition of the LDL receptor, thus 
preventing further entry of LDL. The reduction of HMG-CoA reductase
activity is by inhibition of synthesis of new enzyme molecules rather 
than by direct allosteric inhibition and it occurs rapidly since the 
enzyme has a short half-life of about 3 hours (Brown et al_., 1973 and 
1974). In addition to receptor-mediated uptake, LDL-cholesterol can be 
taken up by non-specific pinocytosis (Goldstein & Brown, 1974), or by 
exchange with plasma membrane cholesterol (Bailey, 1965). However, 
neither of these mechanisms apparently results in net cholesterol 
accumulation or regulation of microsomal enzymes.
Smith et al. (1978) and Brown et al. (1981) provide detailed inform­
ation on the structure, metabolism and functions of the plasma lipo­
proteins.
1.1.4 Overview of lipid metabolism: integration with other 
intermediary metabolic pathways
The basic strategies of metabolism are (i) the formation of ATP, the 
universal unit of energy, generated by the oxidation of fuel molecules 
glucose, fatty acids and amino acids, and (ii) the provision of simple 
building blocks for the biosynthesis of more complex molecules. The 
common intermediate of most of these oxidative pathways is acetyl-CoA, a 
simple two-carbon carboxylic acid from which cholesterol and fatty acids 
are synthesized directly, these molecules in turn being precursors for 
steroid hormones, acylglycerols, phospholipids and other complex lipids. 
The driving force for the reductive biosynthesis of these lipids is
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NADPH, provided by cytosolic conversion of malate to pyruvate and by the 
pentose phosphate pathway (PPP). Thus lipids may be synthesized 
indirectly from two important non-lipid sources, amino acids and, in 
particular, glucose. In addition to providing acetyl-CoA for the de novo 
synthesis of lipids, glucose provides the glycerol backbone for the 
membrane phospholipids as well as acylglycerols.
Figure 1.5 illustrates these links between lipid and carbohydrate 
metabolic pathways. Many of the cytosolic reactions shown are readily 
reversible, although it should be emphasized that animals are unable to 
convert fatty acids into glucose since acetyl-CoA can not be converted to 
oxaloacetate or back to pyruvate. The flux of degradation products 
through the different pathways is strictly regulated by feedback control 
and hormonal actions, although a discussion of these complex events is 
not the purpose of this overview.
1.2 Embryonic lipid and energy metabolism
The principle energy source during early development of the rodent 
embryo is glucose. However, the metabolic fate of this fuel fluctuates 
considerably, particularly during the preimplantation period (see figure 
1.6). In the following two sections these changes in energy providing 
pathways are highlighted, providing an overview of the metabolic status 
of the embryo at different stages of development before describing 
what is currently known about embryonic metabolism of lipids, also a 
potential energy source.
1.2.1 Preimplantation embryonic metabolism
Following fertilization, the embryo undergoes a number of cleavage 
divisions to form the blastocyst which will implant in the uterine 
endothelium. Although no growth is associated with this period, there is
13
a marked increase in metabolic rates accompanied by increased util­
ization of glucose (see Pike, 1981). However, as reviewed by Clough
(1985), only pyruvate and lactate can maintain development up to the 
8-cell stage, energy being produced via their oxidative metabolism in the 
TCA cycle {Brinster, 1967b; Wales, 1975). Glucose is stored as glycogen 
since glycolysis is inhibited at 6-phosphofructokinase (EC 2.7.1.11) 
during this period in the rodent (Barbehenn, 1974) and during an equiv­
alent period in the human (up to day 3 post fertilization; Wales et al., 
1987). From the morula stage onwards glucose is increasingly metabolized 
via glycolysis, the resulting pyruvate being converted essentially to 
lactate with decreasing amounts being oxidized via the TCA cycle 
(Brinster, 1967a; Wales, 1969).
Figure 1.6
Diagrammatic summary of energy metabolism in rodent embryos (taken from 
Clough, 1985).
Recent quantitative determination of the PPP showed a similar decrease 
in glucose oxidative metabolism with development to the late blastocyst 
stage (O'Fallon & Wright, 1986).
Minor incorporation of 14C-bicarbonate (Wales et_ al., 1969), pyruvate
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(Wales & Whittingham, 1970) and glucose (Pike & Wales, 1972; Quinn & 
Wales, 1973) into lipids occurs during implantation, via metabolism to 
acetate, and/or glycerol. While glucose utilization increased, however, 
the proportion incorporated into the lipid fraction decreased with 
development. Flynn & Hillman (1978) showed that about 80% of lipids 
synthesized from glucose were triacylglycerols, while the remainder were 
glycolipids and phospholipids (68% phosphatidylcholine, 25% 
phosphatidylethanolamine); greater than 85% of the label was associated 
with the glycerol backbone of these lipids indicating a major flux from 
DHAP to diacylglycerol.
Mitochondrial activity during the preimplantation period allows the 
potential for p-oxidation of long-chain fatty acids as an additional 
source of energy. Fatty acid oxidation proceeds at a constant rate up to 
the 8-cell stage and then markedly increases with development to the late 
blastocyst (Flynn & Hillman,1980). This pattern appears to reflect a 
similar increase in oxygen utilization during the same period (Mills & 
Brinster, 1967). Flynn & Hillman (1980) showed that fatty acids are also 
readily incorporated by the early embryo for synthesis of complex lipids, 
especially triacylglycerols (83%) as well as polar lipids (74% as 
phosphatidylcholine) and minor amounts of free fatty acids and sterol 
esters. The major contribution of triacylglycerols and phosphatidyl­
choline to the total lipid composition of the pig oocyte (Homa et al., 
1986) corroborates these findings. It is proposed that the large stores 
of triacylglycerols, and also glycogen, are used to provide energy during 
implantation.
Pratt (1978, 1980, 1982) showed that de novo phosphatidylcholine
synthesis increased sharply from the 8-cell stage, and also demonstrated 
the synthesis of cholesterol from mevalonate, establishing that preimp­
lantation mouse embryos have the capacity to synthesize both major
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membrane lipids. Pratt (1982) estimated that the 3-fold increase in 
cholesterol content to the blastocyst stage, which contained lpmole, was 
accounted for by endogenously synthesized cholesterol, suggesting little 
or no utilization of maternal sources. Up to the morula stage, however, 
synthesized lanosterol was not converted to cholesterol, while HMG-CoA 
reductase activity was only detected in fully-expanded blastocysts. 
Cholesterol synthesis from acetate had been demonstrated in rabbit 
blastocysts by Huff & Eik-Ness (1966) confirming the expression of 
HMG-CoA reductase at this stage. These workers also showed that rabbit 
blastocysts were capable of certain steroidal hormone biotransform­
ations. While Dickmann and his colleagues produced histochemical 
evidence for the production of steroid hormones in the rabbit and also 
rat and mouse (see Dickmann et al., 1975 and references therein), direct 
evidence for steroid synthesis in the mouse using radiolabelled 
substrates (especially progesterone) is controversial. Chew & Sherman 
(1975) and Antila et al. (1977) could find no evidence for steroid 
hormone synthesis in the mouse prior to implantation, while a recent 
study by Wu (1987) contradicts these findings. Finally, there is 
some evidence suggesting that preimplantation rabbit and mouse embryos 
are capable of synthesizing prostaglandins (Dickmann & Spilman, 1975; 
Uehara et al., 1984), lipid hormones recently shown to influence glucose 
metabolism in the mouse blastocyst (Khurana & Wales, 1987).
1.2.2 Postimplantation embryonic metabolism
Implantation initiates "gastrulation", a period of extensive embryonic 
growth and differentiation with the formation of large fluid filled 
amniotic, exocoelomic and yolk sac cavities. A further critical period 
of differentiation marks the development of various organs, "organo­
genesis", during which time somitogenesis occurs and the yolk sac
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circulation followed by the allantoic circulation is established.
Glucose continues to be the major energy source and, as illustrated in 
figure 1.6, is predominantly converted to lactate. It is thought that 
oxygen supply to the embryo at implantation is low and oxidative meta­
bolism is probably negligible in vivo. The resulting high glycolytic 
flux thus allows for rapid generation of ATP, faster than it could be 
obtained from the more efficient oxidative metabolism, and this might be 
essential during and immediately after implantation (Ellington, 1987). 
In vitro at least, the PPP is the most active oxidative pathway and 
increases in activity during the pre-organogenesis period (Clough & 
Whittingham, 1983). During organogenesis itself, there is a switch back 
to increasing mitochondrial oxidative metabolism. TCA activity in the 
rat increases measurably at about 10.5 days of gestation, about the same 
time that the yolk sac circulation is established (Tanimura & Shepard, 
1970a). It is estimated that as much as half of the ATP equivalents 
generated by glucose catabolism could be provided by this pathway by the 
25 somite stage (Clough, 1985). At 10 days of gestation, i.e. just prior 
to the switch to oxidative metabolism, striking changes in mitochondrial 
structures and increased activities of TCA and oxidative phosphorylation 
enzymes are detectable (Hackler et al., 1971).
It is, therefore, interesting to speculate that fatty acids might 
become an important energy source to the postimplantation embryo as 
mitochondrial enzyme activities become expressed. Although oxidation of 
long-chain fatty acids has not been studied during this period, the 
ability of mouse embryos to oxidize p-hydroxybutyrate (presumably by the 
TCA cycle following conversion to acetyl-CoA via acetoacetate) increases 
during organogenesis (Horton et al., 1985). Fatty acid p-oxidation is 
certainly active during late gestation in the rabbit (Hudson & Hull, 
1977), and by term in the rat (Zimmermann et al., 1979).
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Although organogenesis-phase rat embryos are able to synthesize lipids 
from glucose (Tanimura & Shepard, 1970b), very little is known about 
embryonic lipid metabolism during this period of development. Carson et 
al. (1982) showed that the rate of cholesterol biosynthesis from acetate 
increased in mouse embryos cultured from the blastocyst stage through 
gastrulation, and demonstrated steroidogenic activity in these embryos. 
Tandon et al. (1983) detected steroid metabolites from androgenic
precursors in early postimplantation rabbit embryos, while Sheth et 
al. (1982) measured both oestrogenic and androgenic activities in rat 
visceral yolk sac homogenates. Thus, steroid hormone synthetic activity
appears to be established soon after implantation. Other lipid hormones, 
prostaglandins, which may aid regulation of blood flow to developing 
organs and/or affect differentiation, continue to be synthesized during 
organogenesis (Klein et al., 1981) and during later development (Chepenik 
& Greene, 1981). Chepenik and colleagues, using day 14 mouse embryo 
palate mesenchyme cells, showed that intracellular cyclic AMP levels 
regulate prostaglandin synthesis by inhibition of a phospholipase
responsible for release of arachidonic acid from membrane phospholipids 
(see Chabot & Chepenik, 1986). De novo synthesis of fatty acids and 
cholesterol from acetate, and their subsequent esterification, has been 
demonstrated in late-organogenesis stage rabbit embryos, although these 
were post-somitogenic and cultured in static, non-physiological
conditions (Beall & Klein, 1971; Beall, 1973).
1.2.3 The visceral yolk sac: role in embryonic nutrition
In the human, the chorionic placenta is the main organ of maternal-
-foetal exchange and the yolk sac is a comparatively rudimentary
structure. However, the human yolk sac is structurally complex and
prominent within the exocoelomic cavity at a time when the placenta is
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still imperfectly constituted and remains a conspicuous structure between 
the second and sixth week of gestation. It presumably functions by 
absorbing maternal products from the 'yolk' fluids for supply to the 
embryo (Gonzalez-Crussi, 1979). In rodents and lagomorphs the visceral 
yolk sac (VYS) is vital for the supply of nutrients to the implanted 
embryo until the chorioallantoic placenta becomes fully operational 
(ll-12th day of gestation in the rat). In these animals the yolk sac is 
inverted and surrounds the embryo, performing a placental function.
The mechanism by which many nutrients are absorbed by the VYS is 
active pinocytotic uptake (Williams et al., 1975arb; Roberts et al., 
1977; Duncan & Lloyd, 1978; Freeman & Lloyd, 1980). Uptake of serum 
proteins by the VYS has received particular attention. Whole embryo 
culture studies showed that radiolabelled proteins added to the media 
were captured by the VYS and digested by lysosomal enzymes, providing 
amino acids for the synthesis of new proteins by both the yolk sac and 
the embryo proper (Freeman et al., 1981; Freeman & Lloyd, 1983a). Subse­
quent studies have revealed that a wide spectrum of proteins is synthe­
sized and secreted by the VYS of different species; a-foetoprotein, 
transferrin, haemoglobin, IgG, ai-antitrypsin and several apolipoproteins 
(Janzen et al., 1982; Rhinehardt et al., 1984; Huxham & Beck, 1984; Shi & 
Heath, 1984; Meehan et al., 1984; Shi et, al., 1985; Williams et al., 
1986). Janzen et al. (1982) showed that a-foetoprotein and transferrin 
together represented up to 60% of the total protein secreted by the mouse 
VYS. The synthesis of apolipoprotein Al (ApoAl) specifically by the 
mouse yolk sac visceral endoderm, and not by the other extraembryonic 
tissues or the embryo proper, suggested that the VYS endoderm was a 
source of lipoproteins for the transport of lipids to the early post­
implantation embryo (Shi & Heath, 1984). Further evidence was provided 
by Meehan et al. (1984) who demonstrated the presence of high levels of
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ApoAl mRNA, and the synthesis of ApoAl, ApoAIV (components of HDL), and 
ApoB's and ApoE (components of LDL) in the mouse VYS, while the synthesis 
of ApoAl and ApoB has been shown in the human yolk sac (Shi et al., 
1985).
In addition to this non-specific fluid-phase pinocytotic uptake, the 
rat VYS is capable of receptor-mediated uptake of transferrin (McArdle & 
Priscott, 1984? Huxham & Beck, 1985) and IgG (Huxham & Beck, 1981? 
Laliberte et al., 1984). Although transferrin is hydrolyzed in the yolk 
sac, it is resynthesized in this tissue before transportation to the 
embryo. In contrast, maternal immunoglobulins do not undergo lysosomal 
proteolysis and are transported intact to the embryo.
These studies provided good evidence for the role of the yolk sac 
in the supply of nutrients to the embryo during the period of development 
before the chorioallantoic placenta is fully functional. Thus the VYS 
appears to have both a placental role and carry out hepatic-like 
functions. In addition, the rodent visceral yolk sac appears to function 
in the storage of energy providing glycogen (Ellington, personal 
communication) and triacylglycerols (Takeuchi, 1980) as well as 
cholesterol esters (Clarke & Brown, 1987b). Although much of the current 
knowledge pertaining to yolk sac function has been provided from studies 
using the whole embryo culture technique, comparative histochemistry of 
VYS endodermal enzymes suggested that the digestive and energy metabolism 
of this tissue was "almost identical in vitro and in vivo at 10.5 and
11.5 days" of gestation (Miki & Kuger, 1984).
The placental role of the VYS declines with the establishment of the 
chorioallantoic placenta. Carbohydrates, amino acids and minerals are 
transferred rapidly across the placenta (Yudilevich & Sweiry, 1985? 
Battaglia, 1986? Lester, 1986) while the amount of lipids (fatty acids 
and cholesterol) supplied to the foetus has been an area of controversy.
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Early studies by Goldwater & Stetten (1947) and by Popjak & Beeckmans 
(1950) suggested that the rat and rabbit foetus synthesized the subs­
tantial part of their lipids de novo and utilized only small amounts of 
maternally derived lipids. More recent studies have revealed that 
maternal fatty acids are readily available to, and incorporated by, the 
rodent foetus (Elphick & Hull, 1977; Hudson & Hull, 1977). Although the 
mechanisms of transport of maternal fatty acid and lipoprotein-carried 
lipid across the placenta remain largely unknown, it appears that the 
placenta resynthesizes and repackages maternally derived lipid 
hydrolysates before their release into the foetal circulation (Robertson 
& Sprechter, 1968; Elphick & Hull, 1984; Coleman, 1986).
1.3 Disturbances of intermediary metabolism as a mechanism 
of teratogenesis
Disruption of any process or pathway which is essential for normal 
growth and differentiation of the developing embryo will by definition 
lead to malformation. During organogenesis particularly the embryo 
undergoes rapid 'metamorphosis', accompanied by considerable metabolic 
changes. It is not surprising, therefore, that this period of develop­
ment is especially sensitive to external influences, and that apparently 
minor insults to the embryo at this time can result in irreversible 
structural damage. During this critical period, intermediary metabolism 
is one of many potential targets through which chemical teratogens might 
exert their toxic actions.
In one classic study, Freinkel et al. (1984) demonstrated the suscep­
tibility of the glycolytic organogenesis-stage embryo to inhibition of 
glycolysis (by the glucose epimer, mannose), prior to the onset of 
mitochondrial metabolism. Mannose was teratogenic during the first 24 
hours of a routine rat embryo culture (9.5-11.5 days e.a.) but not during
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the second 24 hours when oxidative respiration was established and the 
embryo was less dependent on glucose for energy. Similarly, inhibitors 
of mitochondrial enzymes only impair embryonic development from day 10 
onwards (Bass & Oerter, 1977).
Freinkel coined the term "fuel-mediated teratogenesis" to classify the 
embryotoxic actions of pathological fuel mixtures of maternal origin, 
particularly of diabetics. Diabetic serum, and its constituent high 
levels of glucose, ketone bodies and somatomedin inhibitors have all been 
shown to cause malformations, especially exencephalies, in cultured 
organogenic mouse embryos (Sadler, 1980a,b; Horton & Sadler, 1983; Balkan 
et al., 1988), presumably by interfering with the regulation of normal 
embryonic energy metabolism.
The disturbance of yolk sac mediated supply of nutrients to the embryo 
during organogenesis as a mechanism of teratogenesis was first demon­
strated with the lysosomal enzyme inhibitor Trypan Blue (Beck et al., 
1967), which was later demonstrated to inhibit pinocytotic uptake as well 
(Williams, 1976). These two yolk sac functions are particularly 
important for supplying amino acids to the embryo, the disruption of
which results in the production of malformations (Freeman et al., 1982;
Freeman & Lloyd, 1983b; Lloyd et al., 1985).
Chemical interference with lipid pathways can also result in abnormal 
development. The actions of specific inhibitors of cholesterol biosyn­
thesis are teratogenic both in vivo (Minsker et_ al., 1983) and in vitro 
(Jin et al., 1985), while hypolipidaemic drugs have also been shown to 
have a direct action on cultured rat embryos (Steele et al., 1983). 
Hypoglycin-A, a potent rodent teratogen, appears to inhibit mitochondrial 
(J-oxidation of fatty acids (Persaud, 1970), while the leucine analogue,
hypoglycin-B, exerts embryotoxicity by acting as a false substrate for
protein synthesis (Persaud, 1973).
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Since embryonic intermediary metabolism is sensitive to chemical 
influences it is likely that additional inborn errors of metabolism 
would accentuate this sensitivity. For example, one case report has 
associated defects in valine metabolism with physical malformations 
(Brown et al., 1982); deficiency of p-hydroxyisobutyryl CoA deacylase (EC
3.1.2.4) leads to the accumulation of methacrylyl-CoA, believed to 
inhibit mitochondrial functions. Similarly, infants born to women 
handicapped with phenylketonuria have a higher incidence of malformations 
(Drogari et al., 1987).
These studies illustrate that a thorough understanding of the normal 
embryonic metabolism is an essential requirement for the correct mechan­
istic interpretation of the actions of drugs and other chemicals on the 
embryo.
1.4 Whole-embryo culture; applications of the technique
The technique of whole-embryo culture (New et al., 1973; New, 1978)
has enabled easier study of both 'normal' and abnormal metabolic funct­
ioning of the early postimplantation rodent embryo. Using this system, 
the organogenesis-phase embryo can be maintained for a period of up to 
two days from the early head-fold stage to around the 26-29 somite stage, 
during which period embryonic growth and differentiation compares well 
with development in vivo (New et al., 1976). The practical details of 
this technique are described in Chapter 2, section 2.2.
Several factors favour the use of whole-embryo culture for the study 
of metabolism and the action of teratogens, (i) Embryos are cultured 
during the critical period of organogenesis, at which time there is a 
switch to a more oxidative metabolism and the vitelline circulation is 
established. (ii) Organogenesis is the period of development most
sensitive to disturbances by teratogens. (iii) Maternal factors are
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eliminated so that the direct action of a teratogen is investigated,
(iv) The technique gives a low background incidence of abnormalities, it 
is easy to perform, and results can be obtained rapidly, (v) Numerous 
end-points can be measured to assess development (Brown & Fabro, 1981). 
(vi) The culture conditions can be manipulated enabling various different 
approaches to assist a particular investigation.
Although the technique offers potential for screening compounds for 
teratogenicity (see Schmid, 1985; Schmid & Cicurel, 1986), in practical 
terms this is technically demanding (Brown & Freeman, 1984). Its use has 
been much more beneficial for studying embryonic metabolism and 
development, and mechanisms of teratogenesis. One approach to the former 
is to add compounds of known specific actions to the media to discover if 
the targeted pathway is important to normal development. Published 
studies using this approach have included the use of specific inhibitors 
of cholesterol biosynthesis (Jin e_t al., 1985), prostaglandin synthesis
(Klein et al., 1984), proteolytic enzymes (Freeman & Lloyd, 1983b?
Freeman & Brown, 1985) and mitochondrial cytochrome oxidase (Jager & 
Bass, 1975). The use of radioisotopes in whole-embryo culture is popular 
for studying both normal metabolic processes and the mechanisms under­
lying teratogenesis (Tanimura & Shepard, 1970b? Horton et al., 1985; 
Clarke & Brown, 1986; Coakley et al., 1986). Supplementation of the
culture media with excess (but sub-embryotoxic) levels of endogenous 
compounds has proved to be a useful approach to testing hypotheses 
(Ellington, 1980; Jin et al., 1985; Coakley & Brown, 1986). The use of 
serum prepared from dosed animals in whole-embryo culture has provided a 
useful tool for distinguishing between a direct action of a compound on 
the embryo and an indirect, maternally mediated effect (e.g., Steele et 
al., 1983). This approach has also proved particularly useful in the 
study of diabetes-induced teratogenesis (Sadler, 1980a; Sadler & Horton,
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1983). Similarly, human sera from patients receiving various medications 
has been used to assess the potential teratogenicity of therapeutic drugs 
(Chatot et al., 1980 and 1984) although the ability of human sera to 
adequately support rodent embryonic development is controversial (Steele, 
1985).
Whole-embryo culture is therefore highly adaptable to different
research strategies, providing a powerful technique for studying the 
related sciences of embryology and teratology.
1.5 Valproic acid: an overview
Valproic acid (VPA; 2-propylpentanoic acid) is a simple eight-carbon 
branched-chain fatty acid (MWt 144.2, pKa=4.73; fig. 1.7). It is used 
widely as an anticonvulsant in the treatment of epilepsy, particularly
typical absence seizures (Petit Mai), as well as partial and generalized
tonic-clonic (Grand Mai) seizures. Its primary pharmacological effect is
on the central nervous system and lacks significant cardiovascular, 
renal or respiratory effects (Pinder et_ al., 1977). However, its
structure is quite unlike the heterocyclic ring structures of conven­
tional anticonvulsants, e.g. hydantoins, barbiturates and benzodiaze­
pines.
CH3-CH2-CH2 0
\ //
CH-C 
/ Y 
CH3-CH2-CH2 OH
Historically, this colourless liquid was first synthesized in 1882 by 
Burton. The therapeutic value of the chemical, however, was not 
recognised until 1962 when Eymard used it as a solvent for investigating 
the pharmacological properties of some khelline derivatives (Meunier et 
al., 1963). The product was first marketed in France in 1967 as
Figure 1.7
Structure of valproic acid
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"Depakine", and has since been produced in the U.K. as "Epilim", and was 
approved by the U.S. Food and Drugs Administration (FDA) for the treat­
ment of Petit Mai epilepsy in 1978 (Chapman et al., 1982). Valproic acid
is commonly administered as the sodium salt in tablet form or as a syrup, 
although it also available as the magnesium and calcium salts. In
addition, the primary amide of valproic acid, valpromide (2-propyl-
valeramide; "Depamide"; fig. 1.8) which yields valproic acid in vivo
(valpromide is catabolized in the gut; Pisani et al., 1982) is also used
effectively as as anticonvulsant.
CH3-CH2-CH2 0 Figure 1.8
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The daily dosage of valproic acid varies between 5 and 40mg.kg_1 
depending on the severity of epilepsy (Browne, 1980), either alone or in
combination with other anticonvulsants. Valproic acid is absorbed
rapidly in the human, reaching peak plasma levels 1-3 hours after 
ingestion. As it is readily metabolized and has a half-life of about 10 
hours (range 5-20 hours), the drug is usually prescribed three times 
daily and reaches a stable concentration (0.35-1.0mM; Browne, 1980) in 
the blood 48 hours after therapy is commenced (Loiseau et al., 1975).
However, the drug has several side effects, the most serious being 
teratogenicity and potentially fatal hepatotoxicity. The following 
sections briefly describe the metabolism of valproic acid as well as its 
pharmacological, toxic and teratogenic properties. Particular attention 
has been given to the currently proposed and potential mechanisms by 
which valproic acid exerts its therapeutic and toxic actions.
1.5.1 Metabolism of valproic acid
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Metabolism in the adult The most recent review on the metabolism of 
valproic acid was by Granneman et al. (1984). In the adult many metab­
olites have been identified and the complex pathways of their formation 
elucidated. The major portion (as much as 70%) of valproic acid is 
conjugated to glucuronic acid via its hydroxyl group and excreted in the 
urine (Matsumoto et al., 1976). The other major metabolic pathway is via 
p-oxidation to the principal plasma metabolites 2-propyl-2-pentenoic acid 
(2-en-VPA) and 2-propyl-3-keto-pentanoic acid (3-keto-VPA). These two 
pathways predominate in both man and rat.
Other routes of valproic acid metabolism are relatively minor and 
include microsomal w- and w-1 oxidation to 5-OH-VPA and 2-propylglutaric 
acid, and to 4-OH-VPA, respectively. In providing evidence that these 
pathways are mediated by cytochrome P-450 enzymes, Prickett & Baillie 
(1984) discovered further that cytochrome P-450 mediated w-2 
hydroxylation was responsible for the production of 3-OH-VPA. Induction 
of microsomal enzymes by co-administered anticonvulsants such as pheno- 
barbital increase the metabolic plasma clearance of valproic acid 
(Heinemeyer et al., 1985). Mitochondrial conjugation of valproyl-CoA
with glycine occurs but is the least significant route and is apparently 
more important for the excretion of unsaturated metabolites. Many 
other minor metabolites are formed from secondary metabolic routes (see 
Kuhara & Matsumoto, 1974; Matsumoto et al.,1984; Granneman et a K , 1984; 
Rettenmeier et al., 1985).
Metabolism in the embryo/foetus Despite the formation of hydroxylated 
metabolites of valproic acid in human foetal tissues towards the end of 
the first trimester of pregnancy (Rettie et al., 1986), little or no
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metabolism of valproic acid has been detected during early organogenesis 
in cultured rat conceptuses (Brown, 1987; and see Chapter 4, section
4.4). This is probably due to the presence of only low levels of 
microsomal biotransformation enzymes (Pederson et al., 1985; Brown et
al., 1986) and low mitochondrial activity during this period of develop­
ment.
1.5.2 Anticonvulsant action
The abundance of literature pertaining to the therapeutic efficacy of 
valproic acid and its actions on the nervous system has been reviewed 
several times (see Pinder et. al., 1977; Browne, 1980; Chapman et al., 
1982, as well as references therein).
In spite of intense research, the mechanism or mechanisms by which 
valproic acid expresses its anticonvulsant properties remain unknown. Of 
the drug's many actions on the levels of transmitters and other
endogenous metabolites in the brain (see Chapman et al., 1982), its
ability to raise levels of gamma-aminobutyric acid (GABA) in the CNS has 
attracted most interest. Since GABA is an inhibitory neurotransmitter, 
high levels of this compound can prevent seizures. The increase in 
total brain levels of GABA is presumably by competitive inhibition of its 
degradation or via stimulation of its synthesis. While the concen­
trations of valproic acid required to raise GABA levels are greater than
those routinely measured in clinical practice, selective increases in 
GABA levels in specific areas, cells or cellular components (e.g. nerve 
endings), due to regional distribution of valproic acid in the brain have 
been proposed (e.g., Ciesielski et <Q., 1975).
In addition to valproic acid itself, its two principal unconjugated 
metabolites 2-en-VPA and 3-keto-VPA cause regionally selective and total 
brain increases in GABA levels, respectively, while 2-en-VPA also
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inhibited GABA degradation (Nau & Loscher, 1984). Although valproic acid 
itself was originally estimated to be responsible for more than 90% of 
the therapeutic effect, it appears that the trans-isomer of 2-en-VPA may 
contribute significantly to the antiepileptic action (Nau et al., 1984; 
Loscher et al., 1984; Loscher & Nau, 1985). More recent evidence
(Keane & Morre, 1985) suggests that the increase in brain GABA levels is 
not responsible for the anticonvulsant action since a number of other 
medium-chain fatty acids, namely propionate, isovalerate, pent-4-enoate 
and diallylacetate all increased total brain GABA levels although only 
diallylacetate possesses anticonvulsant action.
Finally, the mechanism of anticonvulsant action appears not to be 
the same as that proposed for hepatotoxicity (see below).
1.5.3 Toxicity
It is now known that valproic acid causes a large number of adverse 
side effects, including haematological, neurological, hepatic and 
gastro-intestinal abnormalities, as well as pancreatitis, alopecia and 
weight gain (see review by Turnbull, 1983). Severe hepatotoxicity is 
rare but is the most serious of these effects and can be fatal. Three 
clinical syndromes are associated with valproic acid hepatotoxicity: 
transient elevations of serum concentrations of liver enzymes (e.g. serum 
glutamic oxaloacetic transaminase), hyperammonemia, and acute hepato­
toxicity. The first two are common occurrences and patients improve by 
withholding or reducing valproic acid therapy. Acute hepatotoxicity, 
however, is serious and is most often seen in severely epileptic children 
during the first few months of therapy. Liver biopsies and autopsies 
have revealed major hepatocellular destruction with altered mitochondrial 
structures and accumulation of microvesicular lipids.
Although the mechanism(s) of hepatotoxicity are uncertain, valproic
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acid inhibits a number of intermediary metabolic pathways including fatty 
acid oxidation, fatty acid synthesis, gluconeogenesis, ureagenesis and 
oxidative phosphorylation, which are likely to be implicated. The 
majority of these actions may be explained by the conversion of valproic 
acid to valproyl-CoA, which leads to low cellular CoASH and acetyl-CoA 
levels and a high medium-chain acyl-CoA:CoASH ratio. Either valproyl-CoA 
itself or the sequestration of CoASH is thought to be responsible 
for metabolic inhibition. The high acyl-CoA:CoASH ratio is known 
to inhibit the mitochondrial synthesis of N-acetylglutamate which 
is required to activate the conversion of ornithine to citrulline, thus 
explaining valproic acid-induced inhibition of urea synthesis which 
results in hyperammonaemia (Coude ejt al., 1983a). Inhibition of pyruvate 
decarboxylase by valproyl-CoA limits the synthesis of oxaloacetate, 
thereby inhibiting gluconeogenesis (Turnbull et. al., 1983). In addition, 
gluconeogenesis from lactate, alanine and DHAP are all inhibited (Becker 
& Harris, 1983). Pyruvate oxidation is inhibited either by action on 
pyruvate dehydrogenase (Turnbull et. al., 1983) or by inhibition of the 
pyruvate carrier in brain and liver mitochondria (Benavides et a^., 
1982). Inhibition of fatty acid oxidation results in a Reyes-like 
syndrome (Gerber et al., 1979; Kuhara et al., 1985) with severe metabolic 
acidosis; in particular elevated production of C6-C10 dicarboxylic acids 
(Mortensen et al., 1980) and short-chain carboxylic acids (SCCA; Hillman 
et al., 1978). Inhibited ^-oxidation of palmitate (Shumate et al., 1981; 
Coude et al., 1983b), oleate, butyrate and acetate, but not octanoate 
(Becker & Harris, 1983) is believed to be mediated by valproyl-CoA 
possibly acting as a non-physiological substrate for, and thereby 
inhibiting, acyl-CoA dehydrogenase. Both octanoate and salicylate 
prevented the formation of valproyl-CoA and partially protected against 
inhibition of hepatic metabolic processes, suggesting that activation of
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valproic acid was required for its actions. In addition, ^-oxidation of 
fatty acids is weakly competitively inhibited by several other SCCA which 
form acyl-CoA esters in the mitosol (Holland & Sherrat, 1973). One of 
these, 4-pentenoic acid, may cause hepatic damage via a 
"suicide-substrate" mechanism (Schulz, 1983). The valproic acid 
metabolite 2-propyl-4-pentenoic acid (4-en-VPA), structurally similar to 
4-pentenoic acid, is metabolised by six pathways one of which includes 
the formation of an epoxide intermediate (Rettenmeier et al., 1985), 
which may explain the behaviour of 4-en-VPA as a suicide substrate 
inhibitor of cytochrome P-450 (Prickett et al., 1983). Reduced carnitine 
levels could be another mechanism for inhibition of fatty acid oxidation 
(Mortensen et al., 1980). Indeed, low plasma carnitine levels have been 
associated with valproic acid therapy and a study by Ohtani et al. (1982) 
showed significant inverse relationships between carnitine levels and the 
dose of valproic acid, and between the plasma carnitine levels and blood 
ammonia levels. Following oral administration of D,L-carnitine, both the 
carnitine deficiency and the hyperammonaemia were corrected. There is 
also some evidence for carnitine depletion by its excretion as 
valproyl-carnitine, as well as acetylcarnitine (Bohan et al., 1984; 
Murphy et al., 1985). Mitochondrial oxidative phosphorylation is also 
reduced by valproic acid (Haas et al., 1981; Rumbach ejt al., 1983).
While many of these studies were performed using isolated rat hepato- 
cytes or liver homogenates, the effective concentrations were usually 
£0.5mM, well within the plasma levels of patients receiving valproic acid 
therapy. Hepatic ultrastructure of animals treated with valproic acid 
show similar changes to those observed in human liver biopsies, notably 
altered mitochondria (Jezequel et al., 1984; Graf et al., 1985),
suggesting that the primary effect may be metabolic inhibition. It is 
interesting to note that Becker & Harris (1983) found no evidence for the
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formation of valproyl-CoA, or the depletion of CoASH in the brain, 
suggesting that valproic acid's anticonvulsant action is mediated via a 
different mechanism to that proposed for its hepatotoxicity.
Several other metabolic effects of valproic acid have been observed 
and might be implicated in its toxic mechanism. Inhibition of the 
movement of secretory vesicles in the rat liver (Bellringer et. al., 1988) 
appears to result in the accumulation of lipids, especially cholesterol 
and phospholipids (Jezequel et al., 1984). Addition of free-radical
scavenging agents to rat hepatocytes protected against toxicity by 
valproic acid, suggesting that lipid peroxidation was responsible for 
hepatotoxicity (Buchi et. al., 1984). Inhibition of intestinal folate
absorption leading to a deficiency of this compound (Hendel et. al., 1984) 
and inhibition of glycine metabolism (Jaeken et al., 1977) are other
possibilities.
1.5.4 Teratogenicity
Human studies Brown et al. (1980) first brought attention to the 
potential teratogenic hazard of valproic acid in humans. From animal 
studies they demonstrated a higher 'relative teratogenic index' for 
valproic acid than for phenytoin, an anticonvulsant already proven to be 
teratogenic in man (Loughan et al., 1973) and prompted the FDA to issue 
an alert for possible valproic acid-birth defect associations. Following 
this, several reports suggested that valproic acid did cause congenital 
malformations (see Jeavons, 1982; Editorial, 1982; Robert & Rosa, 1983) 
and particular attention was drawn to a higher incidence of neural tube 
defects, notably lumbro-sacral spina bifida (Lindhout & Meinardi, 1984). 
As a result of a recent analysis of prospective studies, Lindhout & 
Schmidt (1986) estimated that valproic acid produces neural tube defects
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in about 1.5% of first trimester exposures, about 5 to 20-fold higher 
than the general background incidence (Nau & Hendrickx, 1987).
A number of case reports (Editorial, 1982; DiLiberti et al., 1984; 
Jager-Roman et al., 1986) showed that valproic acid produces distinct
patterns of major malformations (skeletal, CNS, cardiovascular and 
urogenital tract) and minor malformations (facial and digit) in infants 
born to treated epileptic mothers.
Animal studies Valproic acid (either as the free acid or salt) produces 
an increased incidence of congenital defects in all laboratory species 
tested (rat, mouse, hamster, rabbit, dog and monkey. Whittle, 1976; Kao 
et al., 1981; Ong et al., 1983; Mast et al., 1986). Skeletal defects
(especially rib & vertebral) were observed in all species, while exen-
cephaly was found in mice and hamsters only.
Pharmacokinetic data The daily dose needed to elicit teratogenicity in 
animals (e.g. 200mg.kg“1 in the rat) is several-fold higher than the 
usual therapeutic doses ingested by man. Furthermore, the plasma 
clearance rate in humans is considerably slower than in animals (e.g. t% 
in the rat is only 0.3-1.0 hours; Nau, 1986c). Thus, it would appear 
that the human embryo is more vulnerable to the teratogenic actions of 
valproic acid than are embryos of animals. However, the free plasma
concentration of valproic acid, which is the important factor when
considering placental transfer and availability to the embryo, is 
considerably lower in man (5-15%) than other species (e.g. 40% in the rat 
and 60-90% in the mouse; Nau & Loscher, 1984). Similarly, it is the peak 
levels of free drug which are important to valproic acid-induced 
exencephaly, rather than the total drug exposure (Nau, 1985), and while 
such peaks levels are reached with teratogenic exposures in laboratory
33
animals, plasma concentrations of valproic acid fluctuate little in 
humans prescribed the usual therapeutic regimen. This suggests that 
particularly high therapeutic doses, especially as a result of single 
daily dose regimens which would give higher peak levels of free drug in 
humans, would more likely be associated with teratogenic risk than a 
multiple daily dosing regime (Nau, 1985).
Structure-teratoqenicity The high teratogenic potency of valproic acid 
is associated with strict structural requirements. Teratogenicity is 
abolished by removal of the carboxyl group, as demonstrated by the 
primary amide of valproic acid, valpromide in vivo (Nau & Loscher, 1986) 
and in vitro (see Chapter 4), or by the introduction of a double bond in 
the C2 or C3 positions (i.e. 2-en- and 3-en-VPA). Introduction of a 
double bond in the C4 position (4-en-VPA), however, has little effect on 
potency. Polar substitutions at C3, C4 and C3 positions also abolish 
activity, at least in vitro (Rettie et al., 1986). Also, a double alkyl 
substitution at C2 inhibits teratogenicity, suggesting the need for an 
a-hydrogen.
Studies by Brown et a^ . (1987) showed that strikingly similar dys- 
morphologies were produced by related SCCA. The potency of straight- 
-chain, saturated acids varied with chain-length, butyric acid being most 
potent (four carbon atoms), followed by propionic and pentanoic acids 
(three and five carbon atoms, respectively). Acetic and octanoic acids 
were inactive. A methyl substitution at the C2 position markedly reduced 
embryotoxicity in vitro, while large alkyl substitutions at this position 
appeared to counteract the reduction or even enhance potency
(e.g. 2-propyl-pentanoic acid {valproic acid}). While the introduction 
of a double bond in the C2 position (trans-2-pentenoic acid; equivalent 
to 2-en-VPA) abolished embryotoxic activity, a double bond in the C4
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position (4-pentenoic acid; equivalent to 4-en-VPA) had no effect.
In summary, a free carboxyl group, saturation of C2 and C3 positions, 
an alkyl substitution at C2 (greater than methyl), and an a-hydrogen are 
all requirements for valproic acid's teratogenic actions.
Direct action of valproic acid In addition to strict structural require­
ments, several other observations have led to the consensus that the 
intrinsic activity of valproic acid itself, and not one or more of 
its metabolites, is responsible for teratogenicity.
(i) Valproic acid metabolite levels in embryos following in vivo 
exposure to the drug are very low; usually <2% of corresponding valproic 
acid levels (Nau, 1986b).
(ii) Measurement of the major 2-en metabolite within the embryo showed 
that even high levels of exposure are not teratogenic (Lewandowski et
al., 1986; Nau, 1986a).
(iii) The major cytochrome P-450 hydroxylation and mitochondrial
(S-oxidation products do not appear to be teratogenic (Nau, 1986b; Rettie 
et al., 1986).
(iv) Phenobarbital increases valproic acid metabolism and concomitantly 
reduces teratogenicity. Thus mixed-function oxidase metabolism of
valproic acid appears to be a process of detoxication (see Nau &
Hendrickx, 1987).
(v) Valproic acid produces structural defects in cultured embryos (Kao 
et al., 1981) at a developmental stage when little drug-metabolizing 
activity is apparent. While endogenous SCCA such as butyrate and
propionate are extensively incorporated by the embryo, valproic acid is
apparently not metabolized (Brown et a1., 1985; Brown, 1987).
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Studies of potential mechanisms of teratogenic action
(i) Interference with zinc metabolism. Although valproic acid has been
shown to alter zinc concentrations in the foetus (Vorman et al., 1986), a
previous study in this laboratory demonstrated that zinc supplementation 
did not prevent valproic acid teratogenicity in cultured organogenesis- 
-stage rat embryos (Coakley & Brown, 1986).
(ii) Altered embryonic pH. Following observations that valproic acid
and other acids became concentrated within the relatively alkaline 
environment of the embryo (Nau & Scott, 1986), it was proposed that
valproic acid might alter embryonic pH, which would be detrimental to a
number of fundamental cellular functions (Scott et al., 1987). However, 
since the pKa values of non-teratogenic SCCA differ little from that of 
valproic acid, these acids probably also accumulate in the embryo, as 
demonstrated with 2-en-VPA (Lewandowski et al., 1986). Using the model
weak acid DMO (5,5-dimethyloxazolidine-2,4-dione), Brown (1987) was 
unable to detect a change in pH in rat embryos exposed to valproic acid
in culture, while more recent attempts to measure this hypothesized
phenomenon in vivo "did not yield any conclusive results" (Nau, personal 
communication, 1988).
(iii) Interference with folate metabolism. Teratogenic doses of 
valproic acid have been shown to reduce embryonic concentrations of 
certain folate metabolites (Wegner & Nau, 1986) whereas similar doses 
of 2-en-VPA had no effect (Wegner et al., 1987). Co-administration of
folinic acid reduced the incidence of valproic acid-induced exencephaly 
in mice from 43% to <20% (Trotz et al., 1987). These observations
support the view of Laurence et al. (1981) and others that periconcep- 
tional vitamin supplementation (folic acid, in particular) may reduce the 
risk of neural tube defects in humans.
(iv) Interference with intermediary metabolism. The changing metabolic
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profile of the embryo during organogenesis is particularly sensitive to 
the actions of chemical agents. Since valproic acid can inhibit several 
metabolic pathways in the adult, research in this laboratory has examined 
the possibility that valproic acid exerts similar actions on embryonic 
metabolism. However, Brown et al. (1985) showed that valproic acid was 
probably not metabolized to valproyl-CoA and did not deplete cellular 
CoASH levels in the cultured embryo, demonstrating that the teratogenic 
mechanism differed from that proposed for valproic acid's hepatotoxic 
actions. Further studies with cultured embryos failed to measure any 
effect on either glycolysis, visceral yolk sac pinocytosis or DNA 
synthesis (Coakley et al., 1986).
1.6 Rationale for studying embryonic lipid metabolism and 
the potential actions of valproic acid
Since some chemicals express embryotoxicity through their actions 
on intermediary metabolism a good understanding of these pathways 
is essential if we are to establish which areas of metabolism are 
particularly sensitive to disturbance and learn more about basic mechan­
isms of teratogenesis. In particular, very little is known about 
embryonic lipid metabolism during the critical organogenesis period of 
mammalian development at which time the embryo is most vulnerable to 
insult from such chemicals.
While it appears that valproic acid does not inhibit embryonic 
intermediary metabolism by a mechanism similar to that proposed for 
its hepatotoxic actions (Brown et al., 1985), this does not discount
potential actions on embryonic metabolism via other mechanisms, since 
pathways may be different from those in the adult. The lipid properties 
of valproic acid and the similar dysmorphogenesis produced by this drug 
and structurally related SCCA in vitro, suggest that embryonic lipid
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pathways are possible targets for disruption by valproic acid.
Previous work in this laboratory (Coakley et al.f 1986) studied the 
potential action of valproic acid on glycolysis and other metabolic
processes during an 8 hour exposure period from the 16th hour of culture
(see fig. 1.9). Valproic acid produces a wide spectrum of structural
defects which may be manipulated by different exposure periods. However, 
conceptuses exposed to 1-1.5mM valproic acid during 16-24 hours of
culture develop somite abnormalities observable at 48 hours. These 
defects appear to be identical to those induced by valproic acid treat­
ments in vivo, which lead to rib and vertebral malformations at term 
(Brown & Colhoun, 1984). Since valproic acid is apparently not incorp­
orated and diffuses out of the embryonic compartment upon removal of 
treatment (Brown, 1987), these defects must be the result of insult(s) 
initiated during the exposure. Thus, the initial biochemical changes in 
the pathway to malformation should be detectable by the end of this 
treatment period.
Figure 1.9
Experimental protocol used to examine initial embryonic responses
during a teratogenic exposure to SCCA.
Early head-fold stage Flexion stage 26-29 somite stage
9.5 (days e.a.) 10.5 11.5
{Exposure I
0 (hours in 16 
culture)
24 48
Addition of Biochemical
Conceptuses radioisotope analysis
explanted ± teratogen of conceptuses
Structural
defects
observed
The same protocol has therefore been employed for many of the studies 
conducted during the course of this research.
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The following chapters present investigations on lipid metabolism 
in the organogenesis-phase rodent embryo and observations of valproic 
acid's actions on these pathways.
Some of the work has been published (Clarke & Brown, 1986 and 
1987a,b).
Chapter 2 
MATERIALS AND METHODS
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2.1 Materials
2.1.1 Drugs
2-Propylpentanoic acid (valproic acid, VPA) and n-butyric acid (each 
>98% pure) were purchased from Aldrich Chemical Co. Ltd., Gillingham, 
Dorset. Dipropylacetamide (valpromide) was provided by Sanofi Pharma 
International S.A., Paris, France (lot E 001) and by Sanofi Centre De 
Recherches Clin Midi, Montpellier, France (lot 5SNS 264). Mevinolin was 
donated by Dr A. W. Alberts, Merck Institute for Therapeutic Research, 
NJ, USA, and d.1-4.4,10-B-trimethyl-trans-decal-3-B-ol (TMD) was a gift 
from Prof. T. A. Spencer, Dartmouth College, NH, USA.
2.1.2 Radiochemicals
The following radio-labelled chemicals were purchased from New England 
Nuclear (NEN; Du Pont), Dreieich, FRG:
[3H]acetic acid, sodium salt (100 and 130mCi.mmol-1),
[2-14C]acetic acid, sodium salt (51 and 58mCi.mmol-1),
[9,10-3H(N)]oleic acid (5.3Ci.mmol-1),
[14C(U)]palmitic acid (800mCi.mmol-1) and 
[1,2-3H(N)]cholesterol (51.9 and 58.0Ci.mmol-1).
Tritium (hydrogen-3) {tritiated water} (5Ci.ml-1),
D-fu-14C]glucose (270mCi.mmol-1),
n-[i-i4c]butyric acid, sodium salt (56mCi.mmol-1) and
[2-14C]diethylmalonate (lOmCi.mmol-1), were purchased from Amersham 
International pic, Amersham, Bucks.
[2-14C]Valproic acid (lOmCi.mmol-1) was kindly prepared by Dr P. Farmer, 
MRC Toxicology Unit, Carshalton, Surrey, from [2-14C]diethylmalonate, by
the method of Ranade and Alter, 1980.
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2.1.3 Reagents
Culture media Minimum essential medium Eagle with Earle's salts (MEM), 
L-glutamine; Imperial Laboratories (Europe) Ltd., Salisbury, Wiltshire. 
Hanks' balanced salt solution (HBSS); Gibco Europe Ltd., Paisley, 
Renfrewshire. Antibiotics; Evans Medical Ltd., and Glaxo Laboratories 
Ltd., Greenford, Middlesex. D-Glucose; British Drug Houses (BDH) Ltd., 
Dagenham, Essex. A 5<6)-cholestene-3p-01, cell culture tested (99% 
pure); Sigma Chemical Co. Ltd., Poole, Dorset. Compressed gases; British 
Oxygen Corporation, London.
Enzymes Horseradish peroxidase, grade 1 (EC 1.11.1.7; 2500iu.mg_1), 
cholesterol oxidase (EC 1.1.3.6; 45iu.mg~1), cholesterol esterase
(EC 3.1.1.13; BBiu.mg"1); Boehringer Mannheim, GmbH, FRG. Acetate kinase 
(EC 2.7.2.1; 170iu.mg-1); Sigma Chemical Co. Ltd..
Lipid standards Fatty acid, fatty-acylglycerols, fatty acid esters (all 
oleic derivatives), sterols, phospholipids (1-a-phosphatidyl choline and 
sphingomyelin); Sigma Chemical Co. Ltd.. Other phospholipids; Koch-Light 
Laboratories Ltd., Colnbrook, Bucks.
Solvents and common laboratory reagents from BDH Ltd.; Sigma Chemical 
Co. Ltd.; Aldrich Chemical Co. Ltd.; Fisons pic, Loughborough, Leicester­
shire ; May & Baker Ltd., Dagenham, Essex; James Burrough Ltd., Witham, 
Essex; Hopkin & Williams Ltd., Chadwell Heath, Essex.
Other reagents Electra HR buffer, lipoprotein stain; Helena Labora­
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tories (UK) Ltd., Gateshead, Tyne and Wear. Mazola pure corn oil; CPC 
(UK) Ltd., Paisley, Renfrewshire. Liquid scintillation cocktails: 
'Monofluor', National Diagnostics, Manville, NJ, USA; 'Ready-Solve MP’, 
Beckman-RIIC Ltd., High Wycombe, Bucks.
2.1.4 Apparatus and equipment
Chromatography and electrophoresis Silicic acid, TLC developing tank; 
Sigma Chemical Co. Ltd.. 'Merck' TLC sheets; BDH Ltd.. Shandon paper 
chromatography developing tank; Payne Scientific Apparatus, Slough, 
Berks. Filter papers; Whatman LabSales Ltd., Maidstone, Kent. Titan 
III-lipo cellulose acetate plates, electrophoresis chamber, sample wells 
and applicators; Helena Laboratories (UK) Ltd..
Plastic ware Sterile pastettes, culture dishes, centrifuge tubes and 
containers: Sterilin Ltd., Hounslow, Middlesex; Falcon, Becton Dickinson 
UK Ltd., Cowley, Oxford. Micro-cuvettes; Elkay Laboratory Products, 
Basingstoke, Hants. Mini-scintillation vials; Gordon Keeble Ltd., 
Watford, Herts. Micro-centrifugation tubes; Sarstedt, FRG. MF-Millipore 
filters; Millipore (UK) Ltd., Harrow, Middlesex.
Other equipment MPS-1 micropartition system; Amicon Ltd., Stonehouse, 
Gloucestershire. Visking dialysis tubing; Gallenkamp, Loughborough, 
Leicestershire. Watchmakers forceps; Ideal-Tec, Switzerland. Sovirel 
culture bottles; R. & L. Slaughter, Romsford, Essex. 'Spiromix 10’ 
haematological rollers; Denley Instruments Ltd., Billingshurst, Sussex. 
Tissue culture incubator; Astell Hearson, Catford, London. Sonifier, 
model B-15; Branson Ultrasonics, Shipley, W. Yorks.
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2.2 Methods A; post-implantation whole-embryo culture
The procedure of whole-embryo culture has been documented many times 
since D.A.T. New of Cambridge University reviewed his technique in 1978. 
Freeman et al (1987), however, present an up-to-date and detailed review 
of the practical aspects involved in embryo culture, as used in this 
laboratory. The following pages offer a brief description of the 
technique and of modifications relevant to studies of lipid biochem­
istry.
2.2.1 Culture media
Whole conceptuses were routinely cultured in a medium of 75% immed­
iately-centrifuged, heat-inactivated rat serum and 25% MEM. In a few 
studies, however, 100% serum, or 100% MEM were used; a description of the 
use of these alternative media is given in the 'experimental design' 
sections when appropriate. The addition of antibiotics, penicillin and 
streptomycin, to the media was not routine, being used only for chol­
esterol supplementation studies.
Collection and preparation of serum Serum for use in embryo culture was 
prepared from adult, male Lac:P rats (250-500g). Rats were anaesthetized 
with diethyl ether and 10-20ml of blood collected from the aorta into a 
syringe. The blood was immediately dispensed into ice-cold sterile 
plastic screw-cap centrifuge tubes and spun at 2000g for 3 minutes. 
After then allowing the serum to clot at room temperature, the serum was 
squeezed from the clot using forceps and the fibrinous material dis­
carded. The tubes were then re-centrifuged at 2000g for 5 minutes and 
the serum decanted by pipette into sterile 30ml screw-cap polystyrene 
containers. The serum was stored at -20°C for up to 2 weeks.
Before using the serum in culture, it was thawed at 37°C and the comp­
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lement within the serum inactivated in a 56°C water bath for 30 minutes. 
During heat-inactivation the container cap was loosened to allow ether to 
evaporate. Finally, the serum was centrifuged at 2000g for*10 minutes to 
sediment any precipitated material.
2.2.2 Animals
Inbred, F344/Tru rats were used in all studies (with the exception of 
initial investigations of lipid synthesis over the 48 hour culture period 
when random outbred Lac:P rats {Wistar derived Porton strain} were used; 
Chapter 3, section 3.2, and Chapter 4, section 4.2). Animals were housed 
in cages in a well ventilated breeding room which had a light/dark cycle 
of 14/10 hours. Rats had free access to water and commercial pelleted 
food.
For mating, 2 females were caged with 1 male overnight and mating 
was confirmed the following morning by examining females for the presence 
of a vaginal plug. Coitus was assumed to have occurred at the midpoint 
of the dark cycle (midnight) and fertilization 2 hours later. The 
morning of plug detection, therefore, indicated the first day of preg­
nancy (embryonic gestation day one) and embryonic ages (e.a.) used 
throughout this thesis were calculated from the presumed time of fertil­
ization (zero time, 2 a.m.).
2.2.3 Explantation and culture procedures
Conceptuses were explanted for culture at various stages of develop­
ment from 9.5-11.5 days e.a. (10th-12th day of gestation). The precise 
age of embryos at the beginning of a particular culture is described in 
the 'experimental design' sections of the following results chapters.
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Explantation Pregnant females were killed by gassing with carbon 
dioxide. The ventral body wall was opened, the uterus exposed and the 
cervix cut. The uterus was lifted with forceps and removed by cutting 
each horn immediately below its oviduct. Excess adipose tissue surround­
ing the uterus was trimmed off. The uterus was layed out in a straight 
line on a piece of tissue paper and the antimesometrial side of the 
uterine wall opened along its entire length, taking care not to damage 
the underlying embryos by keeping the scissor points raised. Using 
forceps, each implant or 'decidua' was carefully freed of its surrounding 
uterine wall and cut from the uterus together with its placenta. The 
decidua were submerged in warm (37°C) HBSS for dissection, which was 
carried out with the use of a binocular microscope and watchmakers 
forceps under the sterile conditions of a down-flow, air ventilation 
unit.
The placenta was removed and the pear-shaped decidua gently torn apart 
along its midline to reveal the conceptus implanted in one of its 
halves. The conceptus was removed by gently pulling it away from the 
decidua half and dissecting the connecting decidual/trophoblastic 
tissue. Reichert's membrane and as much of the trophoblast of the 
ectoplacental cone as possible was removed and the conceptus transferred 
to fresh, warm HBSS for a final examination.
Culture of whole embryos Whole rat embryos were cultured by modif­
ications of the roller-bottle technique first described by New et al., 
1973.
Before putting the embryos into culture they were checked for damage 
and for assessment of developmental stage. Within a single litter the 
precise stage of development varies, particularly at the head-fold 
stage. The possible effect of this variation on the experimental end
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result was minimized by dividing similar stage embryos equally between 
control and treatment groups.
Conceptuses were then transferred to one of the following vessels 
containing a volume of warm (37°C) culture medium (see section 2.2.1) 
gassed with an appropriate mixture of O2 , N2 and CO2 (see below): (a) 
50ml screw-cap Sovirel boroscilicate bottles with 4ml medium, (b) 5ml 
polypropylene mini-scintillation vials with internal-fitting ribbed lids, 
containing 1ml medium, or (c) 2.5ml round-base polystyrene centrifuge 
tubes (65mm x 10mm) with push lids, containing 200-250pl medium. The 
choice of culture vessel was dependent on the type of experiment and the 
period of culture (refer to 'experimental design' sections). Generally, 
50ml Sovirel bottles were used for culturing head-fold stage embryos 
(9.5 days e.a.) for 24-48 hours, while minivials and 2.5ml centrifuge 
tubes were used for shorter culture periods of 3-8 hours. Occasionally, 
head-fold stage embryos were cultured overnight in Sovirel bottles and 
then transferred to a smaller vessel for a period of treatment, after 
which the embryos were either harvested, or washed and replaced into 
bottles containing fresh medium for a further period of culture. The 
number of conceptuses cultured in a particular vessel varied again 
according to the type and duration of experiment. Usually, a maximum of 
3 head-fold stage embryos were cultured in bottles for the full 48 hours, 
while up to 15 embryos of the same stage developed normally in one bottle 
overnight. Between 2 and 20 conceptuses were cultured in single vessels 
for shorter times.
The sealed vessels were rolled for the duration of the experiment 
on motor-driven haematological rollers in standard anhydric tissue 
culture incubators at 37-38°C.
As the embryos requirement for oxygen increases with age, the oxygen 
tension of the gas phase becomes critical for normal development.
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Therefore, the gas phase in the vessels was appropriately maintained 
depending on the developmental stage of the embryos being cultured. 
Head-fold stage embryos (9.5 days e.a.) were cultured in an initial gas 
phase of 5% O2 (5% CO2 , balance N2 ), which was increased to 20% O2 at 16 
hours of culture and to 40% O2 at 24-26 hours. Initial gassing of the 
vessels was for 5 minutes and re-gassing was for 2 minutes. Embryos 
explanted at later developmental stages were cultured in the appropriate 
atmosphere.
At the end of culture embryos were harvested for biochemical analysis 
and/or assessment of embryonic development.
2.2.4 Evaluation of embryonic development
At the end of a standard 48 hour culture the following parameters 
of embryonic growth were routinely recorded: visceral yolk sac diameter, 
crown-rump length, head length and number of somite pairs. In addition, 
any morphological anomalies were noted and the overall morphology of the 
embryo was optionally assessed using the ‘morphological scoring system* 
devised by Brown and Fabro, 1981. Conceptuses harvested for biochemical 
analysis at earlier ages were also examined for abnormalities while 
embryonic development was assessed by the number of somite pairs. The
protein contents of embryos and yolk sacs were routinely measured
on whole tissues or aliquots of tissue homogenates.
2.2.5 Preparation of drugs and chemicals for addition to the
culture medium
Preparation of drugs
(i) Short-chain carboxylic acids. Valproic acid and butyric acid were 
added to cultures as their sodium salts. Acids were mixed with equimolar
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amounts of sodium hydroxide and the neutral solutions diluted with HEM to 
20mM stock solutions. The pH was checked and adjusted to 7.4 if 
necessary.
(ii) Valpromide was dissolved directly into prepared rat serum to a 
maximum stock concentration of l^lmg.ml-1.
(iii) Hevinolinic acid was added to cultures as the sodium salt. Sodium 
mevinolate was prepared from mevinolinic acid lactone by alkaline 
hydrolysis in ethanol, lmg mevinolin was dissolved in lOOpl ethanol, 
mixed with lOOpl sodium hydroxide (0.1N) and heated at 56°C for 2 hours. 
The solution was diluted with MEM to 1ml final volume and the pH adjusted 
to 7.4 with 0.1N hydrochloric acid. The final amount of ethanol added 
to the culture medium was * 0.15pl.ml_1.
(iv) TMD was dissolved in ethanol (100pg.pl) and diluted with MEM. The 
final amount of ethanol added to the culture medium was £ 0.75pl.ml-1.
Preparation of radiochemicals
(i) [3H]acetate and [2-14C]acetate were purchased in ethanol solution. 
Before use, the solvent was evaporated under a stream of nitrogen and the 
labelled salt redissolved in a suitable amount of MEM.
(ii) [9,10-3H]oleic acid, also in ethanol solution, was dried under 
nitrogen and redissolved directly into prepared serum.
(iii) [1,2-3H(N)]cholesterol was purchased in benzene solution. 
Aliquots were transferred to sterile 6ml screw-cap, glass bottles and 
dried down under nitrogen so that the label was deposited as a thin film 
on the bottle walls. Prepared rat serum (or low-density lipoproteins; 
see section 2.3.2.) was added and the bottles incubated (37°C) overnight 
on haematological rollers. (Modified from the method of Bailey and 
Butler, 1973.)
(iv) Tritiated water and D-tU-14C]glucose were added directly to
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cultures.
(v) [2-14C]Valproic acid, neutralized with an equimolar amount of sodium 
hydroxide, and n-[I-14C]butyric acid, sodium salt, were added directly to 
the culture medium.
Preparation of other chemicals
(i) Antibiotics. 48mg (6.67 x 104iu) Crystopen (sodium benzylpeni- 
cillin) and 40mg streptomycin sulphate were dissolved in 10ml MEM and 
filtered through 0.22pm-pore-size filters. This stock solution was 
stored in a 30ml sterile polystyrene container at 4°C. 12.5pl of stock 
solution was added to 1ml final volume of culture medium to give final 
concentrations of lOOiu penicillin and 50pg streptomycin per ml media.
(ii) Cholesterol. 20mg A a<6>-cholestene-3p-01 (cholesterol) was 
suspended in 1ml pure corn oil by sonication, using the tip of an 
ultrasonic generator. Up to 250pl of the suspension, or corn oil alone, 
was mixed with 1ml prepared serum by brief sonication and rolling for 30 
minutes to give a homogeneous preparation. 1ml of the serum-corn oil or 
serum-corn oil-cholesterol preparations was added to culture bottles 
containing 2ml serum and 1ml MEM, and the bottles rolled for 1 hour prior 
to embryo culture. For minivials, volumes were % of those stated.
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2.3 Methods B; analytical techniques
2.3.1 Lipid extraction and analysis
Preparation of biological material At the end of culture conceptuses 
were removed from the culture media into petri dishes containing ice-cold 
saline solution (0.15N). The visceral yolk sac and embryo proper were 
dissected apart (the amnion ana trophoblast tissue being discarded in the 
process) and washed thoroughly in several changes of cold saline solu­
tion. Single yolk sacs and single embryos were treated as separate 
samples, or yolk sacs and embryos from an individual culture unit were 
pooled, providing a total yolk sac sample and a total embryo sample. The 
pooled tissues were transferred in a drop of the final wash into 1.5ml 
microtubes and centrifuged for 30 seconds in a Hettich microfuge. Excess 
saline was aspirated using a finely pulled glass pipette and the 'pellet' 
covered with 20pl of saline solution.
This thorough washing process was essential to remove unincorporated 
label, and in the case of samples being prepared for the determination of 
cholesterol, to remove media serum.
Samples were usually processed immediately, but could be stored for 24 
hours at 4°C if required.
2.3.1.1 Extraction of total lipids
The isolation and purification of total lipids from yolk sac(s) and 
embryo(s) was achieved, essentially, by a micro-version of the method 
described by Folch et al., 1957.
Reagent preparations Rat liver homogenate: 25% homogenate in 50mM 
potassium phosphate buffer, pH 7. Carrier sterols: stock solution
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containing 5mg each of unlabelled cholesterol, lanosterol and squalene 
per ml of chloroform:methanol, 1:1 (v/v). Pure solvents upper phase
(containing 0.29% NaCl): chloroform, methanol and 0.58% NaCl in the
proportions 8:4:3 by volume were mixed, the two phases separated by 
centrifugation, and the upper phase retained.
Procedure Methanol (180pl) was added to each sample and the tissues 
homogenized by sonication, using the micro-tip of an ultrasonic 
generator. Homogenates were resuspended by vortex mixing and lOpl 
aliquots taken for the determination of tissue protein content (section
2.3.3.3). Rat liver homogenate (32pl) was added to each sample to
provide carrier lipid during extraction and for subsequent analysis by 
TLC. Alternatively, 5pl of carrier sterols was added when samples were 
to be analysed for sterol composition. Chloroform and methanol were
added to a final ratio of 2:1 v/v in 1ml final volume, and lipids
extracted overnight at 4°C on a rotary mixer.
Samples were centrifuged for 10 minutes in a Hettich microfuge and the 
supernatants, or 'crude lipid extracts', transferred to clean microtubes 
using pulled glass pipettes. Crude extracts were mixed thoroughly with 
0.2 volumes (200pl) of 0.73% NaCl, and the mixture allowed to separate 
into two phases by standing, followed by a final 2 minute centrifug­
ation. The upper, aqueous phase was removed by pipette and the lower, 
organic phase was carefully rinsed with two consecutive 200pl volumes of 
pure solvents upper phase to yield the pure lipid extract.
An extraction efficiency of £97% was achieved with this method.
2.3.1.2 Extraction of sterol lipids
Sterol lipids were isolated by a modification of the method used by 
Pratt, 1982.
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Procedure Purified lipid extracts in 1.5ml microtubes were evaporated to 
dryness under a stream of nitrogen and redissolved in lOOpl ethanol. 
300m1 digitonin solution {0.1% digitonin in 90% ethanol {w/v}) was added 
and the mixture left in the dark at room temperature overnight. The 
precipitates of digitonides formed were sedimented by centrifugation for 
10 minutes in a Hettich microfuge and the supernatants carefully removed 
by pipetting. The digitonide pellet was rinsed once with 50pl ethanol 
(without resuspending) and then dissolved in lOOpl hot (56°C) DMSO. 
Sterols were extracted twice into 1ml volumes of hexane, and the combined 
extracts dried down and redissolved in 25pl chloroform for TLC analysis.
This procedure extracted 78-92% (83.9 ± 4.3%, mean ± S.D., 20 determ­
inations) of a standard sample (1 x 103 dpm.) of [3H]cholesterol.
2.3.1.3 Separation of phospholipids and neutral lipids
Phospholipids were isolated from lipid extracts essentially as 
described by Dittmer and Wells (1969).
A silicic acid column was prepared by pouring Ig of SIL-LC silicic
acid, 325 mesh (prewashed with methanol and diethyl ether) into a 5ml 
graduated syringe barrel (12mm i.d.) plugged with Pyrex glass wool, and 
washed with 2ml petroleum ether and 3ml chloroform. With the solvent 
level at the top of the column, a lipid extract in 30pl chloroform was
applied down the sides of the column and quantitatively washed into the
column with two 200pl aliquots of chloroform. The column was eluted at a 
flow rate of 0.5ml.min"1, with 20ml chloroform, followed by 20ml 
methanol, the eluant being collected in 10ml conical-bottomed, ground 
glass stoppered test tubes.
The effluent containing the original chloroform solution, washes and 
chloroform eluant contained neutral lipids while the more polar methanol 
eluant contained phospholipids and small amounts of glycolipids.
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2.3.1.4 Thin-layer chromatographic analysis of lipid 
preparations
Reagent preparation Lipid standards: sterols, other neutral lipids 
(oleic acid derivatives) and phospholipid standards were prepared as 
lOmg.ml-1 stock solutions in chloroform:methanol, 2:1 (v/v).
Procedure Lipid samples (total extracts, sterol extracts, or 
phospholipids) dried down and redissolved in 30pl chloroform:methanol, 
2:1 (v/v), were applied 2cm from the bottom of precoated silica gel 60, 
aluminium backed TLC sheets (20cm x 20cm; layer thickness 0.2mm). 
Applications were as a 1cm band along the line of origin, approximately 
1.8 cm apart, enabling 8 samples to be analysed on a sheet. Between 50 
and lOOpg of appropriate unlabelled standard lipids were also applied to 
each sheet. Samples were allowed to dry completely before 
chromatographing.
Chromatography was carried out in a Sigma TLC glass developing tank 
(27.5cm x 27.5cm x 7.5cm, i.d.) fitted with a glass lid. The tank was 
lined with filter paper which was then wetted with the appropriate 
developing solvent (see below) to aid in saturating the tank with 
solvent vapour; in total, 100ml of developing solvent was poured into the 
tank. The tank's rim was lightly smeared with vaseline, the lid sealed 
and the tank allowed to equilibrate for 20 minutes before immersion of 
the chromoplate.
The chromoplates were developed until the solvent front had ascended 
to the desired height; usually within 1cm of the top of the sheet, but 
3-5cm from the top with the phospholipid's developing solvent.
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The following developing solvents were used:
(a) Neutral lipids developing solvent
Petroleum ether : diethyl ether : glacial acetic acid, 80:20:1, by
volume (Wood et al., 1964). Running time approximately 50 minutes.
Rf values (means of 13 determinations) of standard lipids: phospholipids, 
at origin; monoacylglycerols, 0.02; 1,2-diacylglycerols, 0.04; chole­
sterol and 1,3-diacylglycerols, 0.07; fatty alcohols and lanosterol, 
0.10; fatty acids, 0.20 (0.13-0.28); triacylglycerols, 0.39; fatty acid
methyl/ethyl esters, 0.46; cholesterol esters (and squalene), 0.62; 
squalene, 0.68. See figure 2.1 overleaf.
(b) Sterol lipids developing solvent
Petroleum ether : diethyl ether : glacial acetic acid, 40:60:1, by
volume (Bowyer and Davis, 1976). Running time approximately 1 hour.
Rf values (means of 6 determinations) of standard lipids: cholesterol, 
0.31; lanosterol, 0.41; squalene, 0.74.
(c) Phospholipids developing solvent
Chloroform : methanol : glacial acetic acid : distilled water, 25:15:4:2, 
by volume (Skipski et al., 1964). Running time approximately 2£ hours.
Rf values (means of 3 determinations) of standard lipids: lysophosphos- 
phatidyl choline, 0.12; sphingomyelin, 0.20; phosphatidyl choline, 0.32; 
phosphatidyl serine, 0.64; phosphatidyl ethanolamine, 0.85.
Figure 2.1
Thin-layer chromatogram of neutral lipids.
Total lipid extracts (with rat liver carrier) were 
separated with neutral lipids developing solvent and 
visualized with iodine vapour. Individual lipid
classes were identified against standards (oleyl
derivatives) and isolated (fractions 1-12) for analysis 
by LSC. Standards: C, cholesterol; CEr cholesterol 
esters; DG, diacylglycerols; FA, fatty acids; FAE,
fatty acid alkyl esters; Foh, fatty alcohols; TG, 
triacylglycerols.
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The developed chromoplates were removed from the tank and allowed 
to dry in the fume hood for 15 minutes. Lipid spots were visualized by 
exposure to iodine vapour and identified with reference to the standards 
listed above which were run on each plate (see fig. 2.1). Their locat­
ions were marked faintly in pencil and the iodine allowed to evaporate 
for 30 minutes to 1 hour. Radioactivity incorporated into identified 
lipids was quantitated in the following manner. Chromoplates were cut 
into sample channels from bottom to top and fractions of the silica gel 
were scraped across the entire length of each sample channel onto squares 
of aluminium foil. The scrapings were then transferred as carefully and 
quantitatively as possible into mini scintillation vials for counting 
(see section 2.3.5.1.). In this way, the identified lipids were isolated 
and the unmarked areas of the plate were also retained and counted for 
radioactivity.
2.3.1.5 Determination of free and total cholesterol contents
Cholesterol contents of embryos, yolk sacs, serum and lipoprotein 
preparations were determined by the fully enzymatic method of Omodeo Sal€ 
et al., 1984. The procedure was sensitive to 2-3pg of cholesterol and 
moreover enabled the amount of sample required to be kept to a minimum by 
allowing the determination of free and esterified cholesterol contents in 
the same tube.
Reagent preparations Cholesterol standards: 0.2mg.ml-1 stock solution in 
propan-2-ol. Reagent A: 0.1N tris-HCl buffer, pH 6.6; Triton X-100, 
0.5% (w/v); 3mM sodium cholate; horseradish peroxidase, 0.2iu.ml_1.
Stored for a maximum of 2 weeks at 4°C. Reagent 1: reagent A containing 
O-dianisidine dihydrochloride, O.lmg.ml”1, and cholesterol oxidase, 
0.125iu.ml-1, freshly prepared and warmed to 37°C. Cholesterol
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esterase: diluted with tris buffer to lOiu.ml-1. Solvents were of 
analytical grade.
Procedure
(i) Free cholesterol. Lipid extracts were quantitatively transferred 
to 2ml Pyrex test tubes (50mm x 9mm) by pipette and dried under a 
stream of nitrogen. To ensure that all solvent was removed the tubes 
were then heated for 30 minutes in a 95°C oven. The dried lipids were 
then thoroughly redissolved in 200pl ethanol with vigorous vortex mixing 
and the solutions transferred to 2.9ml, 10mm micro square 'Ultra-Vu' 
polystyrene cuvettes. 800pl reagent 1 was added to each cuvette and 
mixed with the sample. When serum or lipoprotein preparations (IOmI 
samples) were assayed, reagent 1 was added before ethanol to prevent 
precipitation. Samples were incubated for 10 minutes at 37°C and the 
absorbance of the resulting yellow/orange solution measured at 450nm 
against a reagent blank in a Pye-Unicam SP8-500 UV/VIS spectrophoto­
meter.
(ii) Total cholesterol. lOpl cholesterol oxidase (O.liu) was then added 
to each sample and the absorbance measured at 450nm after a further 30 
minutes incubation at 37°C.
Cholesterol standards (3-30pg) and reagent blanks were carried in 
duplicate through the same procedure . Sample free and total cholesterol 
levels were determined from their absorbance values by linear regression 
against cholesterol standards absorbance readings. The amount of 
cholesterol ester present in a sample was calculated by subtracting the 
amount of free cholesterol from the amount of total cholesterol. The 
number of embryos or yolk sacs required for a single determination ranged 
from 10 or 11 at 10.3 days e.a. to 1 or 2 at 11.6 days e.a..
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2.3.2 Lipoprotein preparation
2.3.2.1 Isolation of total lipoproteins
Total rat lipoproteins were isolated from freshly drawn serum essen­
tially by the method of Shi and Heath, 1984.
Procedure Rat serum was collected into Na2EDTA (lmg.ml-1) and the 
density adjusted to 1.215g.ml-1 with solid potassium bromide, as des­
cribed by Radding and Steinberg (I960; the apparent specific activity of 
KBr at the final density was calculated from published data {Wolf et al., 
1986} by the method of Terpstra et al., 1981). Total lipoproteins were
isolated by ultracentrifugation at 4°c in a Sorvall OTD-55B ultra­
centrifuge with a Sorvall TH-641 swinging bucket rotor. Serum samples 
were centrifuged in 13.2ml polyallomer tubes at 30,000 rpm (1.11 x 
108g, average relative centrifugal force) for 48 hours.
Lipoproteins were concentrated in a layer at the top of each tube, 
visible as an orange-yellow band above a clear, colourless region. The 
floating lipoprotein fraction was decanted with a finely pulled glass 
pipette and used for the immediate isolation of low-density lipoproteins 
(LDL).
2.3.2.2 Preparation of LDL
Low density lipoprotein was isolated by Mrs A. McCarthy using dis­
continuous density gradient ultracentrifugation (a modification of the 
method described by Terpstra et al., 1981).
Reagent preparations Salt solutions of appropriate densities: 1.06g.ml-1 
(11.42mg NaCl & 75.98mg KBr per ml), l.lOmg.ml'1 (11.42mg NaCl & 133.48mg 
KBr per ml), 1.225mg.ml”1 (11.42mg NaCl & 315.54mg KBr per ml). All
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solutions contained Na2EDTA, 0.lmg.ml"1. Dialysis buffer: 0.15M NaCl, 
0.1% Na2EDTAf pH 7.4.
Procedure Total lipoproteins (2ml) were pipetted into 13.2 polyallomer 
tubes and gently mixed with 200pl ethylene glycol (ethylene glycol 
containing 0.1% Sudan black was pipetted into one tube to pre-stain the 
serum. Lipoprotein bands were subsequently stained enabling easier 
visualization and identification of LDL). The lipoprotein mixture was 
sequentially overlayed with 2ml of a salt solution with a density (6) of
1.225g.ini"1 , 3ml of a salt solution of 5=1.10g.ml"1, and 3ml distilled 
water. Prepared samples were centrifuged for 22 hours at 40,000 rpm (2.0 
x 105g, average relative centrifugal force) and 4°C in a TH-641 swinging 
bucket rotor. During ultracentrifugation, individual lipoprotein classes 
were separated as discreet bands along the length of the tube according 
to their densities. LDL (1.006 < 6 < 1.063) was isolated between VLDL, 
which floated at the top of the tube, and HDL. Material above LDL was 
discarded and LDL carefully decanted by pipette. LDL was rebanded in a 
salt solution of 5=1.06g.ml_1 by ultracentrifugation as above. The 
floating LDL was removed and dialysed at 4°C for 24 hours against several 
1 litre volumes of buffer. The final LDL preparation contained 920pg 
protein.ml"1.
2.3.2.4 Preparation of [3H]cholesterol-LDL
Purified LDL (1ml) was labelled with [l,2-3H(N)]cholesterol (lOOpCi 
deposited on the walls of a sterile screw-cap glass bottle) as described 
in section 2.2.5. Radiolabelled LDL was rebanded in a salt solution 
of 5=1.10 during 24 hours ultracentrifugation at 30,000 rpm and 4°C in a 
TH-641 rotor. The floating LDL was removed and dialysed at 4°C against 
several 1L volumes of dialysis buffer (see above section) for 24 hours,
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followed by 500ml HEM overnight. The final preparation contained 
400pg protein, 123pg total cholesterol and about 8.3pCi 
[1,2-3H(N)1cholesterol per ml (final specific activity approximately 
26.lmCi.mmol”1).
2.3.2.5 Electrophoresis
Purity of the serum LDL preparation was assessed by the Helena lipo­
protein electrophoresis procedure.
Reagent preparations Electra HR buffer: 0.05N Tris-barbital-sodium 
barbital buffer, pH 8.6-9.0 (stable for 2 months). Lipoprotein 
stain: stock solution of 0.28% (w/v) Fat Red 7B in methanol. 30ml
diluted with 10ml IN NaOH immediately before use.
Procedure Serum, isolated LDL, or LPDS samples were loaded into the 
wells of a sample plate and, using an Helena applicator, aliquots were 
applied to blot-dried Titan III-lipo cellulose acetate plates (76mm x 
60mm; washed and stored in buffer). The plates were placed into an 
Helena electrophoresis chamber (application point nearest the cathode) 
and electrophoresed for 25 minutes at 180 volts. Plates were stained for 
15-20 minutes with agitation on a serological rotator, washed under tap 
water for a few seconds and the red-stained lipoprotein band(s) visual­
ized.
2.3.3 Determination of serum acetate content
Serum acetate levels were determined by a modification of the acetate 
kinase method of Rose, 1955.
Reagent preparations Acetate standard stock: potassium acetate,0.05M.
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0.75M tris-HCL buffer, pH 7.4. Magnesium chloride, 0.3M. Neutral 
hydroxylamine solution: equal volumes of potassium hydroxide, 6.43M and 
hydroxylamine hydrochloride, 6.43M (44.7%), freshly prepared. 0.15M ATP, 
pH 7, freshly prepared. Phosphate-cysteine: 0.1M potassium phosphate
buffer, pH 7.4, containing 0.005M cysteine, freshly prepared.
Acetate kinase: stock enzyme diluted with phosphate-cysteine to
lOOiu.ml-1. Ferric chloride reagent: 1.25% FeCl3 in 1.0N HC1. 10% 
trichloroacetic acid (TCA).
Procedure Serum samples (750pl) and acetate standards (0.5-2.5pmoles 
potassium acetate) in a total 800pl volume were mixed with lOOpl tris-HCl 
buffer, 50pl MgCl2 and 350pl neutral hydroxylamine solution in 13.5ml 
polystyrene centrifuge tubes and warmed to 37°C in a water bath. lOOpl 
ATP and lOOpl acetate kinase were added to each sample, the samples mixed 
and incubated for 1 hour at 37°C. The reaction was stopped by the 
addition of 1.5ml cold TCA and the precipitate sedimented by 10 minutes 
centrifugation at 4000g. 2ml ferric chloride solution was mixed with 1ml 
supernatant and the absorbance of the pink-purple solution read 
immediately at 540nm against a reagent blank (distilled water, pH 7.4) in 
a Pye-Unicam SP8-500 UV/VIS spectrophotometer. The amount of acetate 
present in serum was calculated from sample absorbance values by linear 
regression against acetate standard absorbance readings.
2.3.4 Determination of protein content
Protein content of embryos, yolk sacs and other samples were measured 
by a micro-version of the method of Lowry et al., 1951.
Reagent preparations Protein standards: lOmg.ml"1 stock solution of 
bovine serum albumin (BSA) in 0.1N sodium hydroxide. Alkaline copper
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solution: sodium carbonate (2% solution in 0.1N sodium hydroxide), 
potassium sodium (+)-tartrate (2% solution) and copper sulphate 
(CUSO4 .5H2O, 1% solution), in a volume ratio of 100:1:1, prepared fresh. 
Phenol solution: Folin and Ciocalteu's phenol solution diluted 1:1 with 
water immediately before use.
Procedure Sample preparation: (a) lOpl samples from embryonic and yolk 
sac homogenates in methanol:saline, 9:1 (v/v), were mixed with 190pl 0.1N 
NaOH in 1.5ml microtubes and stored at 4°C, prior to assay, (b) Single
11.6 days e.a. (e.g. head-fold stage conceptuses at 48 hours culture) 
embryos and yolk sacs were washed in saline and transferred to 1.5ml 
microtubes. Excess fluid was aspirated and the tissues dissolved in 40pl 
IN NaOH for 1 week. 360pl distilled water was mixed with each sample and 
protein content determined on lOOpl aliquots transferred to fresh 
microtubes and mixed with lOOpl 0.1N NaOH.
Assay: Samples and appropriate BSA standards (2-12pg, or 10-80pg, in
duplicate) prepared in 200pl 0.1N NaOH were mixed with 1ml alkaline
copper solution and stood for 10-15 minutes. lOOpl phenol solution was 
then added to each sample with immediate vortex mixing, and the samples 
stood at room temperature for 40 minutes to allow maximum colour develop­
ment. The absorbance of samples were read against a reagent blank at 
750nm on a Pye-Unicam SP8-500 UV/VIS spectrophotometer.
Protein contents were determined from sample absorbance readings by 
linear regression against BSA standards values.
2.3.5 Miscellaneous techniques
2.3.5.1 Liquid scintillation counting
Radioactive TLC fractions (and other samples) were counted in 5ml
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plastic mini-scintillation vials; 0.5ml water and 4.5ml of 'Ready-Solve 
HP', or 'Monofluor' scintillation cocktails were added to each vial and 
radiolabel eluted from the silica gel by vortex mixing.' Samples were 
counted in an LKB 1211 Minibeta liquid scintillation counter; quench 
correction was by the external standard channels ratio (ESCR) method.
3H-label and 14C-label were counted with mean efficiencies of
approximately 26% and 86% respectively.
Cpm were converted to dpm from quench curves constructed in the 
following manner. Equal aliquots of a known quantity of [3H] or
i14C]toluene were pipetted into minivials containing 0.5ml water, and
increasing amounts of a quenching agent (CCI4 , 0-100pl) were added to 
individual vials. 4.5ml of appropriate scintillant was mixed with each 
vial and radioactivity counted. Curves were prepared in duplicate. 
Background corrected cpm were converted to a percentage of the known 
amount (dpm) of activity present in each vial; this data together with 
corresponding ESC ratios was entered into a regression analysis program 
and an equation for the 'best line of fit’ computed. Dpm were 
subsequently calculated from appropriate regression equations.
2.3.5.2 Protein binding
The amount of a radiolabelled compound binding to serum protein was
assessed using an Amicon MPS-1 micropartition system. This separated 
free from protein-bound microsolute using YMT membranes (MWt 30kd 
cut-off; >99.9% protein retention).
500pl serum samples were pipetted into the reservoir of the MPS-1 
apparatus and centrifuged for 10 minutes at 4000 rpm (2000g) and 37°C. 
The percentage of non protein-bound (free) radiolabel was calculated as 
follows;
% Free = (Dpm in Xpl filtrate t Dpm in Xpl retentate) x 100
2.3.5.3 Fractionation of acid-insoluble metabolites
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Following culture in the presence of radiolabel, pooled embryos and 
pooled yolk sacs transferred to 1.5ml microtubes and homogenized by 
sonication in 200pl ice-cold saline. Aliquots were removed for protein 
and total count measurements. Rat liver homogenate (30pl, to provide 
carrier), 250pl perchloric acid (PCA, 20%) and water to 1ml final volume 
were added, the samples vortexed and stood on ice for 15 minutes. Acid- 
-insoluble material was pelleted by microcentrifugation for 1 minute 
and the supernatant (acid-soluble material) collected. The pellet 
was resuspended in 1ml PCA (5%) and processed as above? this step 
was repeated. The washed pellet was resuspended in 1ml 
chloroform:methanol (2:1, v/v) and total lipids extracted. The final 
pellet was dissolved in IN NaOH. Radioactivity of soluble, insoluble and 
lipid fractions was counted by LSC.
Standard samples of [2-14C]valproic acid and [I-14C]butyric acid taken 
through the procedure, were extracted into the acid-soluble compartment 
with efficiencies of 99.3 ± 0.8%(n=4) and 97.7 ± 1.3%(n=4), munS
2.3.5.4 Purity and purification of radiochemicals
[1,2-3H(N)]cholesterol was purified before use by TLC. Label, dissolved 
in benzene was applied 2cm from the bottom of precoated silica gel 60
aluminium backed TLC plates (20cm x 20cm x 0.2mm) as a discreet 2cm
band. The chromoplate was developed in benzene:ethyl acetate (9:1,
v/v; NEN specification sheet) for 45 minutes and the bulk of
[1,2—3H(N)]cholesterol (Rf 0.15) located by counting fractions scraped 
from the edge of the chromatographed sample. The relevant area of the 
chromoplate was scraped and the 'powdered' silica sucked under vacuum 
into a glass pipette plugged with glass wool. Purified [l,2-3H(N)]chol­
esterol was eluted from the silica with chloroform.
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D-[U-14C]glucose Purity was checked by descending paper chromatography,
essentially as described by Partridge & Westall, 1948.
A standard sample of D-tU-14C]glucose was applied 8cm from the top end 
of a strip of Whatman No.3 chromatography paper {16cm x 43cm) and allowed 
to dry. Meanwhile the developing solvent was prepared as follows. 
Butan-l-ol (40ml), glacial acetic acid (10ml) and distilled water (50ml) 
were mixed in a separating funnel and allowed to settle into two phases. 
The lower, aqueous phase was run into a petri dish which was placed in 
the bottom of the developing tank (Shandon; 50cm x 50cm x 21cm, i.d.). 
At the top of the tank, paper strips were loaded into the solvent trough 
beneath a glass rod. The tank lid was sealed with petroleum jelly and 
left to equilibrate for 1 hour. The upper, organic phase was then poured 
into the trough via a resealable opening in the lid and the strips 
chromatographed for 12 hours. Strips were air dried, cut into 1cm 
fractions and radioactivity measured by LSC. D-tU-14C]Glucose was found 
to be 97.7% pure and was not purified further.
14C-SCCA Purity of [2-14C]valproic acid and n-[I-14C]butyric acid was 
checked by TLC on silica gel 60 chromoplates using chloroform:methanol 
(1:1, v/v; Ranade & Alter, 1980) and by ascending paper chromatography 
(Kennedy & Barker, 1951). Both acids were £96% pure by these methods.
In the latter method, 14C-SCCA were applied 2.5cm from the bottom 
of a sheet of Whatman No.3 chromatography paper cut to 8.5cm x 26cm and 
folded into a triangular shaped cylinder so as to be free standing. The 
dried sheet was placed into a cylindrical glass tank containing 50ml 
developing solvent (ethanol:35% ammonium hydroxide:water, 95:3:3
by volume). The chamber was sealed and the samples chromatographed for
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2-2.5 hours. Sheets were air dried and the radiochemical purity was 
assessed by LSC of strips cut from the sheet.
2.3.6 Statistical methods
2.3.6.1 Design of experiments
Experiments were randomized complete block designs (Snedecor & 
Cochran, 1980). Typically, each block consisted of 6 bottles (or other 
culture vessels), each containing an equal number of conceptuses. 
Tissues from conceptuses in the same bottle were pooled, with embryos and 
yolk sacs being kept separate.
2.3.6.2 Statistical analysis
Analysis of variance was used to analyse the data, using the Genstat
package (Alvey et al., 1982). The following examples illustrate typical
analyses.
Example 1 The first part shows the program format and method of data 
entry of an experiment in which two treatments (i.e. one treated group 
and one control group) were compared. Raw data (dpm counted in each 
lipid fraction, and the tissue protein content), together with the 
block number, the treatment and the tissue type (yolk sac or embryo) were 
entered. In this case there were 5 blocks, 4 containing two bottles and 
1 containing 3 bottles of each treatment. The program calculated 
the dpm.pg protein-1 (CHARI) and the percentage of total lipid radio­
activity incorporated into any particular lipid (CHAR2), as well as the 
total lipids dpm.pg protein-1 (DPM).
Mean treated and control values ± the standard error of the means
(SEM) for these parameters, as well as protein measurements, were
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36.51 
123.11
GRAND MEAN 16.3
TOTAL NUMBER OF OBSERVATIONS 22
xxxxx TABLES OF MEANS xxxxx 
VARIATE5 CHARI<3)
GRAND MEAN 16.3
TRT 1 2
38.0 51.6
xxxxx STANDARO ERRORS OF DIFFERENCES OF MEANS xxxxx
TABLE TRT
REP 11
SED 2.58
xxxxx STRATUM STANDARD ERRORS AND COEFFICIENTS OF VARIATION xxxxx
STRATUM DF SE CVX
EXPNUM 1 X X
EXPNUM.xUNITS* 16 6.01 13.1
subsequently printed with the analysis of variance. Control and treated 
mean values were 38.0 and 54.6 respectively. The variance ratio (VR, or 
*F value’) showed that the difference was highly significant (F PR 
<.001). The SEM was the same for both treated and control groups because 
of equal sample sizes (REP=11) and the use of a pooled within-group 
standard deviation, and was calculated as SE t /n, or in this case SEM =
6.04 * /ll.
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Example 2 In this example, data were analysed from 6 time points
(1,5,10,16,22 and 46 hours of treatment) and the aim of the analysis was
to establish whether linear or quadratic time trends existed.
'REFE’ ACETATEIVDEVELOPMENTALL
•NAME* TIS= E, Y
•UNIT* * 70
■FACT* EXPNUM * 15
5 TRT * 6
J BOTTLE * 4
J TISSUE * TIS
■MATRIX' MMAT '» 2,6=1,3,10,16,22,46,1,25.100,256,484,2116
• READ/P1 EXPNUM,TRT»BOTTLE,TISSUE »PRQT,PL,DG,ST,FL»FA,ND1»TG,FAE,ND2, 
STEST,STESTSO»ND3
• SET1 DATA=PL,DG ,ST,FL,FA,ND1,TG ,FAE,ND2,STEST,STESTSO,ND3
1 CALC1 T0TDPM=PL+DG+ST+FL+FA+ND1+TG+FAE+ND2+STE3T+STESTSQ+N03 
J CHARI<1...12)=DATA/PR0T 
: DPM=TOTDPM/PROT 
J CHAR2(1...12)=(DATA/TQTDPM)*100
•RESTRICT1 C H A R K l . . .12) ,CHAR2(1. . .12) , DPM % TISSUE=1
• BLOCKS * EXPNUM 
•TREAT' REG(TRT,2,MMAT)
•ANOVA/PROB=Y' CHARI(1...12),CHAR2(1...12),DPM,PROT
• RUN'
1 1 I E 8.4 29240 923 2357 686 403 127 3654 141 30 672 3 0 
1 1 1 Y 6.4 8758 387 446 112 257 197 2186 44 3 833 27 17 
1 1 2 E 8.1 24732 659 2276 611 219 1 ?" “ "
1 1 2 Y 6.4 7**’ '
xxxxx ANALYSIS OF VARIANCE xxxxx 
VARIATE: CHAR2(3)
SOURCE OF VARIATION DF SS SSX MS VR F PR
EXPNUM STRATUM
TRT 5 699.6528 83.82 139.9306 10.772 0.001
REG1 1 644.9924 77.27 644.9924 49.651 <.001
REG2 1 43.4839 5.21 43.4839 3.347 0.101
DEVIATIONS 3 11.1770 1.34 3.7257 0.287 0.834
RESIDUAL 9 116.9147 14.01 12.9905
TOTAL 14 816.5674 97.83 58.3262
EXPNUM.xUNITS* STRATUM 20 18.1300 2.17 0.9065
GRAND TOTAL 34 834.6973 100.00
GRAND MEAN 10.73
TOTAL NUMBER OF OBSERVATIONS 35
xxxxx TABLES OF MEANS xxxxx 
VARIATE: CHAR2(3)
GRAND MEAN 10.73
TRT 1 3 4 5 6
3.55 5.81 7.22 11.63 12.76 18.64
REP • 4 4 4 12 6 5
xxxxx STANDARD ERRORS OF DIFFERENCES OF MEANS xxxxx 
TABLE TRT
REP UNEQUAL
SED 2.549 MIN REP
2.081 MAX-MIN 
1.47IX MAX REP
(NO COMPARISONS IN CATEGORIES WHERE SED MARKED WITH AN X)
xxxxx STRATUM STANDARD ERRORS AND COEFFICIENTS OF VARIATION xxxxx 
STRATUM DF SE CVX
EXPNUM
EXPNUM.XUNITS*
9
20
x
0.952
x
8.9
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The analysis of variance table indicates the level of significance for 
the following: differences between any two time points (TRT), a linear 
relationship for treatments 1-6 (REG1; in this case F PR <.001), a 
quadratic relationship for treatments 1 to 6 (REG2; in this case not 
significant) and deviations from either of these. The difference between 
two time points was significant if it was higher than the 'least 
significant difference between means' (LSD) which was calculated manually 
from the standard error of the difference between means (SED, given in 
the printout) using the formula;
LSDp = SED x tdfp
where t = the t-distribution at a given probability for the given degrees 
of freedom, and was obtained from published tables (Fisher & Yates, 
1963). For example, the LSD for treatments 4 and 6 (df={12+5}—2=15) was 
4.435 at P<0.05, 6.132 at P<0.01 and 8.476 at P<0.001. The actual 
difference between these treatments was 7.01 and therefore significant at 
the level of P<0.01.
In this experiment the SEM was different for treatment groups of unequal 
sample sizes; e.g., 0.48 for treatments 1,2 and 3, but only 0.27 for 
treatment 4. When data from unequal replicates is tabulated in
subsequent results chapters, only the SEM for the first treatment 
(control) is usually presented.
Chapter 3
LIPID SYNTHESIS IN THE ORGANOGENESIS-PHASE 
RAT CONCEPTUS
71
3.1 Introduction
This chapter describes and discusses studies on the lipid biosynthetic 
capabilities of the organogenesis-phase rat conceptus. Included are 
"untreated control" data obtained from studies in which the actions of 
teratogenic compounds were investigated, as well as the results of 
studies specifically designed to examine lipid pathways of the ‘normal’ 
conceptus. All studies have been conducted within the embryonic age 
limits of the standard 48 hour whole rat embryo culture period, which is 
approximately equivalent to 9.5-11.5 days e.a. in vivo.
The chapter begins with an examination of lipid biosynthesis during 
the full 48 hour culture period using [3H]acetate as the lipid precursor, 
followed by a similar examination during the shorter experimental period 
of 16-24 hours of culture. Because the latter period parallels the 
protocol designed and currently used in this laboratory for studying 
the mechanism(s) of valproic acid teratogenicity, a more detailed 
investigation of lipid synthesis during this period was conducted. 
Multiple analytical techniques were employed to confirm the identity of 
lipid fractions isolated by TLC. Subsequent studies included time-course 
studies and a detailed investigation comparing lipid biosynthesis in 
cultured and freshly explanted conceptuses at different embryonic ages.
Finally, the results from using other lipid precursors in studies 
of mammalian embryonic lipid synthesis, as alternatives to acetate, are 
presented.
Results have been expressed in two different ways throughout this 
thesis. The 'rate' of incorporation, i.e. reflecting the 'amount' of 
lipid synthesized is described by 'dpm.pg protein-1' data. 
Alternatively, the distribution of total incorporated label into 
individual classes (i.e. the amount of activity (dpm) incorporated into 
an individual lipid class t the amount of activity incorporated into the
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total lipids) have been expressed as percentages and are referred to as 
'% total lipids', or 'percent incorporation'.
3.2 Incorporation of [3H]acetate into embryonic lipids during a 
standard 48 hour culture
Experimental design Conceptuses of 9.5 day e.a. were cultured in the 
presence of [3H]acetate (SpCi.ml”1, lOOmCi.mmol-1) contained in 4ml 
medium (75% serum, 25% MEM) for a duration of 48 hours. Three con­
ceptuses were placed in each bottle. At the end of culture, conceptuses 
were removed from culture and the lipids of pooled embryos and pooled 
yolk sacs from each bottle extracted for analysis by thin-layer chromato­
graphy and liquid scintillation counting (TLC-LSC).
Results Table 3.1 shows the collated data expressed both as dpm.pg 
protein”1 and as the % total lipids (mean values rounded to one decimal 
place).
[3H]acetate was incorporated into all major lipid classes over the 48 
hour culture period. In both embryonic and yolk sac tissues 
incorporation was predominantly into the polar lipid, sterol and triacyl- 
glycerol fractions, the polar lipids accounting for nearly half the 
lipid-associated radioactivity in either tissue. These three lipids 
together accounted for >87% of the total activity incorporated into 
embryonic lipids, and >80% of total yolk sac counts. Other identified 
lipids i.e. fatty acids, diacylglycerols and sterol esters, contained £5% 
of the tissue total lipid counts. Incorporation into the few 'unknown' 
fractions was £1.5%.
Unlike the polar lipids, highly significant differences between yolk 
sac and embryonic incorporation into sterol and triacylglycerol fractions
Table 3.1
Incorporation of pH]acetate into lipid classes of 9.5 day e.a. conceptuses during 48 hours of culture.
BPM/ug Protein % Total lipids
F/N LIPID YOLK SAC EMBRYO E/YS YOLK SAC EMBRYO E/YS
1 Polar lipids 31.2 (.5) 75.4 (1.2)
— 
2.4 * 44.6 (.3) 47.4 (.2) 1.1 *
.
2 Diacylglycerols 2.6 (.1) 4.2 (.2) 1.6 * 3.7 (.1) 2.5 (.1) 0.7 *
3 Sterols 12.7 (.3) 44.5 (.6) 3.5 * 18.3 (.3) 28.0 (.4) 1.5 *
4 Fatty alcohols 1.9 (.1) 5.0 (.5) 2.6 * 2.7 (.2) 3.2 (.3) 1.2
5 Fatty acids 3.7 (.1) 5.9 (.2) 1.6 * 5.3 (.2) 3.6 (.1) 0.7 *
6 n.d. 0.7 (.1) 0.6 (.1) 0.9
’
1.0 (.1) 0.4 (.02) 0.4
7 Triacylglycerols 12.4 (.3) 19.5 (.5) 1.6 * 17.9 (.4) 12.2 (.2) 0.7 *
8 Fatty alkyl 
esters
0.7 (.1) 1.0 (.03) 1.4 * 0.9 (.1) 0.6 (.02) 0.7
9 n.d. 0.3 (.02) 0.6 (.02) 2.0 * 0.4 (.02) 0.4 (.01) 1.0
10 Sterol esters 2.9 (.1) 2.6 (.2) 0.9 4.4 (.1) 1.6 (.1) 0.4 *
11 "10" & Squalene 0.5 (.04) 0.3 (.01) 0.6 * 0.8 (.05) 0.2 (.01) 0.2 *
12 n.d. 0.05 (.01) 0.03 (.003) 0.6 0.07 (.002) 0.02 (.002) 0.3 *
Total lipids 69.6 (1.2) 159.6 (2.5) 2.3 * [100.1] [100.1]
ug Protein/tissue 131.3 (1.9) 248.7 (4.9) 1.9 *
Data are expressed as DPM/ug protein and as the percent of total lipids incorporated into individual 
lipid fractions (% total lipids). Mean values of 19 determinations (+/- SIM) are presented, 
n.d., unknown; * P<0.001, embryo and yolk sac data significantly different, analysis of variance.
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were observed. Where as the yolk sac directed [3H]acetate into these two 
lipids in equal proportions (% total lipids), the embryo preferentially 
concentrated label into sterol lipids (sterols/triacylglycerols ratio,
2.3).
Incorporation of label into sterol esters, although being relatively 
small, also differed considerably between tissues. Not only did this 
lipid class contain a higher proportion of the total yolk sac counts 
compared with the corresponding embryonic fraction, but it was unique in 
the way it contained more incorporated radioactivity per pg protein in 
the yolk sac than in the embryo. It was also interesting to observe that 
the sterol esters together with triacylglycerols, both lipid storage 
molecules, were the only lipids which contained significantly higher 
proportions of the total lipid counts in the yolk sac relative to 
the embryo (i.e. E/YS <1.0).
In general, however, the embryo incorporated more radioactivity per pg 
protein into individual lipid classes than the yolk sac. In particular, 
embryonic polar lipid and sterol fractions contained 2.4 and 3.5 fold 
more counts, respectively, than corresponding yolk sac fractions, while 
triacylglycerol counts were also greater in the embryo. Indeed, the 
abundance of radioactivity associated with these fractions, particularly 
in the embryo, accounted for embryonic total lipids having 2.3-fold 
more incorporated [3H]acetate than yolk sac total lipids.
3.3 Embryonic lipid synthesis from acetate during 16-24 hours of culture
3.3.1 Incorporation of [3H]acetate into neutral lipids
Experimental design Conceptuses (9.5 day e.a.) were cultured in bottles 
containing unlabelled medium (4ml 75% serum, 25% MEM with 3 conceptuses)
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for 16 hours. [3H]acetate, dissolved in a small volume of MEM, was then 
added to each bottle (125pCi.ml medium-1, 100-130mCi.mmol-1) and concep­
tuses cultured for a further 8 hours in the presence of' label. At 24 
hours, conceptuses were removed from culture and the lipids extracted 
from the pooled embryos and pooled yolk sacs of each bottle. Neutral 
lipid classes were separated by TLC and incorporated radioactivity 
measured by LSC.
Results Table 3.2 summarizes the data expressed as dpm.pg protein-1 and 
as the percentage of total lipids incorporated into individual lipid 
fractions (mean values rounded to one decimal place).
Over this short-term culture [3H]acetate was incorporated into all 
isolated lipid classes with the polar lipid, sterol and triacylglycerol 
fractions containing the majority of incorporated radioactivity (see 
fig. 3.1? combined '% total lipids’: 84.1% and 91.2% in yolk sac and 
embryo, respectively). The proportion of total lipid counts in other 
fractions, namely sterol esters, fatty acids, diacylglycerols, fatty 
alcohols and fatty alkyl esters, in descending order of magnitude, was 
not higher than about 5%, while 'unknown' fractions accounted for £1.5% 
of the total incorporated radioactivity. These results were very similar 
to those obtained for the previous study. Polar lipids again accounted 
for about half the total lipid counts of both tissues, while the amount 
of label incorporated into sterols and triacylglycerols differed between 
embryo and yolk sac. The percent incorporation into sterol lipids was 
2-fold higher in the embryo, while, in contrast, that into triacyl­
glycerols was 2-fold higher in the yolk sac. Similarly, the proportion 
of counts measured in sterol esters was about 5 times higher in the yolk 
sac than in the embryo.
Embryonic lipids generally contained about 3 times more total labelled
Table 3.2
Incorporation of pH]acetate into lipid classes of 9.5 day e.a. conceptuses during 16-24 hours of culture.
BFM/ug Protein i j % Total lipids
m  lipid YOUCSAC EMBRYO E/YS !! YtM SAC EMBRYO E/YS
1 Polar lipids 237.8 (4.5) 739.4 (7.6)
1 1 
1 1
3.1 * !! 
1 1
51.4 (.2) 54.2 (.2) 1.1 *
2 Diacylglycerols ' 11.4 (.5) 25.0 (.9) 2.2 * !S
I 1
2.6 (.1) 2.0 (.1) 1.8 *
3 Sterols 52.8 (1.2) 363.3 (4.8) 6.9 * !!
I I
11.8 (.1) 26.9 (.2) 2.3 *
4 Fatty alcohols 7.2 (.4) 29.3 (1.5)
1 1
4.1 * !i 
11
1.7 (.05) 2.3 (.1) 1.4 *
5 Fatty acids 17.8 (.5) 31.7 (.7) 1.8 * !!
1 t
3.8 (.1) 2.4 (.04) 0.6 *
6 n.d. 3.7 (.3) 3.2 (.2) 0.9 j! 
1 1
0.8 (.05) 0.3 (.02) 0.4 *
7 Triacylglycerols 98.3 (2.3) 132.7 (1.9)
1 1
1.3 * j! 
1 1
20.9 (.3) 10.1 (.2) 0.5 *
8 Fatty alkyl 3.9 (.2) 7.6 (.5)
I I
1.9 * i! 0.9 (.04) 0.6 (.04) 0.7 *
esters 1 1 1 1 
I 1
9 n.d. 1.3 (.1) 1.8 (.3)
t 1
1.4 II
1 t
0.3 (.01) 0.2 (.02) 0.6 *
10 Sterol esters 21.2 (.7) 12.3 (.4) 0.6 * !i
1 I
4.4 (.1) 0.9 (.03) 0.2 *
U- "10" & Squalene ' 5.2 (.3) 1.8 (.2) 0.3 * !! 
1 1
1.0 (.06) 0.1 (.02) 0.1 *
12 n.d. 1.4 (.3) 1.0 (.2)
It
0.7 !!
1 t 
1 1
1 1
0.3 (.06) 0.1 (.02) 0.3
Total lipids 462.0 (8.7) 1349.1 (12.8) 2.9 * !! 
1 1
[99.9] [100.1]
ug Protein/tissue 47.9 (.7) 65.9 (.7) 1.4 * !!
Data are expressed as DFM/ug protein and as the percent of total lipids incorporated into individual 
lipid fractions (% total lipids). Mean values of 35 determinations (+/- SIM) are presented, 
n.d., unknown; * P<0.001, embryo and yolk sac data significantly different, analysis of variance.
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Figure 3.1
Representative chromatographic profiles of [3H]acetate incorporation 
(16-24 hours of culture) into (a) embryonic and (b) VYS lipids of the 9.5 
day e.a. rat conceptus at 24 hours of culture.
Amounts of radioactivity are from pools of 3 tissues. Abbreviations: CE, 
cholesterol esters; FA, fatty acids? PL, polar lipids; S, sterol lipids; 
TG, triacylglycerols.
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lipid than the yolk sac, although embryonic sterols contained almost 
7-times more radioactivity than yolk sac sterols. In contrast, however, 
the amount of activity incorporated into esterified sterols was 2-fold 
higher in the yolk sac. As observed in the previous study, sterol esters 
were the only yolk sac lipids to incorporate significantly more label 
than corresponding embryonic lipids. Interestingly, the other lipid 
storage molecule, triacylglycerols, also contained considerably higher 
proportions of the total tritiated lipids in the yolk sac than in the 
embryo. The other esters, diacylglycerols and fatty alkyl esters, 
followed a similar trend, although only relatively small amounts of label 
were incorporated into these fractions.
Finally, the high concentration of tritium used in this experiment was 
not toxic to the conceptus. No dysmorphologies were visible at 48 hours 
of culture following exposure to [3H]acetate between during 16-24 hours.
3.3.2 Incorporation of O 4C]acetate into neutral lipids: 
comparison with [3H]acetate incorporation
The purpose of this experiment was to demonstrate whether tritiated 
acetate was incorporated the same way as 14C-labelled acetate. Tritiated 
compounds may give false incorporation rates due to proton transfer, and 
this potential artifact needed to be clarified.
Experimental design This was identical to the experimental design used 
in 3.3.1 except that 9.5 day e.a. conceptuses were transferred at 16 
hours of culture to minivials containing 1ml medium (75% serum, 25% MEM) 
with added acetate-label: [3H]acetate (125pCi.ml medium-1, 
100-130mCi.mmol-1) and [14C]acetate (13MCi.ml medium-1, 51mCi.mmol-1). 
At 24 hours, conceptuses were removed from culture and the lipids 
extracted from the pooled embryos and pooled yolk sacs of each bottle for
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Table 3.3
Incorporation of [3H]acetate and [14C]acetate into lipid classes of 9.5 day e.a. conceptuses 
during 16-24 hours of culture.
[3H] Acetate !i [14 c] Acetate I
! F/N LIPID CPU % Total lipids j! CFM % Total lipids !
•
! YOUC SAC
! 1 Polar lipids 8056 (647) 51.5 (1.6) !i 5690 (367) 53.7 (.6) !
! 2 Diacylglycerols 336 (9) 2.2 (.2) |! 225 (14) 2.0 (.4) !
i 3 Sterols 1328 (155) 8.5 (.3) i! 747 (14) 7.0 (.4) b 1
; 4 Fatty alcohols 74 (27) 0.5 (.1) i! 38 (10) 0.3 (.1) i
! 5 Fatty acids (FA) 249 (43) 1.6 (.2) i! 155 (19) 1.5 (.9) i
S 7 Triacylglycerols 3972 (243) 25.3 (.1) !i 2763 (14) 26.1 (.3) c !
: 8 FA alkyl esters 239 (48) 1.6 (.5) I! 176 (31) 1.7 (.4) i
! 10 
1+11
Sterol esters 
& Squalene
984 (79) 6.6 (.6) Ij 593 (46) 5.7 (.4) {
! EMBRYO
i 1 Polar lipids 31479 (2902) 57.0 (.6) !{ 20431 (2860) 58.3 (1.5) !
! 2 Diacylglycerols 840 (149) 1.5 (.1) !{ 555 (65) 1.6 (.1) !
i 3 Sterols 12287 (705) 21.8 (.03) ii 6610 (392) 18.8 (1.1) c i
: 4 Fatty alcohols 356 (28) 0.6 (.02) i{ 181 (18) 0.5 (.01) b !
! 5 Fatty acids 853 (76) 1.5 (.1) !! 445 (54) 1.3 (.1) i
! 7 Triacylglycerols 8163 (963) 14.3 (.6) ii 5767 (629) 16.3 (.5) b I
: 8 FA alkyl esters 560 (88) 1.0 (.1) i! 415 (70) 1.2 (.1) 1
! 10 
i+11
Sterol esters 
& Squalene
715 (53) 1.3 (.1) i{ 389 (33) 1.1 (.04) c !
Data are expressed as CFM (total counts in individual lipid fractions frcm pools of 3 yolk 
sacs or embryos) and as the % of total lipids incorporated into individual lipid fractions 
(% total lipids; calculated frcm computed dpm data). Mean values of 3 determinations 
(+/- SM) are presented, c P<0.05, b P<0.01, 3H and 14C % incorporation data significantly 
different, Student's t test.
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analysis by TLC-LSC.
Results The results of this dual-label study are summarized in table
3.3. Although the '% total lipids’ data was calculated from computed dpm 
data, the absolute counts (cpm) measured have been included in the table 
to show the relative final amounts of [3H]acetate and t14C]acetate 
incorporated into each lipid class. Equal amounts of 3H- and 14C-label 
incorporation was attempted so that any apparent differences between the 
metabolism of the two labels were likely to be significant observations 
rather than artifacts due to largely unequal count sizes. Under the 
present experimental conditions the incorporation of 3H was approximately
1.5-fold that of 14C. The percent incorporation into individual 
fractions was very similar, with each isotope being incorporated into 
different lipids in the same order of magnitude. Subtle but statis­
tically significant differences in isotope incorporation were observed in 
a few fractions, notably sterols and triacylglycerols. In both yolk sac 
and embryo, the percent incorporation of C14C]acetate into the sterol 
fraction was slightly lower compared with the incorporation of 
[3H]acetate. Conversely, triacylglycerols appeared to contain relatively 
higher proportions of 14C-label than 3H-label. In either case the 
differences between the % incorporation of the two isotopes were small 
(0.8-3.0%).
3.3.3 Incorporation of t3H]acetate into sterol lipids
Experimental design Embryo culture in the presence of [3H]acetate was 
identical to the protocol in 3.3.1. Three conceptuses in each of four 
bottles provided the biological material. Following lipid extraction, 
digitonin-precipitable sterols (DPS) were isolated and analysed by
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TLC-LSC using two different solvent systems. Non-precipitable lipids and 
half of the DPS samples were separated using neutral lipids developing 
solvent (plate a) and the remaining DPS samples were analysed using 
sterol lipids developing solvent (plate b).
Results The summarized data, expressed as the '% total lipids' and/or '% 
DPS' are presented in table 3.4. Separation of non-digitonin precipit- 
able lipids into neutral lipid classes gave some indication of the levels 
of non-sterol lipids which normally co-elute with, and are therefore not 
resolved from, sterols present in a particular fraction of the chrom­
atogram. The amount of 1,3-diacylglycerol present in fraction 3, where 
the bulk of sterol lipids are also found, appeared to contain only 1% of 
the total labelled lipids of either tissue, about the same amount 
as was incorporated into its isomer 1,2-diacylglycerol (fraction 2). 
Quantitation of fractions 10 and 11 together, showed that only 14% of 
their total combined counts, in both yolk sac and embryo, were precip­
itated as digitonides. This suggested that the majority of counts in the 
two fractions were incorporated into sterol esters (86%) while incorp­
oration of label into squalene was minimal.
Analysis of the DPS by either solvent system showed that the majority 
of radiolabel incorporated into DPS was associated with cholesterol 
(between 74% and 90%) and that £94% of the counts in fraction 3 of the 
neutral lipids plate was sterol (cholesterol) lipid. In contrast, 
analysis of DPS with a solvent system designed to separate the more 
commonly occurring sterols (plate b) indicated only very low levels of 
incorporation into mevalonate and lanosterol in both the yolk sac and 
embryo. From this data it could be estimated that the quantity of counts 
attributable to lanosterol in fraction 4 of the neutral lipids plate 
(a) was between 25% and 50%. However, the estimated percent incorp-
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Table 3.4
Incorporation of [3H]acetate into sterol and non-sterol lipids of 9.5 day e.a. conceptuses during 
16-24 hours of culture.
1
1
t
YOliC SAC - EMBRYO
1
1
1
1
1
1
1
1.
Noo-digitonin 
precipitable 
lipids (n=4)
! Digitcuin 
i precipitable 
i sterols (n=2)
Nco-digitonin 
precipitable 
lipids (n=4)
! Digitcuin 
I precipitable 
S sterols (n=2)
I F/N LIPID
1
1
1
1.
% Total lipids % DPS % Total lipids % DPS
1 I I "
S Plate a. Neutral lipids developing sol
I 1 1 -
vent
■
i 1 Polar lipids
1
1 1 
1
1
39.9 (2.8) 0.7 (.1) 3.3
'
48.2 (2.2) 1.5 (.2) 4.4
i 2 1,2-DG
1
t 1 
1 1
1 1
1.7 (.2) 0.9 (.1) 4.2 1.1 (.2) 2.8 (1.0) 8.3
i 3 Sterols & 1,3-DG
t 1 
I I 
1 1 
I 1
1.1 (.1) 16.4 (3.7) 76.9 1.0 (.2) 27.6 (3.0) 81.8
! 4 Fatty alcohols 
! & lanosterol
1 t 
1 I 
1 I
1 1 
t 1 
1 1
0.4 (.05)
0.5 (.3) u
0.4 (.06)
0.7 (.03)
1
2.1 !
I 5 Fatty acids
1 f 
I 1 
1 1 
1 t
2.4 (.1) 1.6 (.1)
! 7 Triacylglycerols
i 8 Fatty alkyl 
! esters
1 1 
1 1 
1 1 
t 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1
26.2
1.5
(2.3)
(.3)
1.9 (.1) 8.9
12.2
0.9
(1.7)
(.3)
0.9 (.2) 2.7 !
! 10 Sterol esters 
I+11 & Squalene
1 1 
1 1 
1 1 
1 1 
1 1 
1 1
5.6 (.7) 0.9 (.2) 4.2
1
1.2 (.03) 0.2 (.06) 0.5 i
i
Other (n.d.)
1 1
I 1 
1 1
1 1 
1 1
1.5 (.04) <0.1 <0.5
1
1
«
0.5 (.03) <0.1 <0.3 !
Sum %
1 1
1 1 
1 1 80.3 21.3 . 100.1 ! 66.9 33.8 100.1 !
Plate b. Sterol lipids developing solve
1 t
int 11
1
1 ? Mevalcnate
1 1
1 1 
1 1 1.0 (.5)
1
5.4 ! 
1
0.4 (.1) 1.2 !
3 ? Oestrogen &
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Plate a. Ifon-digitonin precipitable lipids and half of the digitcnin-precipitable sterols (DPS) were 
separated by TLC with neutral lipids developing solvent. Plate b. The remaining EPS were separated by 
TLC with sterol lipids developing solvent. Data are expressed as the % of total lipids incorporated 
into individual fractions (% total lipids) and as the % of total DPS incorporated into individual 
sterol fractions (% DPS). Mean values {+/- SEM) are presented. DG, diacylglycerol; n.d., unknown.
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oration into squalene was higher using this solvent system than in 
previous estimations using the neutral lipids developing solvent. This 
may be due to contamination of DPS with small amounts of non-sterol
lipids, or less likely, the presence of other sterols co-eluting with 
squalene in this system. Incorporation of [3H]acetate into fraction 2 of 
plate b, possibly containing steroid hormones progesterone and oestrogen
was also low: <2% of the total lipid counts (the location of these lipids
was determined from documented Rf values for this solvent system; Pratt, 
1982).
In conclusion, the high proportion of radioactivity incorporated into 
DPS (20-30% of total lipid counts) was predominantly cholesterol. 
Incorporation of label into other identified digitonin precipitable 
lipids, mevalonate, lanosterol and squalene (and possibly oestrogen and 
progesterone) was essentially very low and certainly no higher than 2% of 
the total lipid counts in any one fraction.
3.3.4 Incorporation of C3H]acetate into phospholipids
Experimental design Conceptuses were cultured in the presence of
[3H]acetate as described in 3.3.1. Polar lipids were separated from 
neutral lipids by column chromatography on silicic acid. Retained 
aliquots of total lipid extracts, the chloroform-eluted neutral lipid 
samples, and methanol-eluted phospholipids were analysed by TLC-LSC.
Results Table 3.5 presents the summarized data which are expressed as '% 
total lipids' and/or '% polar lipids'. The cumulative data shows that 
the neutral lipids were efficiently separated from the polar lipids and 
that the two fractions were eluted from the columns without any appreci­
able loss of associated radioactivity from any particular lipid.
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Incorporation of [3H]acetate into polar and neutral lipids of 9.5 day e.a. conceptuses during 
16-24 hours of culture.
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Following separation on silicic acid columns, nan-polar lipids (chloroform eluant) were further 
analysed by TLC using neutral lipids developing solvent (plate a), while polar lipids (methanol 
eluant) were analysed by TLC using phospholipids developing solvent (plate b). Aliquots of total 
lipid extracts were analysed alongside non-polar lipids. Data are expressed as the % of total 
lipids incorporated into individual fractions (% total lipids) and as the % of total phospho­
lipids incorporated into individual phospholipid fractions (% polar lipids). Mean values of 4 
determinations (+/- SEM) are presented. DG, diacylglycerol; n.d., unknown.
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In plate a, the 1-2% of total lipid counts still present in fraction 1 
of the chromatographed chloroform eluants are probably attributable to 
monoacylglycerols. Monoacylglycerols were not usually clearly resolved 
from phospholipids (which remained at the origin of chromoplates dev­
eloped with the neutral lipids solvent) and were therefore counted in the 
polar lipid fraction. The low incorporation into monoacylglycerols was 
approximately equal to incorporation into 1,2-diacylglycerols. Thin- 
-layer chromatographic separation of the methanol eluant into its 
constitutive phospholipids (plate b) revealed that [3H]acetate was 
chiefly incorporated into phosphatidylcholine (about 75% of total 
phospholipids) accounting, therefore, for one-third to two-fifths of the 
total [3H]acetate incorporated into lipids. Considerably less label was 
incorporated into phosphatidylethanolamine, although this class still 
contained 8-9% of the tissue total lipid counts (16-18% of total phospho­
lipids) . Incorporation of [3H]acetate into phosphatidylserine and/or 
phosphatidylinositol accounted for only a few percent of the total 
phospholipid associated radioactivity, while incorporation into sphingo­
myelin and lysophosphatidylcholine was negligible.
3.4 Time-course studies of embryonic lipid synthesis during 
16-24 and 22-30 hours of culture
3.4.1 Time-related incorporation of [3H]acetate during 16-24 
hours of culture
Experimental design 9.5 day e.a. conceptuses were cultured for 16 hours 
as described in section 3.3.1 and then transferred to minivials cont­
aining [3H]acetate (125pCi» lOO-^OmCi.mmol-1) dissolved in 1ml medium 
(75% rat serum, 25% MEM). 2-4 conceptuses were cultured for up to 8
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hours in each vial. Conceptuses were removed from culture after 0.5, 1, 
2, 4 and 8 hours (16.5-24 hours of culture) and the lipids extracted from 
the pooled embryos and pooled yolk sacs of each vial. Neutral lipid 
classes were separated by TLC and incorporated radioactivity measured by 
LSC.
Results The results of this time-course study are graphically illust­
rated by figures 3.2 and 3.3 which, respectively, present the data 
expressed as dpm.pg protein-1 and as the percentage of total lipid counts 
incorporated into individual classes (% total lipids). Incorporation 
into embryonic lipids relative to incorporation into yolk sac lipids 
(E/YS) data is not tabulated but is referred to in the text where 
appropriate; statistical analyses of the E/YS data were by Student's t 
test.
Figure 3.2 shows that [3H]acetate incorporation into embryonic total 
lipids was linear with time over the 8 hour period. Incorporation into 
total yolk sac lipids, however, was only linear over the first two hours 
after which the rate slowed down. After 0.5 hours, acetate incorporation 
into total embryonic and yolk sac lipids was about the same (E/YSsl.O), 
but by 1 hour the E/YS ratio for total lipids had increased to 1.5 
(P<0.001) and after 8 hours the ratio was 3.1 (P<0.001). Incorporation 
into embryonic and yolk sac polar lipid and sterol fractions showed 
similar time-dependent relationships to that of total lipids. E/YS 
ratios for polar lipids at 0.5 and 8 hours were essentially identical to 
those quoted above for total lipids. This is not surprising since 
acetate incorporation into polar lipids accounted for 40-45% of the 
total lipids at 0.5 hours and a fairly steady 50-55% of the total lipids 
from 1 hour onwards (fig.3.3).
Like polar lipids the sterol lipids also contained a high proportion
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Time-course for [3H]acetate incorporation into lipid classes of 9.5 day 
e.a. conceptuses during 16-24 hours of culture. I. Dpm.pg protein-1.
Mean values ± SE are plotted, n=6.
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of the total lipid counts by 0.5 hours. In the yolk sac this was about 
10% and remained at this level during the whole 8 hour period, and in the 
embryo the percent incorporation increased by a few percent only (fig 
3.3). Unlike polar lipids (and total lipids), however, the E/YS ratio 
was already 2.3 by 0.5 hours (P<0.001) and had risen to 8.5 (P<0.001) by 
the end of the experimental period. Similarly, incorporation into sterol 
esters, although never containing more than 6% and 2% of the total lipid 
radioactivity in the yolk sac and embryo respectively, was also main­
tained at a steady level throughout the 8 hour period. Incorporation, 
quite linear with time in both tissues, was significantly higher in the 
yolk sac at all time-points (E/YS 0.35-0.7; fig. 3.2).
In contrast with the two membrane lipids, the other major lipid class 
synthesized during 16-24 hours of culture, the triacylglycerols (see 
section 3.3.1) appeared to incorporate very little [3H]acetate before the 
first 1-2 hours. In the yolk sac, triacylglycerols contained <5% 
of the total lipid associated radioactivity at 0.5 and 1 hour, less than 
any other class, including fatty acids and diacylglycerols. In the 
embryo, triacylglycerols contained only about 2% of the total labelled 
lipids during the first 2 hours; only sterol esters contained a smaller 
percentage (fig. 3.3). Only after this 1-2 hour 'lag' was label 
incorporated into this fraction to any large extent and then incorp­
oration into embryo and yolk sac was very similar (E/YSsl.0; fig. 3.2) 
and reached high percent incorporation levels by the end of the 8 hours 
(9% and 23% in embryo and yolk sac, respectively; fig. 3.3).
The percentage of total labelled lipids incorporated into fatty acids 
in particular, and also diacylglycerols, appeared to be inversely related 
to, and therefore associated with, the percent incorporation time-course 
observed for triacylglycerols. Fatty acids accounted for as much as 14% 
(yolk sac) and 10% (embryo) at 0.5-1 hour, after which the percent
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incorporation decreased linearly with time to £2% by 8 hours in either 
tissue (fig. 3.3). Incorporation into diacylglycerols was substantially 
lower but followed a very similar time-course to that described for fatty 
acids. Dpm.pg protein-1 data profiles for these two classes of lipid 
were also very similar and quite unlike those of other lipids 
(fig. 3.2); after an initial 2 hours linear incorporation the amount of 
acetate incorporated into these fractions actually decreased. This 
observation, together with the incorporation 'lag' into triacylglycerols 
and the apparent link between fatty acid, diacylglycerol and triacyl- 
glycerol lipids provided strong evidence for the metabolic conversion of 
fatty acids and diacylglycerols into the more complex triacylglycerols in 
both yolk sac and embryonic tissues.
3.4.2 Time-related incorporation of [9,10-3H(N)1 oleic acid during 
16-24 hours of culture 
Oleic acid was employed to study further the apparent 'lag' in 
triacylglycerol synthesis from acetate during the early part of this 
period of development.
Experimental design The experimental design for this study was identic­
al to that employed for the above [3H]acetate time-course study (section 
3.4.1.) except that conceptuses were exposed to [9,10-3H(N)]oleic acid 
(3.9MCi.ml medium-1, 5.3Ci.mmol-1) for 0.5-8 hours.
Results Figures 3.4 and 3.5 present the results of this time-course
study in graphic form, data being expressed as dpm.pg protein-1 and as 
the percentage of total lipid counts incorporated into individual classes 
(% total lipids), respectively. Statistical analysis of the E/YS data 
(not tabulated) was by Student's t test.
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Incorporation of oleic acid into total lipids was essentially linear 
with time during the 8 hour incubation, and substantially more label was 
incorporated by the yolk sac than by the embryo at all time-points 
(P<0.001). E/YS ratios increased only slightly from 0.1 to 0.3 by 8 
hours (fig 3.4). Each of the lipid classes isolated (polar lipids, fatty 
acids, diacyl- and triacylglycerols, and sterol esters) contained more 
radiolabel in the yolk sac than in the embryo.
Polar lipids and triacylglycerols contained the majority of the total 
lipid counts, at least by the end of the experimental period, as illus­
trated both in figure 3.4 and by a separate study in which conceptuses 
were exposed to oleic acid, under the same conditions as described above, 
for the full 8 hour period between 16 and 24 hours of culture (table 
3.6). In the latter study, triacylglycerols contained 60% and polar 
lipids contained 28% (total 88%) of the total yolk sac lipid counts while 
in the embryo polar lipids (61%) accounted for most of the 95% of total 
lipid counts incorporated into the two lipid classes. Yolk sac sterol
esters were the only other lipid class to incorporate an appreciable
amount of the radiolabelled oleic acid.
The time-course data presented in figure 3.5 shows that the high 
percentage incorporation into the polar lipids does not vary throughout 
the 8 hour period in the yolk sac but increases in the embryo by about
10%. On the other hand, the percentage incorporation into triacyl­
glycerols is only 5% or less during the first hour in the yolk sac and 
during the first two hours in the embryo. After these initial 'lag' 
phases label became rapidly incorporated into the triacylglycerols in 
both tissues, particularly the yolk sac (this observation is also 
illustrated in figure 3.4). In direct contrast with these observations, 
the percent incorporation into the fatty acid fraction (i.e. oleic acid) 
was initially very high (50% and 35% in the yolk sac and embryo respecti-
Table 3.6
Incorporation of [^ lO-sHflJHoleic acid into lipid classes of 9.5 day e.a. conceptuses during 
16-24 hours of culture.
i DPM/ug Protein ! % Total lipids i
i F/N LIPID !i YOLK SAC EMBRYO E/YS i YOLK SAC EMBRYO E/YS !
i 1 Polar lipids j! 286.1 (11.2) 201.1 (8.6) 0.7 * ! 28.2 (.7) 61.4 (.6) 2.2 * i
! 2+3 Diacylglycerols j! 17.5 (1.2) 5.1 (.4) 0.3 * i 1.7 (.1) 1.6 (.1) 0.9 i
! 5 Fatty acids !} 7.3 (.5) 1.7 (.2) 0.2 * i 0.7 (.1) 0.5 (.03) 0.7 !
i 7 Triacylglycerols ii 606.0 (27.6) 111.0 (6.1) 0.2 * i 59.6 (.7) 34.0 (.6) 0.6 * !
i 10 Sterol esters iI 96.7 (3.3) 8.0 (.7) 0.1 * i 9.8 (.3) 2.5 (.2) 0.3 * !
i Total lipids i! 1013.6 (38.8) 326.9 (14.2) 0.3 * ! [100.0] [100.0]
i ug Protein/tissue !j 42.4 (1.3) 61.4 (4.7) 1.4 *
Data are expressed as DPM/ug protein and as the percent of total lipids incorporated into individual 
lipid fractions (% total lipids). Mean values of 6 determinations {+/- SIM) are presented.
* P<0.001, embryo and yolk sac data significantly different, analysis of variance.
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vely) before dropping to £1% in each tissue. Also, as shown in figure 
3.5, the time-points at which the percent incorporation in this fraction 
began to decrease coincided with the end of the 'lag' time observed for 
triacylglycerols. The percent of total labelled lipids incorporated into 
diacylglycerols was, like the fatty acid fraction, initially fairly high 
(13% and 7.5% in the yolk sac and embryo respectively) but only 1-2% by 8 
hours. Figure 3.4 shows the rapid incorporation of oleic acid, peaking 
at 2 hours, by both yolk sac and embryo, and it’s incorporation or 
metabolism to diacylglycerols which reach peak levels one hour later. 
The subsequent dramatic decrease in actual counts within these two 
fractions suggests further metabolism, the weight of evidence indicating 
conversion to triacylglycerols.
3.4.3 Time-related incorporation of [3H]acetate during 22-30 
hours of culture: comparison with [3H]acetate 
incorporation during 16-24 hours of culture 
A further time-course experiment was conducted during a later period 
of culture (22-30 hours) to see if the ’lag' in triacylglycerol synthesis 
observed during the early part of 16-24 hours was an artifact of the 
system or a true, perhaps developmentally-related, phenomenon.
Experimental design 9.5 day e.a. conceptuses were cultured for 22 hours 
and then transferred to minivials containing [3H]acetate (125pCi, 
lOO-llOmCi.mmol-1) dissolved in 1ml medium (75% rat serum, 25% MEM). Two 
to four conceptuses were cultured for up to 8 hours in each vial; 
conceptuses were removed from culture after 0.5, 1, 2, 4 and 8 hours
(22.5-30 hours of culture). Lipids were extracted from the pooled 
embryos and pooled yolk sacs of each vial and analysed as in previous 
time-course studies.
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Results Figures 3.6 and 3.7 present graphic illustrations of the results 
obtained from this time-course study, data being expressed as dpm.pg 
protein-1 and as the percentage of total lipid counts incorporated into 
individual classes (% total lipids), respectively. E/YS data referred to 
in the text were analysed using Student's t test.
As shown by figure 3.6, the rate of [3H]acetate incorporation into 
total, polar, and sterol lipids was very similar to the rates previously 
observed during 16-24 hours of culture (see section 3.4.1). Incorp­
oration of label into total lipids and the two major membrane lipids was 
essentially linear with time, being several fold higher in the embryo. 
E/YS ratios at the end of the 8 hour incubation were: 2.9, total lipids;
3.4, polar lipids; and 8.9, sterols (all with significance levels 
P<0.001). The percent incorporation data (fig. 3.7), however, show 
some differences from the 16-24 hour data for these two lipids. In the 
embryo, for example, the relative distribution of [3H]acetate into 
polar lipids increased over the first four hours in complete contrast to 
the amount of total incorporated label directed into sterol lipids.
Incorporation of acetate into sterol esters was again greatest in 
the yolk sac; E/YS ratios even decreased from 0.8 to 0.25 (P<0.001) over 
the 8 hours. The percent of total incorporated label into yolk sac 
sterol esters was approximately equal to the percent incorporation 
into yolk sac sterols during this later period of culture.
The most striking difference between the present study and the earlier 
[3H]acetate time-course, however, was the immediate (0.5 hours), high 
percent incorporation into both yolk sac and embryonic triacylglycerols 
observed in the 22-30 hour period of culture (fig's 3.6 and 3.7). No 
'lag' period was observed before radiolabel was incorporated into 
triacylglycerols, and the low levels of incorporation into fatty acid and 
diacylglycerol fractions (5% and 2%, both falling to £1% at 8 hours) were
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consistent with this observation. The actual rates of incorporation into 
these latter lipids were similar to the 16-24 hour profiles with both 
fatty acids and diacylglycerols reaching peak levels midway during the 
incubation period (one time-point later than observed during 16-24 hours) 
and then beginning to drop. The amounts of radioactivity measured in 
these fractions were, however, considerably lower in the present study 
and never higher than levels measured in triacylglycerols.
A comparison of the fatty acid/triacylglycerol events observed during 
the two time-course studies is graphically summarized in figure 3.8 (dia­
cylglycerols have been excluded only for the sake of brevity). The 
'links' between the two sets of data, expressed here as '% total lipids', 
are remarkably close, the percent incorporation into both fatty acids and 
triacylglycerols at the start of the 22-30 hour period continuing the 
progressions initiated during the earlier period of culture.
Finally, figure 3.9 shows the amount of growth achieved by conceptuses 
between 16 and 30 hours of culture during which period the above time- 
-course studies were conducted. During each 8 hour period protein 
content increased by approximately 2-fold in embryos and yolk sacs alike 
and about 4 somite pairs developed. The establishment of the vitelline 
circulation, observed during this period, may be of significant 
importance to the observed changes in lipid metabolism.
3.5 Developmental patterns of embryonic lipid synthesis: 
comparison of cultured conceptuses with fresh explants 
From the previous time-course studies it appeared that triacylglycerol 
synthesis was inhibited in the cultured 9.5 day e.a. rat conceptus until 
about the 18th hour of culture. It was not known, however, if this 
effect was truly developmental or whether it was induced by the in vitro 
environment. The following study was designed to examine these ques­
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tions.
Experimental design The design of this study enabled lipid biosynthesis 
to be compared in conceptuses which had been cultured for up to 47 hours 
with conceptuses which were freshly explanted at equivalent in vivo 
developmental ages.
"Pre-cultured" conceptuses were explanted at 9.58 days e.a. and 
incubated in culture bottles containing 4ml medium for 5, 10, 16, 22 and 
47 hours. These conceptuses were then transferred to minivials contain­
ing 1ml medium (75% rat serum, 25% MEM) and [3H]acetate (125MCi.ml_1, 
lOOmCi.mmol-1). Fresh explants of corresponding developmental ages 
(9.58, 9.75, 9.96, 10.21, 10.46 and 11.50 days e.a.) were placed into
minivials with 1ml medium and incubated on rollers for 1 hour prior to 
the addition of [3H]acetate. The number of conceptuses required for a
single incubation was chosen on the basis of estimated protein content of 
the whole conceptus, and ranged from twenty 9.58 day e.a. conceptuses to 
a single conceptus of 11.5 days e.a. Following a 2 hour incubation in 
the presence of label, conceptuses were removed to cold saline and the 
yolk sacs and embryos separated. Particular care was necessary when 
dissecting early developmental stage conceptuses. The pooled yolk sacs 
and pooled embryos of each vial were pelleted in microtubes and total 
lipids subsequently extracted for analysis by TLC-LSC.
Results The cumulative results of this study are presented in two ways, 
each comparing the data obtained from pre-cultured and freshly explanted 
conceptuses. Tables 3.7.1 and 3.7.2 express the results as dpm.pg 
protein-1 for yolk sac and embryo lipids respectively. The same data 
transformed to '% total lipids’ are illustrated in figures 3.10.1 and
3.10.2 (fatty acid and diacylglycerol data are not included). In 
addition to statistical comparisons between cultured and fresh explants,
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classes plotted. See figure 3.10.1 for an explanation of statistical 
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regression analyses were performed on the developmental data for each 
isolated lipid class of each tissue within each 'treatment1, to assist 
the interpretation of any apparent developmental patterns.
Because of the large numbers of conceptuses required for this study as 
a whole, the presented data was pooled from a large number of individual 
experiments, each experiment consisting of a set of "pre-cultured" 
incubations and a set of "fresh explant" incubations. Therefore, when 
expressed as dpm.pg protein-1, meaningful comparisons could only be made 
between these two 'treatments' at any one equivalent-age time-point, as 
differences in the incorporation of label into total lipids might not 
fully reflect developmental changes, but will be altered to some degree 
by subtle differences in the incubation environment, e.g. the precise 
final specific activity of added [3H]acetate, or the metabolite composit­
ion of culture serum. When data are expressed, however, as the 
percentage of total labelled lipids incorporated into individual lipid 
classes (% total lipids), experience suggests that the variation within 
replicate samples is small. The consistency achieved with this method of 
data expression allows interpretation of inter-experimental comparisons 
to be made with a fair amount of confidence. Bearing this in mind, 
special emphasis is placed on the data illustrated in figures 3.10.1 and
3.10.2 particularly when considering developmental patterns of lipid 
biosynthesis.
During the two hour incubation period the major lipid classes synthes­
ized from [3H]acetate were the polar lipids, sterols and their esters, 
and triacylglycerols. Polar lipids incorporated more [3H]acetate than 
other lipids at all time-points, pre-cultured conceptuses and fresh 
explants alike, in both embryo and yolk sac. The percent incorporation 
into polar lipids was extremely high at 9.58 days e.a. (64% in the yolk 
sac, 75% in the embryo) and progressively decreased over 47 hours
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pre-culture in both tissues, but was only decreased in the yolk sac in 
vivo (fig's 3.10.1 and 3.10.2). These age dependent decreases were 
highly significant as demonstrated by regression analysis. For example, 
by 47 hours of culture only about 27% of total incorporated label was 
directed into pre-cultured yolk sacs while equivalent-age explants 
directed only 40% of incorporated label into their yolk sac polar 
lipids. Also highly significant was the fact that pre-cultured conceptu­
ses incorporated considerably less label into this lipid class than
freshly explanted conceptuses throughout the developmental period 
studied. Indeed, the margin between the two ‘treatments' widened with 
age? this was particularly so in the embryo as freshly explanted
conceptuses continued to direct *70% of incorporated label into polar 
lipids. Dpm.pg protein-1 data generally supported these observations. 
Statistically significant linear decreases in the amount of activity 
contained within the polar lipids over the last few time-points were 
demonstrated for all but freshly explanted embryos, while incorporation 
of [3H]acetate into polar lipids was also significantly lower in pre- 
cultured conceptuses in most cases.
In contrast to polar lipids, the percent incorporation into sterol 
lipids increased with age in a highly significant fashion. This was 
particularly evident in precultured embryos which incorporated con­
siderably increasing amounts of label into the sterol fraction during the 
first 22 hours and, together with the decreased incorporation into polar 
lipids, was responsible for the dramatic changes in the distribution of 
total incorporated counts into these two lipid classes (table 3.7.2 and 
fig. 3.10.2). The increased incorporation into embryonic and yolk sac 
sterols of equivalent-age explants was also linear over the same develop­
mental period. Unlike these observations, the yolk sac of precultured
conceptuses did not appear to incorporate label into its sterols in a
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linear fashion, although the more reliable percent incorporation data did 
show a highly significant linear increase in this fraction, probably 
largely due also to the decreased incorporation into polar lipids.
The amount of label incorporated into sterol lipids of precultured 
conceptuses was always significantly higher than in the equivalent-age 
freshly explanted conceptuses. After 5 hours of preculture, these 
conceptuses contained only about 1.5-fold higher sterol counts than 
corresponding explants, but this difference had increased to 2.3-fold by 
10 hours and to 3.4-fold (embryo) and 4.4-fold (yolk sac) by 16 hours of 
preculture. Thereafter, the increase progressively fell to 1.6-2.0-fold 
higher by 47 hours. The amount of label incorporated into sterol esters 
was, in contrast, only slightly higher in yolk sacs of precultured 
conceptuses after 16 hours of culture. In these conceptuses, the percent 
incorporation into sterol esters was about the same as that for free 
sterols and increased linearly during culture, while the percent incorpo­
ration into sterol esters of fresh explants yolk sacs was generally 
double that into free sterols and increased only slightly with age (table
3.7.1 and fig. 3.10.1). Incorporation into embryonic sterol esters was 
consistently £2.5% in both precultured and fresh explants.
The amount of [3 H]acetate incorporated into triacylglycerols showed 
no distinct developmental patterns in either precultured or freshly 
explanted conceptuses. However, embryos of precultured conceptuses 
incorporated significantly more label into this lipid class than embryos 
of fresh explants. This increase was generally 1.5-fold, although levels 
were only slightly higher in these embryos at 16 hours of culture 
compared with 10.21 days e.a., but increased to 1.9-fold at 24 hours of 
culture. Yolk sac triacylglycerols were even lower in precultured 
conceptuses at 16 hours of culture. The percent incorporation data for 
triacylglycerols reflect this apparent 'slump' in triacylglycerol
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synthesis at 16 hours of culture in both yolk sac and embryo. The 
decrease appeared to begin between 5 and 10 hours of culture but had 
in fact recovered by 22 hours. The percent incorporation into triacyl­
glycerols of fresh explants, on the other hand, was fairly constant 
during the 2 days in the embryo although levels did fall initially; in 
the yolk sac the percent incorporation increased at 9.96 days e.a. in 
parallel with the fall in incorporation into polar lipids.
Fatty acids and diacylglycerols contained similar levels of incorpora­
ted radioactivity in freshly explanted conceptuses but only in yolk sacs 
of precultured conceptuses. The embryos of precultured conceptuses 
incorporated 2-fold more label into fatty acids than into diacylglycerols 
except after 47 hours, both lipids containing peak levels of measured 
activity between 10 and 16 hours of culture. A peak incorporation into 
fatty acids and diacylglycerols also occurred at 16 hours of culture in 
the yolk sacs of these conceptuses. These peak levels coincided with, 
and were almost certainly associated with, the observed 'slump' in 
triacylglycerol synthesis during the same period. Similarly, incorporat­
ion into fatty acids and diacylglycerols of freshly explanted conceptuses 
appeared to reach peak levels at the earlier time-point of 9.96 days 
e.a. and this seemed to coincide with lower levels of incorporation 
into triacylglycerols in these conceptuses.
Overall, developmental patterns were apparent for the synthesis of 
most lipid classes of both embryo and yolk sac during this critical 2 day 
period of organogenesis. Polar lipid synthesis was dramatically reduced 
during development in both precultured and freshly explanted yolk sacs, 
while in embryos increased sterol synthesis was the predominant event 
observed. Precultured conceptuses synthesized relatively more sterol 
than equivalent age explants. Esterification of fatty acids to triacyl­
glycerols was apparently inhibited to some extent during the early part
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of a standard 2 day culture, although this phenomenon also appeared 
at a slightly earlier embryonic age in fresh explants.
Development during the 2 day period studied is reflected by the 
increase in embryonic and yolk sac protein contents and by the increase 
in the number of somite pairs, as illustrated in figure 3.11. As usual 
for a standard 48 hour rat embryo culture, somite number increased from 
1-3 at the head-fold stage (9.58 days e.a.) to approximately 27 somites 
by the end of culture; linear regression showed that about 1 somite 
developed every 1.8 hours. More importantly, there was no difference 
between the number of somite pairs of cultured embryos and equivalent-age 
explants. Likewise, no morphological differences were observed between 
cultured and in vivo embryos or yolk sacs at any stage except at 48 hours 
of culture when embryos were a little smaller and craniofacial developme­
nt was very slightly less advanced than 11.5 day e.a. explants. Protein 
contents increased about 28-fold in the yolk sac during this time, while 
embryonic protein contents increased 40-fold in cultured conceptuses, and 
50-fold in vivo; in vivo embryos were significantly larger (P<0.01).
Commencement of yolk sac vascularization was first evident at about 16 
hours of culture and similarly at 10.21 days e.a., and allantoic circu­
lation was established by the subsequent time-point studied.
3.6 Embryonic lipid synthesis of freshly explanted day 11 
conceptuses during an 8 hour culture 
The previous studies illustrated the influence of the culture 
environment on lipid metabolism of the rat conceptus; lipid synthetic 
pathways were most unusual during the early part of 16-24 hours of 
culture. Thus, effects of valproic acid on lipid biochemistry during 
this period (routinely used in this laboratory for studies of valproic 
acid teratogenicity) might be difficult to interpret. It was necessary,
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therefore, to study lipid synthesis from acetate during a similar 8 
hour period using equivalent aged freshly explanted conceptuses.
Experimental design Conceptuses were explanted at 10.2 days e.a. and 
placed in minivials containing 1ml medium (75% rat serum, 25% MEM; 3 
conceptuses per vial). After a one hour 'equilibration' period in 
culture, [3H]acetate (125pCi, lOOmCi.mmol-1) was added in a small volume 
of MEM and conceptuses cultured in the presence of label for a further 8 
hours. At the end of the experimental period total lipids were extrac­
ted from the pooled embryos and pooled yolk sacs of each vial and 
analysed by TLC-LSC.
Results The results obtained from this study are presented in table 
3.8. Data are expressed as both dpm.pg protein-1 and as '% total lipids' 
as in previous studies. In addition to statistical comparisons of yolk 
sac and embryo counts, the present study was compared by analysis of 
variance with data from that presented earlier in which lipid synthesis 
was examined in 9.5 day e.a. conceptuses during 16-24 hours of culture 
(table 3.2, section 3.2). At the start of the experimental period in the 
present study, conceptuses were of an equivalent developmental age to 
those at 16 hours of culture in the earlier study.
Overall, the amount of radioisotope incorporated into most lipid 
classes and, therefore, the whole conceptus was roughly the same in both 
this and the '16-24 hour' study. Also, E/YS ratios were of the same 
order in each study, except for triacylglycerols which now contained 
equal dpm.pg protein-1 in embryo and yolk sac in contrast to the higher 
embryonic triacylglycerol counts in the earlier study. As previously 
observed, polar lipids accounted for more than half of the total lipid 
associated radioactivity in both tissues, sterol lipids and triacyl-
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Table 3.8
Incorporation of [^acetate into lipid classes of 10.2 day e.a. conceptuses during 1-9 hours of culture.
DPM/ug Protein i! % Total lipids
F/N LIPID YOLK SAC EMBRYO E/YS i!
1 1-
YOLK SAC EMBRYO E/YS
. .
1 Polar lipids 254.1 (5.4) 799.0 (23.2)
1 1“ 
1 1 
1 1
3.1 * i i 
1 1
54.5 (.7) 63.1 (.5) a 1.2 *
2 Diacylglycerols 13.9 (.5) 28.2 (1.4) 2.0 * i! 
1 1
3.0 (.1) 2.2 (.1) 0.7 *
3 Sterols' 37.7 (1.7) 267.0 (9.8)
1 1
7.1 * !!
1 1
8.3 (.5) c 21.1 (.5) a 2.5 *
4 Fatty alcohols 
& lanosterol
2.0 (.1) c 7.7 (.6) c 3.9 * !!
t 1 
1 1
0.4 (.02)d 0.6 (.06)d 1.5
5 Fatty adds (FA) 10.0 (.3) 26.7 (1.1) 2.7 * !! 1 |
2.2 (.1) 2.1 (.1) 1.0
7 Triacylglycerols 107.2 (3.8) 113.0 (2.2)
I 1
1.1 ! i 
1 1
23.1 (.6) 9.0 (.2) 0.4 *
8 FA alkyl esters 2.4 (.1) d 3.8 (.3) c 1.6 * J! 
1 1
0.5 (.02) c 0.3 (.02)c 0.6 *
10 Sterol esters 16.6 (.8) 7.6 (.4) d 0.5 * !! 3.5 (.1) 0.6 (.02)b 0.2 *
11 "10" & Squalene 9.0 (.7) 1.8 (.2) 0.2 * ii
f 1 
1 1
2.0 (.2) c 0.1 (.02) 0.1 *
.
Total lipids 464.5 (8.8) 1265.0 (32.8) 2.7 * !!
. . i »_
[97.5] [99.1]
.
ug Protein/tissue 36.3 (1.2) 52.1 (1.6) 1.4 * !!
Data are expressed as DPM/ug protein and as the percent of total lipids incorporated into individual 
lipid fractions (% total lipids). Mean values of 11 determinations (+/- SEH) are presented. * PC0.001, 
embryo and yolk sac data significantly different, analysis of variance, d P<0.1, c P<0.05, b P<0.01, 
a P<0.001, data significantly different from [3H]acetate incorporation data presented in table 3.2.
(9.5 day e.a. during 16-24 hours of culture), analysis of variance.
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glycerols accounting for another 30% or so of the total. Under the 
conditions of the present experimental design, however, the percent 
incorporation into free sterols was significantly lower by 4-5% in both 
embryo and yolk sac, compared with the distribution of [3H]acetate into 
this lipid during 16-24 hours of culture of 9.5 day conceptuses.
Smaller percent incorporation values for the lanosterol fraction and 
sterol esters in the present study were in agreement with this major 
observation. Examining the dpm.pg protein-1 data more closely, the 
amounts of label contained in these three lipids were considerably less 
in this study (although apparently not significant for sterol lipids) and 
differed from values in the 16-24 hour study more than any other lipids 
did. Therefore, reduced synthesis of sterols appeared to be the main 
difference between lipid synthetic processes in fresh explants compared 
with equivalent-age conceptuses which had been in culture for 16 hours.
As a direct result of this event label was redirected into other lipid 
classes. However, unlike the yolk sac in which label was redistributed 
into both polar lipids and triacylglycerols alike (the percent incorp­
oration into each of these fractions was increased by a few percent), in
the embryo triacylglycerol synthesis was unchanged and 'extra' radio­
activity was directed into polar lipids.
3.7 Potential alternatives to acetate as lipid precursors for
the study of embryonic lipid biosynthesis
3.7.1 Glucose
Experimental design The experimental protocol described in the preceding 
section (3.6) was used to study the potential embryonic metabolism of 
glucose to lipids. Following 1 hour 'equilibration' of 10.2 day
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e.a. conceptuses, groups of 6-8 conceptuses were transferred to minivials 
containing D-[U-14C]glucose (4.9pCi, 270mCi.mmol-1) in 1ml medium (75% 
rat serum, 19% MEM, 6% radiolabelled glucose in aqueous (3%) ethanol). 
As serum and MEM contain approximately 1.5mg.ml-1 and l.Omg.ml-1 respect­
ively, the final specific activity of radiolabelled glucose was about 
0.67mCi.mmol-1. Conceptuses were cultured for 8 hours in the presence of 
label after which total lipids were extracted from pooled embryos and 
pooled yolk sacs and analysed by TLC-LSC.
Results Table 3.9 summarizes the results of this study, expressed as 
both dpm.pg protein-1 and as '% total lipids1. Radioactivity from 
metabolised D- [U-14C]glucose was incorporated into all lipid classes 
isolated. However, apart from polar lipids and triacylglycerols, the 
amount of label incorporated into individual lipid classes was quite low 
under the experimental conditions. In particular, the amount of label 
incorporated into free sterol was very low in the yolk sac and equal to
the amount incorporated into esterified sterol. In this tissue, polar
lipids and triacylglycerols together accounted for 93% of the total lipid 
associated radioactivity, polar lipids containing 1.7-fold more activity 
than triacylglycerols. In the embryo these two lipids again accounted 
for nearly 90% of the total counts, but the amount of radioactivity
incorporated into triacylglycerols was approximately the same (dpm.pg
protein-1) as that incorporated into this fraction in the yolk sac
whereas embryonic polar lipids contained about 3-fold more counts than in
the yolk sac. Thus, polar lipids alone accounted for about three-
quarters of the total activity incorporated into embryonic lipids. The 
amount of label incorporated into embryonic free sterol was considerably 
higher than in the yolk sac and accounted for 7.5% of the total lipid 
counts in this tissue; sterol esters contained just 0.5% of the total
117
Table 3.9
Incorporation of [U-14C]glucose into lipid classes of 10.2 day e.a. conceptuses during 1-9 hours of culture.
DPM/ug Protein !! % Total lipids
F/N LIPID YOLK SAC EMBRYO E/YS !!
t t-
YOLK SAC EMBRYO E/YS
1 Polar lipids 38.4 (.8) 112.9 (3.1)
I 1“
j j
2.9 * jj 
1 1
58.3 (.6) 74.4 (.5) 1.3 *
2 Diacylglycerols 1.1 (.05) 1.8 (.1) 1.6 * !S 
1 1
1.7 (.1) 1.2 (.04) 0.7 *
3 Sterols 1.1 (.04) 11.4 (.3) 10.7 * i! 
1 1
1.6 (.03) 7.5 (.2) 4.7 *
4 Fatty alcohols 
& lanosterol
<0.01 0.4 (.05) 44.4 * !!
11 11
11
<0.02 0.3 (.03) 20.8 *
5 Fatty adds 0.5 (.03) 1.6 (.1)
11
3.3 * i! 
11
0.8 (.04) 1.1 (.05) 1.5 *
7 Triacylglycerols 23.0 (.8) 21.4 (.9)
11
0.9 i 
11
34.7 (.6) 14.1 (.4) 0.4 *
8 Fatty alkyl 
esters
0.3 (.01) 0.8 (.03)
11
3.2 * j!
11 11 
11
0.4 (.01) 0.5 (.02) 1.3 *
10 Sterol esters 1.0 (.04) 0.7 (.03) 0.7 * !! 
11
1.6 (.05) 0.5 (.02) 0.3 *
11 "10" & Squalene 0.3 (.08) 0.1 (.01)
11
0.3 j!
1111 
11
0.5 (.1) <0.1 0.1
Total lipids 66.0 (1.7) 151.7 (4.2) 2.3 * !! 
1 1
[100.0] [100.0]
ug Protein/tissue 34.3 (.7) 49.1 (1.2) 1.4 * !!
Data are expressed as DPM/ug protein and as the percent of total lipids incorporated into individual 
lipid fractions (% total lipids). Mean values of 7 determinations (+/- SIM) are presented, 
n.d., unknown; * P<0.001, embryo and yolk sac data significantly different, analysis of variance.
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embryonic lipid counts, approximately 3-fold lower than in the yolk sac. 
In both tissues, therefore, sterol synthesis from D-tU-14C]glucose was 
markedly lower than from [3H]acetate during the same experimental period, 
the majority of label used for lipid synthesis being directed towards 
polar lipid, and to a lesser extent triacylglycerol synthesis. The total 
amount of label incorporated into lipids was only about 15% and 12% of 
the total radioactivity measured respectively in embryo and yolk sac 
homogenates prior to extraction.
3.7.2 3H20
Experimental design The experimental period described above was used to 
examine the potential use of 3H2 0 for studies of embryonic lipid biosyn­
thesis; i.e. 10.2 day e.a. conceptuses were exposed to labelled water 
between 1 and 9 hours of culture. Incubations were carried out in 
minivials containing 1ml medium (75% rat serum, 25% MEM) and up to 7mCi 
3H20 (specific activity of added 3H20, 5Ci.ml_1).
Results Studies with 3H20 were largely unsuccessful and no presentable 
results were obtained. This was because high concentrations of 
radiolabel were required in the media to obtain any sizeable incorp­
oration into the lipid compartment of the conceptus. Preliminary 
'radiolabel concentration finding studies’ revealed that the higher 
levels of added label were especially toxic to the cultured conceptus. 
At 7mCi.ml“1 embryonic development was severely stunted and the tissue 
was blackened due to extreme levels of cell necrosis. At 4mCi.ml_1, cell 
death was still evident in areas such as the tail, head and limb bud, 
where cell division is usually prolific during this stage of devel­
opment.
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A concentration of 2.5mCi.ml-1 appeared to be the highest acceptable 
to the developing conceptuses which showed little or no signs of retarded 
growth after 8 hours exposure to this level of radioactivity. However, 
at this concentration less than 550 cpm were measured in the total lipids 
extracted from a single conceptus of which only about 30% were present in 
the yolk sac. TLC showed that the majority of label was present in polar 
lipids (69%, embryo; 57%, yolk sac), followed by triacylglycerols 
(15%, embryo; 29%, yolk sac). Incorporation into free sterol and 
sterol esters was respectively 8% and 1% in the embryo but just 3% and 
4% in the yolk sac. At least ten 10.2 day e.a. conceptuses were 
required under these conditions to obtain accurately measurable amounts 
of activity. A concise study with 3H20 would, therefore, have proved 
costly in terms of both radiolabel and embryos, especially if the effects 
of teratogenic compounds were to be examined in parallel with untreated 
controls.
Parallel incubations with adult F344/Tru rat isolated hepatocytes 
(5.6mg {protein} suspended in 1ml Williams' medium E supplemented with 5% 
FCS) incubated for 30 minutes at 37°C in minivials containing 2.5mCi 3H20 
per ml medium, incorporated »10,000 dpm.mg protein-1.hr-1 into total 
lipids (95% into polar lipids, sterols and triacylglycerols). This 
compared with re-expressed whole conceptus data of about 2,900 dpm.mg 
protein-1.hr-1. Thus the 10.5 day e.a. conceptus apparently synthesised 
lipids at a rate approximately 3-fold lower than adult liver.
3.8 Discussion
Lipid biochemistry of the developing mammalian embryo is generally 
poorly understood. In particular, very little is known about this area 
of metabolism during organogenesis, the period of embryonic development 
most sensitive to teratogenic insult. A fuller understanding of embryo­
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nic metabolism in general would undoubtedly benefit teratologists in 
their efforts to discover fundamental mechanisms of abnormal 
development. The experiments presented in this chapter begin to examine 
the metabolism of lipids, particularly the synthetic processes, in the 
organogenesis-phase rat embryo (9.5 to 11.5 days e.a.), the period of 
development during which rat whole conceptuses are routinely cultured to 
assess teratogenic capacities of drugs and other chemicals.
Preliminary experiments were performed using tritiated water in an 
attempt to measure absolute rates of synthesis of fatty acids, 
cholesterol and their respective esters. Although the use of this 
isotope in lipid biochemistry is well documented for both adult tissues 
(Jungus, 1968; Anderson & Dietschy, 1979; Geelen et al., 1983) and late 
foetal tissues (Leoni et: al., 1984), extremely high levels of 3H20
were needed to obtain even low levels of incorporation into lipids of 
early postimplantation embryos. An equivalent protein mass of isolated 
hepatocytes incorporated 3-fold more radioactivity into total lipids,
suggesting that overall rates of lipid synthesis in the conceptuses were 
substantially lower than in adult liver. However, when conceptuses were
incubated in the presence of considerably smaller quantities of radio­
labelled acetate, the basic 2-carbon building block for the biosynthesis 
of cholesterol and fatty acids, high levels of incorporated radioactivity 
were measured in isolated lipid fractions of both yolk sac and embryonic 
tissues. Consequently, this substrate which would be available to the 
developing embryo in utero (concentrations measured in adult rat serum 
were in the range 1.7-2.0mM), was utilized in the majority of subsequent 
studies.
All studies performed with this simple carboxylic acid showed that the 
early organogenic conceptus is able to synthesize de novo the major lipid 
classes. This demonstrated the ability of conceptuses to activate
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exogenously derived acetate to acetyl-CoA, presumably via acetate thio- 
kinase. Initial experiments during the whole 48 hour culture period 
showed that acetate was particularly utilized for the synthesis of
membrane lipids, polar (phospho-) and sterol lipids, reflecting the 
extensive membrane synthesis required during this period of rapid 
growth and development. In addition, considerable amounts of the
high energy fat storage molecules, triacylglycerols, were synthesised.
Incorporation studies conducted over shorter culture periods (as little 
as 30 minutes; section 3.4) showed that acetate was rapidly incorporated 
into these lipid classes, thus demonstrating rapid fatty acid synthesis 
and esterification. These pathways have not previously been studied in 
viable conceptuses.
A closer inspection of the polar and sterol lipids synthesised during 
16-24 hours of culture identified the major components of these
fractions. Also, by extracting these from the total lipid fraction, the 
presence of other lipid classes usually 'masked* by the membrane lipids 
in TLC fractions could be quantified, therefore allowing the degree of 
resolution obtained with this technique, routinely used in these studies, 
to be determined (see sections 3.4.2 and 3.4.3). Analysis of polar 
lipids, separated from total lipids by column chromatography, showed that 
phosphatidylcholine was synthesised far in excess of other phospholipids 
and accounted for about 75% of the total phospholipid associated radio­
activity. Phosphatidylethanolamine was the other predominant phospho­
lipid synthesised but only accounted for *18% of the total phospholipid 
counts, while serine and inositol phospholipids together contained about 
half this amount. These relative amounts of phospholipids were very 
similar to the percent incorporation of radiolabelled D-glucose or 
palmitate measured in phospholipids of preimplantation mouse embryos 
(Flynn & Hillman, 1978 and 1980). Moreover, Chepenik & Waite (1973)
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demonstrated that phosphatidylethanolamine pre-labelled with ethanolamine 
was predominantly converted to phosphatidylcholine in 14 and 16 day 
e.a. rat embryos.
Further analysis of digitonin-precipitable sterol lipids showed that 
cholesterol was the predominant sterol synthesized. Only very small 
amounts of lanosterol and squalene, intermediate metabolites of chol­
esterol biosynthesis were present, again reflecting the rapid flux of 
this pathway. TLC of the non-precipitable fractions confirmed that the 
sterol ester fractions contained relatively little squalene, and proved 
that the yolk sac esterified considerably more cholesterol than the 
embryo.
During 16-24 hours of culture and also during the later 8 hour study 
with fresh 10.2 day explants, the major lipid classes synthesised were 
again membrane sterols and phospholipids, and triacylglycerols. In the 
embryo, measured levels of acetate incorporation were in the order: polar 
lipids>cholesterol>triacylglycerols, as observed at the end of 48 hours 
culture with this isotope. However, yolk sac levels of synthesis
followed the pattern: polar lipids>triacylglycerols>cholesterol, unlike
the longer study where the amounts of radioactivity incorporated into 
cholesterol and triacylglycerols were equal at the end of 48 hours. The 
high triacylglycerol:cholesterol ratio in the yolk sac compared with the 
embryo was consistently observed in all studies performed. Similarly, 
the yolk sac produced more sterol esters, the other main lipid storage 
molecule, than the embryo proper. Indeed, yolk sac sterol ester syn­
thesis was actually considerably greater in terms of dpm.pg protein-1 
than embryonic synthesis of this lipid, a phenomenon not observed for 
any other lipid class synthesised from [3H]acetate. Thus the proportion 
of sterol esters to free sterol was considerably different in the two 
tissues. It is conceivable that the embryo itself has extremely low
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activities of ACAT (Acyl-CoA:cholesterol-0-acyl transferase) responsible 
for sterol esterification, and obtains a certain amount of its 
cholesterol via transport of yolk sac sterol esters in the vitelline 
circulation or across the fluid cavities (amniotic and exocoelomic) 
between the visceral yolk sac and embryo proper.
Studies with [3H]oleic acid highlighted this preferential synthesis of 
lipid storage molecules in the yolk sac. Esterification of this long- 
-chain fatty acid to triacylglycerols was 5.5-fold higher in the yolk sac 
than the embryo, while yolk sac sterol ester formation was 12-fold 
higher. This effect did not appear to be due to differences in the 
availability of free fatty acid to each tissue since the rate of esterif­
ication into polar lipids was, very similar in both yolk sacs and 
embryos.
Similarly, the percent incorporation of glycolytic metabolites of 
D-fu-14C]glucose into triacylglycerols was considerably higher in 
yolk sac tissue than the embryo although the rate of synthesis (dpm.pg 
protein-1.hr-1) was similar in both tissues.
The greater synthesis of triacylglycerols and sterol esters in the 
yolk sac suggests that this tissue plays an important role in the storage 
of excess lipid and the regulation of free fatty acid and cholesterol 
levels. Although the amounts of either of these storage molecules had 
not been quantified, iodine staining of both lipids was quite obviously 
more intense in yolk sac tissue than embryonic tissue following TLC of 
lipid extracts from the same conceptuses, quite unlike the staining 
intensities of other fractions which were greater in embryonic tissue (no 
added carriers; data not presented). Thus qualitatively it appears that 
the embryo proper contains considerably less triacylglycerol and sterol 
ester than its surrounding yolk sac. Aggregation of newly synthesised 
triacylglycerols as cytoplasmic lipid 'droplets' has been observed in the
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visceral yolk sac endodermal cells of similar aged rat conceptuses 
(Takeuchi, 1980). The importance of such large triacylglycerol stores, 
particularly within the yolk sac, at this stage of embryonic development 
is unclear. It may be that this store becomes increasingly more 
important as oxidative pathways become operable, providing a rich supply 
of fuel in the form of fatty acids. Although triacylglycerol turnover 
was not studied, the 'build up' of fat stores suggests that lipolysis of 
the acyl groups for oxidation is minimal. In addition only small amounts 
of [9,10-3H]oleic acid were incorporated into fractions 2 and 3 of TLC 
plates developed with neutral lipids developing solvent (also yolk sac 
activity in these fractions was greater than that in the embryo). Thus 
the counts in fraction 3 appeared to be of diacylglycerol rather than 
sterol nature, indicating little or no oxidation of this long-chain fatty 
acid to acetyl-CoA, a proportion of which would then be utilized for 
sterol synthesis. Furthermore, preliminary studies designed to measure 
p-oxidation directly, indicated minimal amounts of 14C02 production from 
labelled palmitic acid in 11.5 day e.a. conceptuses (incomplete data; not 
presented).
The role of sterol esters might be more easily explained, since free 
cholesterol can be toxic if present in amounts in excess of a particular 
tissue's requirements (Brown & Goldstein, 1976). As mentioned above, 
sterol esters may also play a role in the transport of cholesterol 
between the yolk sac and embryo. Transportation of newly synthesised
yolk sac lipids to the embryo might offer an explanation for the observed 
non-linear time-course of [3H]acetate incorporation into sterol and polar 
lipids and the resulting time-dependent increases in E/YS ratios of these 
fractions.
In contrast to the large amounts of triacylglycerol lipids synth­
esized, mono- and diacylglycerols each accounted for no more than a few
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percent of the total lipid associated radioactivity in either tissue. 
The low 1,3-diacylglycerol activities 'unmasked' following extraction of 
digitonin-precipitable sterols were about the same as those of the 1,2 
isomer in this study. However, when corrected for sterol extraction
efficiency (78-92%) it becomes clear that 1,2-diacylglycerols, the 
physiological form, were the predominant isomer of this class. 
Similarly, following extraction of the more polar (methanol soluble) 
lipids, only small amounts of radioactivity, presumably monoacylglycerols 
were detected near the origin of chromoplates developed with neutral 
lipids developing solvent. Low levels of fatty acid alkyl esters 
(0.5-1%) appearing on the TLC plate may be derived entirely from free 
fatty acids during extraction procedures involving the use of methanol or 
ethanol (Kates, 1972). However, these esters may also be found 'physio­
logically' following alcohol metabolism (Lange e£ al., 1983) and inhibit­
ors of cholesterol biosynthesis appear to produce relatively high levels 
of these esters in the developing embryo and yolk sac (see Chapter 4, 
section 4.2.1). No attempts were made to determine the composition of 
the non-esterified fatty acids or the acyl chains present on esterified 
complexes.
The time-course for [3H]acetate incorporation into lipids during 16-24 
hours initially indicated that non-esterified fatty acids are rapidly 
esterified to 1,2-diacylglycerols, while high rates of triacylglycerol 
synthesis from this precursor are delayed, possibly because of greater 
conversion of 1,2-diacylglycerol to phospholipids. This seemed possible 
since the rate of triacylglycerol synthesis only increased when polar 
lipids had reached steady state levels of synthesis (steady '% total 
lipids' levels). Thus, polar lipids appeared to be synthesised de novo 
from [3H]acetate in addition, presumably, to acylation (with newly 
synthesised 'radioactive' fatty acids) of preformed glycerol. However,
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the parallel time-course measuring the incorporation of [9,10-3H]oleic 
acid showed no such relationship between polar lipid and triacylglycerol 
syntheses, and in addition when [3H]acetate incorporation was examined 
during 22-30 hours of culture triacylglycerols were synthesized immed­
iately, before polar lipids had reached steady state levels. Thus, 
the 'lag' prior to high rates of triacylglycerol synthesis being achieved 
was apparently not directly related to a preferential esterification of 
fatty acids into polar lipids. Instead, the decrease in fatty acid and 
1,2-diacylglycerol synthesis at the start of rapid triacylglycerol 
synthesis, suggested inhibition of diacylglycerol acyltransferase (EC 
2.3.1.20), the enzyme responsible for the further acylation of diacyl­
glycerol to triacylglycerol. The time-course for [3H]acetate incorp­
oration during 22-30 hours of culture provided further evidence for the 
relationship of fatty acids and 1,2-diacylglycerols with triacylgly­
cerols, since the percent incorporations into these fractions at the 
start of this period were very similar to those towards the end of 16-24 
hours. The reason for inhibition of triacylglycerol synthesis around 
16-18 hours of culture was unclear. Was it the influence of culture
conditions, or indeed was it a true biochemical event in postimplantation 
embryonic development?
In an attempt to answer this, lipid synthesis was examined in concept­
uses which had been exposed to increasing periods of culture, and in 
equivalent age freshly explanted conceptuses. The percent incorporation 
data showed that the amount of acetate incorporated into triacylglycerols 
increased initially, but had decreased by 10 hours of culture. In 
agreement with the time-course data, minimum relative levels of triacyl­
glycerol synthesis were reached by 16 hours of culture, prior to a 
subsequent increase. Thus it appeared that it was the period of culture 
which was responsible for a gradual decrease in triacylglycerol synthesis
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during the first 16 hours, after which the conceptuses began to recover. 
Closer inspection of the data obtained from equivalent aged fresh 
explants showed that the relative levels of triacylglycerol synthesis 
were also lower in vivo during the earlier part of the developmental 
period studied. Concomitant with this event, the amount of radioactivity 
incorporated into fatty acid and 1,2-diacylglycerols was higher during 
this period, similar to but earlier than the effect observed in cultured 
conceptuses. Therefore, although the mechanism for this phenomenon 
remained unresolved after this comparative study it did appear that 
similar biochemical changes in fatty acid metabolism also occurred in 
vivo, while the effect of culture was to amplify these changes. It is 
possible that changes and/or brief disturbances in lipid metabolism might 
occur during this period of development especially, reflecting the 
growing importance of oxidative metabolism as first the yolk sac circu­
lation and then allantoic placentation is established.
Possibly also related to the mammalian embryos switch to a more 
aerobic metabolism during mid-gestation, developmental patterns of change 
in other lipid classes, notably polar (phospho-) lipids and sterols, were 
also observed. These changes generally showed similar profiles both in 
vivo (fresh explants) and in vitro (cultured conceptuses), although again 
the culture environment appeared to amplify the changes. In both the 
yolk sac and the embryo de novo synthesis of total lipids was maximal at 
about 10 days e.a., or slightly later at 16 hours in cultured con­
ceptuses, while total [3H]acetate incorporation into lipids at 9.58 and 
11.5 days e.a. and 47 hours of culture were approximately equal. 
However, the profiles of acetate incorporation differed considerably at 
different ages mainly due to decreased levels of polar lipid synthesis in 
both the yolk sac and embryo, plus increased sterol synthesis in the 
embryo. Because of the considerable changes observed during the two day
128
period of development it is worth reiterating some of the data. In the 
yolk sac, distribution into polar lipids was 63% at 9.58 days e.a. but 
had decreased to just 28% in cultured conceptuses, and to 39% in fresh 
explants at the end of the two days. Percentage incorporations into yolk 
sac sterol and triacylglycerol lipids were increased in response. 
In the embryo itself the distribution of label into polar lipids was only 
slightly reduced in response to small but significant increases in free 
sterol synthesis in vivo, in contrast to cultured conceptuses in which 
the amount of total label incorporated into sterols increased from 10% to 
30% and that into polar lipids decreased from 75% to 46% during the 48 
hours. Thus, although major and similar changes in the profile of lipid 
synthesis were observed in the yolk sac, the culture environment appar­
ently had a considerable influence on the lipid metabolism of the embryo 
proper. The main difference was the greater synthesis of sterol lipids 
in cultured conceptuses, both the embryo and the yolk sac, producing 
higher free sterol to esterified sterol ratios than in fresh explants. 
Not only did cultured conceptuses synthesize more sterol than fresh 
explants at all times studied, but the proportion of acetate utilized for 
sterol synthesis was greatly increased with embryonic development. These 
observations seemed to suggest that cholesterol or other sterols required 
by the developing embryo were not available to cultured conceptuses in 
such plentiful supply as in utero. For example, certain hormones might 
be important for normal development and could be in short supply in the 
culture medium, particularly towards the latter stages of a 48 hour 
culture. It is also possible that uptake mechanisms to provide the 
conceptus with sufficient membrane cholesterol might be impaired in 
culture. In either situation the cultured conceptus, if it is like other 
extra-hepatic tissues, would attempt metabolic compensation, responding 
by increasing its own rate of sterol lipids synthesis.
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Finally, the use of D-[U-14C]glucose as an alternative precursor of 
embryonic lipids was examined. Incorporation of radiolabelled D-glucose 
into lipids has previously been recorded in both preimplantation mouse 
embryos (Flynn & Hillman, 1978) and in day 11 rat embryos (Tanimura & 
Shepard, 1970a). In the latter study, lipids accounted for 13% of the 
total incorporated activity, which agrees closely with the data presented 
in section 3.7.1. The predominant conversion of D-[U-14C]glucose to 
polar and triacylglycerol lipids, together with the small amount of 
sterol lipid synthesized, produced a lipid incorporation profile quite 
unlike that observed for acetate. This suggested that relatively little 
glucose is converted to lipids via acetyl-CoA, indicating that the major 
route of lipid biosynthesis from glucose in embryos is like adult tissues 
(e.g. rat liver) from DHAP via the 'glycerol phosphate pathway', or to a 
lesser extent via the 'DHAP pathway'. In both pathways phosphatidic acid 
is synthesized and converted to 1,2-diacylglycerol, the precursor of 
triacylglycerols, and phosphoglycerides such as phosphatidylcholine (Gurr 
& James, 1980). In addition, the polar lipid fraction might contain 
glycolipids synthesized either directly from glucose-6-phosphate via 
UDP-glucose, or indirectly via glycogen, as observed in preimplantation 
mouse embryos (Flynn & Hillman, 1978). Tanimura & Shepard (1970b) showed 
that £80% of D-glucose metabolised by the 10.5 day e.a. rat conceptus in 
culture is converted to lactate while approximately 12% is incorporated 
into macromolecules, the remainder being oxidized to C02. While the data 
presented indicate that the predominant route of entry into complex 
lipids is via glycolytic intermediates, the small amount of non-est­
erified fatty acids, sterols and sterol esters synthesized via acetyl-CoA 
suggests that a certain proportion of polar and triacylglycerol lipids 
formed from D-tU-14C]glucose should be labelled in the acyl chains as 
well as the glycerol backbone. Alkaline hydrolysis and analysis of
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subsequent chloroform and water soluble fractions was, however, not 
performed.
Summary This chapter has described the ability of the developing organo- 
genesis-phase conceptus to synthesize de novo all major lipid classes. 
In addition, the capacity to take up and esterify long-chain fatty acids 
has been demonstrated, while the ability to utilize its major energy 
source, glucose, for conversion to complex lipid esters as well as 
membrane sterols has been shown. In contrast, it appears that the
conceptus has little or no capacity for oxidative catabolism of fatty
acids. As observed in studies of carbohydrate metabolism, the overall 
lipid biochemistry of the conceptus appears to be developmentally 
regulated in utero and this has also been observed in cultured
conceptuses. However, the lack of maternal influences and the in vitro
environment appears to modify the lipid metabolic profiles of cultured 
conceptuses; differences in lipid metabolism from that in freshly 
explanted conceptuses become greater with increased culture time.
Chapter 4
VALPROIC ACID TERATOGENESIS AND ACTIONS 
ON EMBRYONIC LIPID SYNTHESIS
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4.1 Introduction
This chapter describes studies which investigated actions of the 
teratogen valproic acid on lipid synthesis in the organogenesis-phase
conceptus. The first of these studies looked for possible effects of
valproic acid on [3H]acetate incorporation into lipids during the
standard 48 hour culture period. Subsequent investigations, however,
examined this possibility during the shorter experimental period of 16-24 
hours of culture (from 9.5 days e.a.), previously used in this laboratory 
to study the potential actions of valproic acid and related SCCA on other
biochemical processes (Coakley et al., 1986; see Chapter 1, section
1.6). By investigating valproic acid's actions during a short and
relatively sensitive exposure to conceptuses it was hoped that any
significant effects on lipid biosynthesis would either show or reflect
the initial biochemical insult inflicted by this drug. Also, by com­
paring valproic acid's actions with the effects of butyric acid, a potent 
SCCA teratogen expressing similar structural abnormalities to those of 
valproic acid in embryo culture, and with the effects of valpromide, 
which was known not to induce valproic acid-like anomalies in vivo, it 
might be possible to identify actions specific to the two SCCA which 
would be worthy of further investigation. These principles provided the
foundations for the research presented in section 4.3.
Apparently specific actions on the incorporation of [3H]acetate were 
observed and subsequent investigations (sections 4.4-4.8) were designed 
to explore these actions in more detail and under different experimental 
conditions.
In addition to studying valproic acid, the two opening sections of 
this chapter examine the actions of known specific inhibitors of lipid 
biosynthesis: mevinolinic acid, a specific competitive inhibitor of 
HMG-CoA reductase (Alberts et al.,1980) and TMD, a specific competitive
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inhibitor of 2,3-oxidosqualene lanosterol cyclase (EC 5.4.99.7; Chang et_ 
al.f 1979). Specific chemical inhibitors provide valuable tools for 
studying metabolic pathways and their regulation. In the present 
studies, these agents proved additionally useful for assessing the 
sensitivity of the techniques employed for examining lipid synthesis and 
the actions of chemical teratogens in the mammalian conceptus.
Note Treatment-induced changes from control levels of radioactivity 
measured in lipid fractions, quoted as %'s in the text, were calculated 
from the ’raw' experimental data and may differ slightly from values 
which could be calculated from the 'rounded' data presented.
4.2 Effects of teratogenic treatments on the incorporation of
[3H]acetate into lipids of 9.5 day e.a. conceptuses during 0-48 
hours of culture
Experimental design Conceptuses of 9.5 days e.a. were cultured in 50ml 
culture bottles containing 4ml medium (75% rat serum, 25% MEM) and 
[3H]acetate (125pCi.ml-1, 130mCi.mmol-1) with or without added terato­
genic compound for a period of 48 hours. Three conceptuses were cultured 
in each bottle. At the end of culture embryonic morphology and develop­
ment were assessed. Total lipids were then extracted from the pooled 
embryos and pooled yolk sacs of each bottle and analysed by TLC-LSC.
4.2.1 Effects of mevinolinic acid and TMD
Tables 4.1 and 4.2 respectively summarize the effects of mevinolinic 
acid (l.Opg.ml-1 {2.25pM} and 1.5pg.ml-1 {3.37pM}) and TMD (50pg.ml-1 
{25.5mM} and 75pg.ml-1 {38.3mM}) on embryonic lipid synthesis from
[3H]acetate. Data are expressed both as dpm.pg protein-1 and as '% total 
lipids'.
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Mevinolinic acid Mevinolinic acid significantly decreased the amount of 
[3H]acetate incorporated into free and esterified sterol lipids in a 
dose-dependent fashion, and was more potent at producing this effect in 
the yolk sac than embryo. In this tissue, the two concentrations of 
mevinolinic acid inhibited the incorporation of [3H]acetate into free 
sterols by 28% and 73%, and decreased activity into sterol esters 
(fraction 10) by 63% and 67% with respect to untreated controls. The 
percent incorporation into these lipids was reduced by similar orders of 
magnitude. In the embryo, however, incorporation of label into free 
sterols was only inhibited by 14% at the lower dose of lpg.ml-1 (not 
significant) and by 42% (P<0.05) at 1.5pg.ml_1; the percent incorporation 
into sterols was reduced by 40% and 62% but was more a reflection of 
increased counts in other lipids (see below). Incorporation of 
[3H]acetate into embryonic sterol esters was significantly decreased by a 
similar amount. Reduced levels of radioactivity were also measured in 
other sterol related fractions (4 and 11) and these changes too were 
mostly significant.
In addition to the expected actions on sterol lipid synthesis, mevino­
linic acid also produced significant alterations in levels of incorp­
orated activity in other classes. Notably, triacylglycerols contained
1.8 to 2.2-fold more label in the yolk sac and 2.6 to 3.8-fold more label 
in the embryo, at the two mevinolinic acid concentrations, than control 
conceptuses. Incorporation of [3H]acetate into fatty alkyl esters was 
increased by mevinolinic acid treatment to a similar degree in both 
tissues. Increased incorporation of radiolabel into embryonic polar 
lipids was also highly significant but a clear dose-response relationship 
was not apparent in this fraction.
The extent of embryonic development and the morphology of the same 
mevinolinic acid treated conceptuses at 48 hours of culture is shown in
Table 4.1
Effects of mevinolinic acid (1.0 & 1.5ug/ml) on the incorporation of pH]acetate into lipid classes 
of 9.5 day e.a. conceptuses during 48 hours exposure (0-48 hours of culture).
11 Ii DPM/ug ProteinI I
% Total lipids
.
1
I
1 1
1! CCNIR0L 
1 1
MEVINOLINIC ACID CCNIR0L ! MEVINOLINIC ACID
1
F/N LIPID
I 1
I! l.Oug/m] 1.5ug/ml 
-  ,
1
l.Oug/ml 1 1.5ug/ml
I ...— . .... - --j
YOLK SAC {!
1 1
. “ - -1-------
1
1 Polar lipids !! 32 (3) 
1 1
42 * 37
‘
48.0 (1.6 52.4 + 1 52.5 
1
2 Diacylglycerols I! 2 (.3) 
1 1
2 2 3.4 (.4) 2.3 +
1
i 2.8 
1
3 Sterols i! 13 (.5) 9 *** 3 *** 19.2 (.7) 11.2 ***
1
5.1 ***
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& lanosterol
!! 2 (.2) 
1 1
1 1
2 i ** 2.6 (.2) 1.8 * 1.2 **
5 Fatty acids (FA) I! 3 (.5) 
11
4 2 + 4.4 (.4) 4.2 2.7 *
7 Triacylglycerols i! 10 (1) 18 *** 22 *** 15.3 (1.5 23.9 ** 31.1 ***
8 FA alkyl esters S! 0.8 (.2) 
1 1
2 * 2 * 1.2 (.2) 1.8 2.2 +
10 Sterol esters i! 2 (.2) 
1 1
1 ** 1 ** 3.4 (.3) 1.1 * * * 1.1 **
11 "10" & Squalene i! 0.8 (.2)
t 1 1 1
• •
0.3 0.1 ** • 1.2 (.3) 0.3 + 0.1 *
Total lipids !! 67 (3) 
1 1
80 *
i
70 !!
it
ug Protein/tissue !! 131 (6) 118 124 ii
EMBRYO
1 Polar lipids ! 73 (5) 112 *** 119 ** 49.7 (.9) 53.9 * 54.4
2 Diacylglycerols
.
! 3 (.6) 
1
4 5
.
2.2 (.2) 1.8 2.2
3 Sterols ; 42 (4) 
1
36 24 * 28.5 (.8) 17.2 *** 10.9 ***
.
4 Fatty alcohols 
& lanosterol
I
! 5 (.4) 4 3 3.2 (.2) 2.0 ** 1#3 ***
1
5 Fatty acids
1
! 5 (.9) 7 + 5 3.3 (.3) 3.5 2.3 *
1
7 Triacylglycerols ’
I
! 15 (3) 40 ** 57 * 10.3 (1.3) 19.3 ** 2 5 .1 * *
1
8 FA alkyl esters !
1
! 1 (.3) 3 * 5 0.7 (.1) 1.2 * 2.0 *
1
10 Sterol esters !
I
! 2 (.2) 0.8 ** 0.6 ** 1.2 (.06) 0.4 * * * 0.3 ***
11 "10" St Squalene !
1*
1
! 0.3 (.06) 0.2 0.02 ** 0.2 (.05) 0.1 0.01 **
1
Total lipids !
1
! 147 (11) 208 ** 221 + !! 
111
ug Protein/tissue !! 261 (9) 222 * 188 i!
Data are expressed as DPM/ug protein (most values rounded to integers) and as the percent of total lipids 
incorporated into individual fractions (% total lipids). Mean values of 5 determinations, control and 
l.Oug/ml mevinolinic acid (MVA), and 2 determinations, 1.5ug/ml MVA, are presented. The pooled SEW for 
each set of control and low dose MVA data (analysed by anova) is presented in brackets. High dose MVA 
data was statistically compared with concomitant control data using Student's t test. + P<0.1, * P<0.05, 
** P<0.01, *** P<0.001, MVA data significantly different from control data.
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table 4.3. In agreement with the above observations on lipid biosyn­
thesis, a dose-response relationship was apparent for both measured 
growth parameters of embryo and yolk sac and the various' morphological 
anomalies associated with this compound in embryo culture. Even the 
lowest dose was highly potent, resulting in significantly smaller embryos 
and yolk sacs and producing the abnormalities characteristic of this 
teratogen (cephalic retardation, turning defects and neural tube defects) 
in a high percentage of treated embryos.
TMD In many respects the actions of TMD were similar to those observed 
for mevinolinic acid, although the most significant effects on the 
synthesis of free sterols were now associated with the embryo proper. In 
this tissue, TMD significantly inhibited incorporation of [3H]acetate 
into sterol lipids by 30% and 47% at the two doses; the percent incorp­
oration was also reduced by a similar amount. In the yolk sac, however, 
the 27% or so decrease (dpm.gg protein-1) in sterols was only signif­
icant at the level P<0.1, and was apparently not dose-related despite 
decreased percent incorporations of 48 and 53 at the two doses. In 
neither tissue were the measured activities in the lanosterol or sterol 
ester fractions lower than those in untreated controls. However, the 
amount of radioactivity present in fraction 11 which contained the 
cholesterol biosynthesis intermediate squalene (in addition to a small 
amount of sterol esters) was considerably higher with TMD treatments. In 
both tissues, incorporation into this fraction was increased by about 30% 
and >130% with the low and high TMD concentrations, respectively, 
although these were not significant by analysis of variance.
As with mevinolinic acid, incorporation of [3H]acetate into triacyl­
glycerols and fatty alkyl esters was increased by TMD treatment. 
However, triacylglycerol synthesis was only significantly increased in
Table 4.2 '
Effects of TMD (50 & 75ug/ml) on the incorporation of [3H]acetate into lipid classes of 9.5 day e.a. 
conceptuses during 48 hours exposure (0-48 hours of culture).
11 I! DPM/ug Protein % Total lipids
.1
s
11
II CCNIP0L 
1 1
TMD CONTROL 1 TMD
F/N LIPID
1 1
50ug/ml 75ug/ml
i
S 50ug/ml 
1
t
i 75ug/ml i
.1 i
YOLK SAC •
t* "" " "" 
1 1 
1
“1 1 
1 i
1 Polar lipids 38 (4) 56 * 58 * 46.8 (1.4)
-
I 48.6 
1
45.7 !
2 Diacylglycerols 3 (.5) 7 ** 5 ** 3.6 (.3) ! 5.7 ** 
1
4.2 I
3 Sterols 14 (1)
'
10 + 10 +'
17.5 (1.0)
.
1
j 9.i *** 
1
8.3 *** i
.
4 Fatty alcohols 
& lanosterol
2 (.4)
.
2 3 2.4 (.4) 1.4
11
1
2.1 !
5 Fatty acids (FA) 5 (2) 10 15 * 5.7 (1.6) ! 8.6 11.5 + I
7 Triacylglycerols
\
15 (2) 20 23 + 18.8 (1.5) 18.0
'
18.6
8 FA alkyl esters 1 (.5) 5 *** 6 ***
■
0.8 (.6) 4.9 *** 5.2 *** !
10 Sterol esters 2 (.3) 2 2 2.7 (.2) 1.5 * 2.0 + !
11 "10" & Squalene
•
0.5 (.2) 0.7 1.2
,
0.6 (.2)
I1
0.7 1.0 I
Total lipids 81 (8) 114 * 127 **
1
11
1
ug Protein/tissue 116 (5) 126 121
1
11
EMBRYO 11
1
1 Polar lipids 81 (7) 121 ** 98 45.4 (1.4)!
1
53.7 ** . 50.9 * !
2 Diacylglycerols
.
6 (.8) 11 ** 9 + 3.6 (.4) !
1
4.8 4.6 I
.
3 Sterols 49 (2) 35 ** 26 *** 27.6 (1.0)!
1
15.5 *** 13.8 *** I
4 Fatty alcohols 
& lanosterol
5 (.7) 3 5 2.7 (.5) !
11
1
1.3 2.5
5 Fatty acids 9 (1) 13 + 11 5.1 (.5) I 
1
5.7 5.8 I
7 Triacylglycerols 24 (1) 33 ** 32 ** 13.5 (.9) ! 
1
14.5 16.7 !
8 FA alkyl esters
'
1 (1) 6 ** 8 ** 0.6 (.4) ! 
1
2.8 *** 3.9 *** I
10 Sterol esters 1 (.2) 1 1 0.8 (.1) ! 
1
0.5 0.8 j
11 "10" & Squalene
1
■
0.3 (.2) 0.4 0.7 0.2 (.1) i
11
»
0.2 0.4
Total lipids
I
178 (9) 225 ** 192
1
ug Protein/tissue I 231 (8) 232 223
Data are expressed as DPM/ug protein (most values rounded to integers) and as the percent of total lipid 
incorporated into individual fractions (% total lipids). Mean values of 6 determinations, control, and 
4 determinations, treated groups, are presented. The SEM for control data are presented in brackets.
+ P<0.1, * P<0.05, ** P<0.01, *** P<0.001, TMD data significantly different from control data, analysis 
of variance.
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Table 4.3
Growth parameters and morphological abnormalities of 9.5 day e.a. conceptuses at 48 hours of 
culture following 48 hours exposure to mevinolinic acid (1.0 & 1.5ug/ml) and TMD (50 & 75ug/ml).
1 II CCWreCL I! MEVINOLINIC ACID 11 . T O D  i
1 i* * I II I
1 II II
1 1! i! l.Oug/ml
i M ii
11
! 1.5ug/ml I! 50ug/ml
i 11
1 75ug/ml i
I S! [n=30,*ll] !! [n=16,*6,13] 
1 .. . 1 ■ | 1 ■ — .........1 1...
! [n=5,*2,6] Ii [n=12,*4,ll]
* ii
1 i
1 [n=ll,*4,12] !
1 II II
1 II II 1 II II
! GROWTH PARAMETER !!Absolute values!
i ii ii i ii ii
I 1
1 t 1 1
Percent of mean control values
11 11
•1 1 
1 1 1 1
i ::
1 Crown-rump length (ran) !! 4.6 (.3) !! 91 (8) b
j j
72 (20) c i! 100 (8) 
1 1
97 (4) {
1 It II
i No. scrnite pairs i! 26.8 (.8) !! 96 (4) CC ii 97 (6) 96 (3) b !
i ! i !! [CC,n=ll]
1 II II
1 1 1 1 
1 11 II II
! Etabryonic protein (ug) j! 245 (31) !! 85 (5) d
1 II II 1 II II
72 (40) ii 98 (12)
1 1 1 1
95 (3) !
1 II II
i Yolk sac diameter (ran) S! 5.1 (.3) !! 94 (7) c
j j
82 (16) c i i 96 (8) 
1 1
101 (4) i
! Yolk sac protein (ug) ! i 123 (16) !! 91 (19)
1 II II 1 II II
87 (41) ii 104 (4)
1 I 1 1 
t 1
101 (11) i
1 II II
i ABNORMALITY !! Percent of tot<
i it ii i ii ii
1 1
I 1 t 1
il embryos with abnormalities
II II
i ii ii i ii ii
1 Yolk sac defects !! 3 i i 6
i it ii
o  i i  o 0 i
i m ii
i Generally retarded embryo ! j 3 !! 31
1 It 11
100 ii 25 
1 1
22 i
1 II 11
j Retarded/abnormal head !! 0 !! 81
1 11 II
1 1
100 {} 8 
1 1
35 i
1 I I '  II
! Missing 3rd branchial bar !! 0 !! 19
1 II II
ioo :: o
i
0 i
1 II II
! Retarded otic development !! 0 !! 0 0 ii 33 82 I
! [open otics] j i !!
1 II II
[25]
1
[55] !
1 II II
! Irregular somites i! 0 j! 56
1 II II
100 !i 0 
1
64 (at FNP) !
1 II II
j Turning defects !! 10 i! 81
1 II II
100 !i 33 
1
9 !
1 II II
! Neural tube defects: !! ! i
1 II If
1
11
11 It II
! Slight wave/single kink i! 30 !! 6
1 II II
0 !i 17 
1
36 i
1 II II
! Crooked !! 0 ! i 88
1 II II
100 !i 67 
1
55 !
1 It II
! Open posterior neuropore: !! !!
1 II II
1
1I
1
! 'Pinhole' 1! 3 !! 19
1 II II
0 i i 8 
1
0 i
1 I! II
1 Wide open !! 0 !! 0
I
!! 67 100 !
t ii it i ii ii 11
Growth parameters (mean values, +/- SD) are presented as absolute values (controls) or as the percentage 
of concomitant controls (treated groups). [n=x,*y,z]: x is the number of embryos in the experimental group, 
y is the number of protein determinations (measured on aliquots of extraction hcroogenates with 2/3 pooled 
tissues) and z is the number of concomitant control embryos. CC, could not count, d P<0.1, c P<0.05, 
b P<0.01, control and treated significantly different, Student's t test.
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the embryo and was not dose-related. Incorporated activity in fatty 
alkyl esters, in contrast, was between 5.7 and 9.9-fold higher than 
corresponding controls and increased the percentage of total lipid 
counts in this fraction from <1% to as high as 5.2%. These increases 
were both highly significant and apparently dose-related. In addition, 
both polar lipids and diacylglycerols contained more incorporated radio­
label after TMD treatment, although no clear dose-response relationships 
were observed for the increased counts in these lipid classes. The total 
radioactivity incorporated into total yolk sac lipids was, nevertheless, 
increased in a dose-related manner.
In general agreement with the dose-related changes in lipid biosyn­
thesis observed with TMD treatment, a dose-response relationship also 
existed for recorded abnormalities associated with the same treated 
conceptuses (table 4.3). The anomaly most characteristic of TMD treat­
ment in cultured embryos was severe interruption of posterior neural tube 
development and closure. At the lower dose of 50pg.ml_1, 67% of embryos 
displayed this defect while all those exposed to the higher TMD 
concentration were affected. Other abnormalities which were exhibited to 
a greater extent by embryos in the higher treatment group included 
retarded cephalic morphology (especially development of the otic system) 
and irregular somite morphology in the region proximal to the open 
posterior neuropore.
4.2.2 Effects of valproic acid
The actions of valproic acid (0.6, 0.8 and l.OmM) on the incorporation 
of [3H]acetate into yolk sac and embryo lipids are shown in table 4.4.
In both tissues the total amount of lipid-associated radioactivity was 
increased by each treatment and this in turn largely reflected an 
increased incorporation of label into the major lipid classes. A good
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Table 4.4
Effects of valproic add (0.6, 0.8 & 1.0c40 on the incorporation of pH]acetate into lipid classes of 9.5 day 
e.a. oonceptuses during 48 hours exposure (0-48 hours of culture).
1
1
II 
11
DPM/ug Protein
—
% Total lipids 11
11
11
1
i i
S S CCfTTROL 
11
1 VAIPROIC ACID CONTROL 11
t
VALPROIC ACID .
t
S F/N LIPID
11
II 
11
0.6edM 0.8nM 1 l.Octt
1
! 0.6mM I 0.8mM l.OnM
YOLK SAC
11 
i < 11 
■ i
■
“1
11
1 Polar lipids :: 26 (2) 
11
38 ** 36 * 43 *** 40.9 (.8)
1
44.3 * ! 41.4 44.8 *
2 Diacylglycerols S! 3 (.2)
t 1
3 3 4 * 4.0 (.3) 4.0
i
3.8 4.0
3 Sterols I! 11 (1) 
1 1
17 ** 18 * * * 18 *** 18.4 (.9) 20.1 20.6 17.8
4 Fatty alcohols 
& lanosterol
!! 2 (.2)
1 i 1 I 
1 I
4 ** 3 ** 5 ***
•
3.0 (.3) 4.3 * 4.0 + 5.1 **
5 Fatty adds (FA) i! 3 (.6) 
1 1
3 7 ** 4 5.5 (.9) 3.9 7.3 3.9
7 Triacylglycerols S S 12 (2) 
1 1
17 + 13 20 * 18.8 (1.4) 18.9 16.1 19.8
8 FA alkyl esters !! 0.5 (.1) 
1 1
0.3 0.5 0.5 0.8 (.1) 0.3 0.6 0.5
10 Sterol esters SS 4 (.3) 
1 1
2 ** 4 2 * 6.1 (.5) 2.4 ** 4.5 + 2.7 **
11 "10" & Squalene !! 0.4 (.1)
1 1 I 1 
> 1
0.4 0.04 0.1 0.6 (.2) 0.6 0.1 0.1
Total lipids !! 63 (4) 
1 1
87 ** 86 ** 97 *** !!
1 1
ug Protein/tissue i! 143 (7) 133 ' 124 94 ** !!
EMBRYO . !
1 1
1 Polar lipids !! 73 (5) 
1 1
105 ** 91 * 115 *** 47.3 (1) 47.4 44.2 47.9
2 Diacylglycerols i! 3 (.6) 
1 1
5 + 6 * 6 *
'
2.0 (.3) 2.5 3.0 2.3
3 Sterols !! 43 (2) 
1 1
60 * * * 61 *** 67 ***
•
27.9 (.8) 27.6 29.8 27.3
4 Fatty alcohols 
& lanosterol
!! 6 (1) 
f f 1 1 
1 1
9 7 7 3.6 (.6)
'
4.1 3.1 2.9
5 Fatty adds 4 (.4)
11
7 *** 6 ** 8 *** 2.7 (.2) 3.1 3.1 3.2
7 Triacylglycerols !! 19 (1) 
1 1
29 *** 29 *** 32 ***
'
12.4 (.4) 12.9 14.1 * 13.6 +
8 FA alkyl esters !! 1 (.1) 
1 t
1 1 1 0.5 (.04) 0.6 0.5 0.5
10 Sterol esters !! 4 (.8) 2 3 3 2.5 (.4) 1.1 1.4 1.5
11 "10" & Squalene i! 0.2 (.1)
1 1 1 1
0.5 * 0.1 0.1 0.1 (.05) 0.3 0.02 0.05
Total lipids !! 154 (8) i 
-1 1 1
220 *** 206 **
1 1
241 *** i!
1 1
ug Protein/tissue !! 255 (12) ! 224 170 *** 135 *** !!
Data are expressed as DPM/ug protein (most values rounded to integers) and as the percent of total lipids 
incorporated into individual fractions (% total lipids). Mean values of 8 determinations, control, and 
4 determinations, treated groups, are presented. The SEH for control data are presented in brackets.
+ P<0.1, * P<0.05, ** P<0.01, *** P<0.001, valproic acid data significantly different from control data, 
analysis of variance.
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dose-response correlation was not, however, apparent for any lipid class 
except perhaps embryonic triacylglycerols and sterols, in which fractions 
the amount of label incorporated was increased by 51-70% and by 42-57%, 
respectively. Large increases in the amount of radioactivity contained 
in other embryonic lipid classes, namely polar lipids, diacylglycerols 
and fatty acids, were also observed in valproic acid treated groups. 
Because these increases were of roughly the same order of magnitude, the 
percentage of the total embryonic lipid counts incorporated into
individual lipids was altered very little. Embryonic protein contents
were significantly reduced in a dose-dependent fashion (12, 33 and 
47%) and had little in common with the larger differences from untreated 
control levels of [3H]acetate incorporation observed at even the lowest 
concentration of valproic acid exposure.
Like the embryo, polar and sterol lipids of valproic acid treated 
yolk sac tissue contained considerably higher amounts of radioactivity 
than controls. In contrast, triacylglycerols and fatty acids were 
relatively unchanged. In the yolk sac other sterol-related lipid
fractions were also affected. Incorporation of label into the lanosterol 
fraction was significantly increased (76-155%) while incorporation into 
sterol esters was decreased in at least two treatment groups, these 
changes remaining significant when the data were re-expressed as '% total 
lipids’.
Table 4.5 shows the extent of embryonic growth and morphological 
development displayed by the same control and treated conceptuses at the 
end of 48 hours culture. Embryos exposed to the lowest concentration of 
valproic acid (0.6mM) were, on average, only slightly smaller than 
untreated embryos but a high percentage already had numerous develop­
mental aberrations. Embryos were generally retarded, with non-specific 
abnormalities which included retarded optic and otic development,
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Table 4.5
Growth parameters and morphological abnormalities of 9.5 day e.a. conceptuses at 48 hours of 
culture following 48 hours exposure to valproic acid (0.6, 0.8 & l.OmM).
i;
11
11 
11 
11 
11
11 
11-
CONTROL
[n=22,*8]
VALPROIC ACID
0.6mM
[n=ll,*4,10]
Q.8mM
[n=12,*4,12]
I l.OmM 
! [n=12,*4,ll]
11 
11 
11
GROWTH PARAMETER ! {Absolute values
1 I 
1 1
Percent of mean contro1 values
1 1 
1 I
Crcwn-rump length (mm) !!
1 t
4.6 (.3) 95 (6) c 84 (6) a 82 (7) a
1 1
No. somite pairs i!
11
27.4 (.8) 98 (3)
-
94 (1) c CC
ii
Bnbryonic protein (ug) {!
11 
11
255 (48) 88 (17) 67 (7) b 53 (6) a
11 
11
• Yolk sac diameter (urn) {! 5.0 (.3)
'
96 (7) 92 (7) b 87 (7) a
Yolk sac protein (ug) {!
1 t 
I I 
1 1
143 (23) 94 (35) 87 (7) d 66 (17) b
—  ---- 11
1 t
I I
ABNORMALITY {{
II
■ ....—  ii
Percent
1
1
of total embryt)s with abnorma ities
11 
i >
Yolk sac defects {I
11
1
1
0 ! 
1
92 100
11
Generally retarded embryo !!
1 1
1
14 i 
1
91
•
92 100
1 1
Retarded otic development {!
1
0 !! 91 100 100
[open otics] !!
1 1
1 1 
1 1 
1 1
[27] [75] [100]
1 1
Retarded optic development !{
II
1 1
0 !
1 1
82 100 100
1 1
Irregular somites !!
11
1 1
0 i! 
1 1
82 100 100
■ i
Turning defects 1 i
1 1
1 1
0  > 13  | I
1 1
0 0 42
1 I
Neural tube defects: i {
1 1
1 1 
1 1 
1 1 
I 1
1 1
Slight wave/single kink !!
1 1
1 1
23 !i 
1 1
11 8 0
Crooked !!
1 1
1 I
0 !! 
1 1
89 • 92 100
1 1
Open posterior neuropore i!
1 1
1 1
0 i! 
1 1
46 100 92
1 1
Open cranial folds !{
1 1 
1 1
1 1
0 i!
11 ■ i
0 0 42
Growth parameters (mean values, +/- SD) are presented as absolute values (controls) or as 
the percentage of concomitant controls (treated groups). [n=x,*y,z]: x is the number of 
embryos in the experimental group, y is the number of protein determinations (measured on 
aliquots of extraction haaogenates with 2/3 pooled tissues) and z is the number of 
concomitant control embryos. CC, could not count, d P<0.1, c P<0.05, b P<0.01, a P<0.001, 
control and treated significantly different, Student's t test.
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irregular somite and neural tube morphology and yolk sac defects, 
e.g. poor vascularization. Embryonic growth retardation and occurrence of 
abnormalities was dose-dependent. In particular, dose-response relation­
ships were evident for tissue protein contents, yolk sac defects, 
irregular otic development and failure of posterior neuropore closure. 
At the highest dose embryos were quite badly affected and displayed 
abnormal turning positions and failure of cranial neural tube closure in 
addition to the aforementioned abnormalities.
4.3 Effects of teratogenic treatments on the incorporation of
[3H]acetate into lipids of 9.5 day e.a. conceptuses during 16-24 
hours of culture
Experimental design Conceptuses of 9.5 days e.a. were cultured in 50ml 
culture bottles containing 4ml medium (75% rat serum, 25% MEM; 3 
conceptuses per bottle). At 16 hours of culture [3H]acetate 
(125pCi.ml_1, lOO-lSOmCi.mmol”1) was added to each bottle, with or 
without teratogenic agent and the conceptuses cultured for a further 8 
hours. Conceptuses exposed to valpromide during this experimental period 
were transferred at 16 hours to fresh bottles containing the drug 
dissolved in serum from the same stock as that present in other bottles, 
plus radiolabel. At 24 hours of culture total lipids were extracted from 
the pooled embryos and pooled yolk sacs of each bottle and analysed by 
TLC-LSC.
To assess the effect of these short-term teratogenic exposures on 
embryonic development separate experiments were conducted in which 9.5 
day e.a. conceptuses were exposed to teratogenic agents (in the absence 
of radiolabel) during 16-24 hours of culture, rinsed in MEM and cultured 
to 48 hours in fresh bottles containing 4ml 'control' medium. The usual
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growth parameters were measured and any abnormal development recorded 
(table 4.10).
4.3.1 Effects of mevinolinic acid
As shown in table 4.6 and figure 4.1 mevinolinic acid markedly 
inhibited the incorporation of [3H]acetate into all sterol-related 
fractions in both embryonic and yolk sac tissues. In particular, the 
activity measured in free sterols was reduced by about 90% in both 
tissues whether expressed as dpm.pg protein-1 or as '% total lipids',
while incorporation of label into sterol esters (and squalene) was
inhibited by 65-76%. Activities measured in the other sterol fraction 
(fraction 4, lanosterol) were also significantly reduced compared with 
untreated control levels of activity but only by about 40% due to the 
presence of fatty alcohols. Control levels of lanosterol associated 
radioactivity in this fraction accounted for about half the total 
fraction 4 counts (see section 3.3.4). Interestingly, incorporation of 
activity into diacylglycerols was also reduced in both tissues.
As a result of the marked mevinolinic acid-induced inhibition of 
sterol synthesis over this short culture period, the amount of 
[3H]acetate incorporated into tissue total lipids was significantly lower 
than controls. Also, the pattern of distribution of the total lipid 
associated radioactivity into individual lipid classes was altered 
considerably with respect to the distribution in untreated conceptuses. 
In the embryo, radiolabel appeared to be redirected into the other 
lipids as determined from actual increases in the amounts of incorporated 
label. In particular, the amount of [3H]acetate incorporated into
triacylglycerols was increased by nearly 90% and synthesis of fatty alkyl 
esters was double that of control embryos. A smaller increase in
embryonic polar lipid synthesis was also evident.
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Table 4.6
Effects of 2.5ug/ml mevinolinic add on the incorporation of [3H]acetate into lipid classes of 9.5 day e.a. 
conceptuses during 8 hours exposure (16-24 hours of culture).
YOLK SAC HIBKYO
DPM/ug Protein % Total lipids DPM/ug Protein % Total lipids
F/N LIPID CONTROL MVA CONTROL MVA CCNIR0L MVA CeOTROL MVA
1 Polar lipids 186 (10) 184 51.6 (.7) 59.4 *** 669 (29) 754 + 55.1 (.6) 70.3 ***
2 Diacylglycerols 9 (.8) 5 ** 2.6 (.3) 1.7 * 22 (2) 14 * 1.9 (.2) 1.3
3 Sterols 42 (3) 4 *** 11.5 (.3) 1.4 *** 349 (15) 42 *** 28.2 (.3) 3.6 ***
4 Fatty alcohols 
& lanosterol
3 (.3) 2 * 1.0 (.1) 0.7 +
111
10 (1) 6 * 0.8 (.08) 0.6 *
5 Fatty adds (FA) 24 (1) 17 ** 5.6 (.2)
1
4.5 *** 44 (3) 39 3.3 (.2) 3.3
7 Triacylglycerols 74 (6) 88 19.9 (.9) 28.4 *** !
i
112 (9) 211 *** 9.2 (.6) 19.3 ***
8 FA alkyl esters 3 (.1) 3 0.7 (.05) 0.9 * !
i
6 (.7) 11 *** 0.5 (.06) 1.0 ***
10 Sterol esters 20 (2) 7 ** 4.9 (.3)
i
1.9 *** 1
i
9 (.5) 2 *** 0.8 (.02) 0.2 ***
11 "lO" & Squalene 
•
5 (.8) 
*
1 * 1.2 (.1) 0.4 ** !
ii
i
1 (.1) 0.5** 0.1 (.01) 0.04 **
Total lipids 368 (20) 312 +
i
ii
t
1226 (42) 1082 *
ug Protein/tissue 46 (1) 42 *
i
ii 67 (2) 57 *
Data are expressed as DPM/ug protein (most values rounded to integers) and as the percent of total lipids 
incorporated into individual fractions (% total lipids). Mean values of 6 determinations, control and 
treated, are presented. The pooled SHI for each set of control and treated data is presented in brackets. 
+ P<0.1, * P<0.05, ** P<0.01, *** P<0.001, mevinolinic add (MVA) data significantly different from 
control data, analysis of variance.
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Figure 4.1
Effects of mevinolinic acid (2.5pg.ml~1) on the incorporation of 
[3H]acetate into lipid classes of 9.5 day e.a. conceptuses during 16-24 
hours of culture.
Data are expressed as the percent change {mean ± SEM) from mean control 
'dpm.pg protein-1’ values. Controls and treated, n=6. * P<0.05, **
P<0.01, *** P<0.001, analysis of variance. Abbreviations: C, chole­
sterol; LF, lanosterol+fatty alcohols; CE, cholesterol esters; FA, fatty 
acids; FAE, fatty acid alkyl esters; DG, diacylglycerols; TG, triacyl­
glycerols; PL, polar lipids; ToT, total lipids.
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At 24 hours of culture the protein contents of both embryo and yolk 
sac were significantly reduced by the previous 8 hours exposure to 
mevinolinic acid. When treated conceptuses were transferred to fresh 
'control' medium for a further 24 hours, however, protein contents 
recovered to those of untreated control conceptuses {see table 4.10, page 
156). Despite this apparent recovery, about one-third of treated con­
ceptuses looked slightly retarded in some way; abnormal cephalic
development was the most prominent feature.
4.3.2 Effects of valproic acid
The effects of valproic acid on the incorporation of [3H]acetate into 
lipids of conceptuses during 16-24 hours of culture are presented in 
table 4.7. A summary of the observed effects is given in figure 4.3 on 
page 157.
Several significant differences were observed between control and 
treated conceptuses, although the only change consistent in embryo 
and yolk sac alike was a 40% increase in [3H]acetate incorporation into 
free fatty acids. Possibly related to this observation was a 24% 
increase in the amount of label incorporated into embryonic triacyl­
glycerols. These effects accounted for the small but significant 
alterations in the overall distribution of incorporated radioactivity 
within the embryonic lipid pool.
The other predominant effect was in the yolk sac and involved the 
sterol lipids. Valproic acid treatment induced a 44% increase in the 
amount of label incorporated into yolk sac free sterols (the most 
significant effect recorded) causing the percentage of total lipid 
radioactivity in this fraction to increase from 13.7% to 17%. In agree­
ment with an apparent increase in sterol synthesis in this tissue, the 
amount of activity contained in the lanosterol fraction was signif-
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Table 4.7
Effects of 1.25mM valproic acid on the incorporation of [3H]acetate into lipid classes of 9.5 day e.a. 
conceptuses during 8 hours exposure (16-24 hours of culture).
YOLK SAC EMBRYO
DPM/ug Protein % Total lipids DPM/ug Protein % Total lipids
F/N LIPID CONTROL VPA CONTROL VPA
. . _
.
CCNIROL
..
VPA CCNIROL VPA
1 Polar lipids 142 (7) 152 49.8 (.9) 47.3 +
------
360 (7) 351 50.8 (.5) 48.2 **
2 Diacylglycerols 10 (1) 11 3.4 (.3) 3.5 16 (1) 17 2.2 (.1) 2.4
3 Sterols 38 (2) 55 *** 13.7 (.4) 17,0 *** 192 (6) 188 26.8 (.4) 25.4 **
4 Fatty alcohols 
& lanosterol
6 (.5) 8 * 2.4 (.2) 2.6 19 (2) 22 3.1 (.3) 3.3
5 Fatty acids (FA) 11 (1) 15 ** 3.7 (.2) 4.5 ** 19 (2) 27 ** 2.6 (.2) 3.5 **
7 Triacylglycerols 58 (3) 64 19.7 (.5) 19.6 84 (5) 105 ** 11.5 (.5) 14.1 **
8 FA alkyl esters 3 (.4) 3 1.1 (.1) 1.0 5 (.7) 6 0.7 (.1) 0.8
10 Sterol esters 10 (.6) 8 ** 3.6 (.2) 2.3 *** 8 (1) 9 1.1 (.1) 1.2
11 "10” & Squalene
■
2 (.4) 2 0.8 (.2) 0.6 1 (.3) 1 0.2 (.1) 0.1
Total lipids 285 (12) 322 * 1! 710 (18) 
1
734
“
ug Protein/tissue 48 (2) 52 i! 66 (2) 65
Data are expressed as DPM/ug protein (rounded to integers) and as the percent of total lipids incorporated 
into individual fractions (% total lipids). Mean values of 11 determinations, control and treated, are 
presented. The pooled SIM for each set of control and treated data is presented in brackets. + P<0.1,
* P<0.05, ** P<0.01, *** P<0.001, valproic acid (VPA) data significantly different frcro control data, 
analysis of variance.
Figure 4.2
Valproic acid-induced somite defects.
A and B show control and valproic acid-treated concep­
tuses, respectively; C and D are enlargements of their 
somites in the fore limb-bud (FL) region. Concep­
tuses were cultured from 9.5 days e.a. for 48 hours. 
Conceptus B was exposed to 1.25mM valproic acid during 
16-24 hours of culture. Somite architecture in the 
control (C) is normal, whereas exposure to valproic 
acid (D) during this period results in irregularly 
shaped and fused (x and y) somites.
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icantly higher (by 29%) following valproic acid treatment. Incorporation 
of [3H]acetate into yolk sac total lipids was significantly increased 
with respect to control levels.
Concomitant with these events, the incorporation of label into yolk 
sac sterol esters was reduced by 25% with treatment. However, the 
reduced amount of activity in this lipid did not account for the much 
larger increase in the free sterol fraction. Embryonic levels of sterol 
associated radioactivity were unchanged by valproic acid treatment.
In this study, and a separate one in which conceptuses were cultured 
to 48 hours following teratogenic exposure during 16-24 hours of culture, 
embryonic and yolk sac protein contents were not significantly altered 
from control levels by 1.25mM valproic acid (see table 4.10, page 156). 
In the latter study, treated embryos appeared to be healthy and not very 
different from untreated control embryos. Morphological scores, however, 
were lower than those of controls, accounted for by subtle alterations of 
embryonic morphology, characteristic of valproic acid and some other SCCA 
treatments over this period of development (see figure 4.2). In partic­
ular, all embryos treated with this concentration of valproic acid had 
irregular morphology of somites 13 to 18. As depicted in figure 
4.2, somites in this range had lost their usual columnar appearance, 
while fusion of adjacent somites was also displayed in about two-thirds 
of treated embryos. A similar fraction had crooked neural suture lines, 
especially in the post forelimb-bud region. In addition, otic and optic 
development was retarded in all valproic acid exposed embryos.
4.3.3 Effects of butyric acid
Table 4.8 and figure 4.3 summarize the effects of butyric acid upon 
the incorporation of [3H]acetate into lipids of 9.5 days e.a. conceptuses 
during 16-24 hours of culture.
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Like valproic acid, butyric acid treatment significantly increased 
incorporation of label into yolk sac sterols (by 27%) concomitantly 
reducing incorporation into yolk sac sterol esters (by 39%). Activity in 
the lanosterol fraction was slightly increased in this tissue following 
butyric acid treatment but only at the significance level P<0.1. No 
other changes in yolk sac lipids were induced by butyric acid.
However, in contrast to the effects of valproic acid, the amounts 
of radioactivity incorporated into embryonic sterols and sterol esters 
were influenced by exposure to butyric acid. In this tissue, the 
effects were in direct opposition to the aforementioned observations in 
the yolk sac. [3H]Acetate incorporation into embryonic sterols was 
decreased by 17%, not a small effect considering that this fraction 
accounted for over one-quarter of the total embryonic lipid-associated 
radioactivity, while incorporation into sterol esters was increased by 
73%.
In addition, butyric acid caused a highly significant decrease in 
the amount of [3H]acetate incorporated into embryonic polar lipids, as 
well as decreasing incorporation into embryonic diacylglycerols. In
contrast to valproic acid, butyric acid had no effect on acetate incorp-
/
oration into either fatty acids or triacylglycerols, although the percent 
incorporation into the latter was altered in each tissue as a result of 
the redistribution of label described above.
The concentration of butyric acid used in this study (0.75mM) signif­
icantly lowered embryonic protein levels with respect to controls. 
Treated embryos subsequently cultured to 48 hours in fresh 'control' 
medium were generally a little smaller than untreated embryos (table 
4.10). In particular, butyric acid treated embryos had almost 2 fewer 
somite pairs than controls. Yolk sac protein content was, however, 
apparently greater following butyric acid treatment. Morphological
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Table 4.8
Effects of 0.75mM butyric acid on the incorporation of pH]acetate into lipid .classes of 9.5 day e.a. 
conceptuses during 8 hours exposure (16-24 hours of culture).
F/N LIPID
1 Polar lipids
2 Diacylglycerols
3 Sterols
4 Fatty alcohols 
& lanosterol
5 Fatty acids (FA)
7 Triacylglycerols
8 FA alkyl esters
10 Sterol esters
11 "10" & Squalene
Total lipids
ug Protein/tissue
11 11 
11
YOLK SAC 11
1
EMBRYO
11
i i DPM/ug Protein 
1 1
1 1
% Tbtal lipids i! DPM/ug Protein
l 1
% Total lipids
1 1
!! CCfTTROL
i
BUTYRIC CCNIROL
1
BUTYRIC || CONTROL 
1
BUTYRIC CONTROL BUTYRIC
-- 11 
1! 270 (12)
1 f
286 52.3 (.4)
1
j
I 53.1 II 964 (30) 
1
715 *** 55.9 (.5) 51.3 ***
I! 12 (1)
1 I
13 2.3 (.1) 2.4 II 37(3)
1 I
27 * 2.1 (.1) 2.0
!! 57 (4)
II
73 ** 10.7 (.3) 13.5 *** {1 473 (23) 391 * 27.3 (.5) 28.0
ii 7 (.8)
1 1 1 1
9 + 1.4 (.2) 1.8 + II 30 (3)
1 I 
1 1
23 1.7 (.2) 1.7
1 I
ii 13 (2) 
1 1
15 2.5 (.4)
II
2.8 I! 23 (2) 
1 1
22 1.3 (.1) 1.6
1! 119 (5)
1 I
111 22.9 (.4) 21.0 ** II 168 (7) 
1 1
170 9.7 (.2) 12.3 ***
!! 5 (.5) 
1 1
5 0.9 (.08) 1.0 || 10 (1) 
1 1
10 0.6 (.05) 0.7
!! 26 (1) 
1 1
16 *** 4.9 (.2) 2.9 *** I! 15 (2) 
1 1
25 *** 0.8 (.06) 1.8 ***
!! 2 (.8)
I 1 ( 1
f t
2 0.5 (.1) 0.4 1 1 1  (.4)
t f
l •
1 0.1 (.02) 0.1
!i 520 (22)
i i ... _
538 111728 (61) 
1 1
1393 **
!! 46 (.7) 46 I! 64 (1) 56 ***
Data are expressed as DPM/ug protein (rounded to integers) and as the percent of total lipids incorporated 
into individual fractions (% total lipids). Mean values of 9 determinations, control and treated, are 
presented. The pooled SIM for each set of control and treated data is presented in brackets. + P<0.1,
* P<0.05, ** P<0.01, *** P<0.001, butyric acid (BUTYRIC) data significantly different from control data, 
analysis of variance.
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abnormalities observed at 48 hours of culture, following treatment during 
16-24 hours, were similar to those observed in valproic acid treated 
conceptuses, although the neural tube was more severely affected and 
cephalic development (otic and optic systems especially) more noticeably 
stunted. The abnormal appearance of somites in the range 13-18 was again 
in evidence for this SCCA, while the frequency of somite fusion was about 
30%.
4.3.4 Effects of valpromide
The effects of valpromide on embryonic lipid synthesis from 
[3H]acetate during 16-24 hours of culture are presented in table 4.9 and 
summarized in figure 4.3.
Exposure of conceptuses to valpromide during this period also resulted 
in altered synthesis of sterol lipids. In both embryonic and yolk sac 
tissues incorporation of label into free sterols was significantly
decreased by 13-16%. Likewise, incorporated activity measured in the 
lanosterol fraction of each tissue was reduced. Valpromide-induced 
changes in the amount of activity incorporated into sterol esters, on the 
other hand, differed in the two tissues. In the yolk sac, sterol 
esters (both fractions 10 and 11 in this study) contained 38% less 
incorporated label than corresponding untreated controls, while embryonic 
sterol esters contained 39% more activity (dpm.pg protein-1) than 
controls. Overall, the net valpromide-induced reduction in sterol 
associated radioactivity was about 6300 dpm.conceptus-1.
Although valpromide did not affect the amount of radioactivity incorp­
orated into fatty acids per se, [3H]acetate incorporation was signif­
icantly increased into yolk sac polar lipids (by 27%) and fatty alkyl
esters (40%) and, like valproic acid, into embryonic triacylglycerols
(19%). Overall, re-expression of the data as '% cotal lipids' reflected
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Table 4.9
Effects of 3.0oM valprcnide on the incorporation of [3H]acetate into lipid classes of 9.5 day e.a. conceptuses 
during 8 hours exposure (16-24 hours of culture).
! YOUC SAC EMBRYO
! DPM/ug Protein % Total lipids DPM/ug Protein % Total lipids
m lipid ! cewracL VPMD CONTROL VPMD CCNIR0L i VPMD 
1 --
CONTROL VPMD
1 Polar lipids ! 358 (20) 455 ** 52.5 (.6) 59.3 *** 1026 (24)
1
1008 56.0 (.3) 56.8
2 Diacylglycerols ! 14 (0) 14 2.1 (.1) 1.8 27 (2) 29 1.5 (.1) 1.7
3 Sterols i 74 (3) 64 * 10.8 (.3) 3#4 *** 474 (14) 400 ** 25.7 (.3) 22.4 ***
4 Fatty alcohols 
& lanosterol
! U  (1) 8 * 1.7 (.1) 1.0 ** 54 (5) 40 + 2.9 (.3) 2.3
5 Fatty acids (FA) ! 27 (2) 28 4.0 (.1) 3.6 * 48 (2) 51 2.6 (.1) 2.9
7 Triacylglycerols ! 144 (8) 156 21.1 (.6) 20.6 171 (7) 202 ** 9.3 (.3) U.4 ***
8 FA alkyl esters ! 5 (.6) 7 * 0.7 (.1) 0.9 10 (1) 11 0.5 (.05) 0.6
10 Sterol esters ! 31 (2) 20 *** 4.5 (.2) 2.6 *** 18 (1) 25 ** 1.0 (.05) 3^4 ***
11' "10" & Squalene ! 12 (.8) 7 ** 1.7 (.1) 1.0 ** 3 (.3) 4 0.2 (.02) 0.2
Total lipids ! 682 (33) 765 1834 (45) 1777
ug Protein/tissue ! 51 (1) 49 66 (1) 61 *
Data are expressed as DPM/ug protein (rounded to integers) and as the percent of total lipids incorporated 
into individual fractions (% total lipids). Mean values of 9 determinations, control and treated, are 
presented. The pooled SEM for each set of control and treated data is presented in brackets. + P<0.1,
* P<0.05, ** P<0.01, *** P<0.001, valpromide (VFMD) data significantly different from control data, 
analysis of variance.
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these observations. Incorporation of label into diacylglycerols remained 
unaltered.
The high concentration (3.0mM) of valpromide to which conceptuses 
were exposed in this study was enough to significantly reduce the 
protein content of embryos by about 8% with respect to controls. 
Although protein levels had recovered by the end of a further 24 hour 
culture in 'control' medium (a separate study; see table 4.10), embryos 
were slightly smaller and, on average, had 1 less somite pair than 
untreated controls. Over half the embryos exposed to valpromide during 
16-24 hours of culture exhibited non-specific developmental retardation 
at 48 hours, while morphological abnormalities per se occurred in only 
one-third or so of embryos. The few 'morphologically' affected embryos 
had slightly retarded optic and otic development and/or slightly wavy 
neural suture lines. In addition, somites appeared a little narrow 
but were never very abnormal, irregularly shaped or fused.
4.3.5 Comparisons of the effects of valproic acid, butyric acid and 
valpromide: teratogenicity and actions on lipid biosynthesis
Table 4.10 presents the observed morphological abnormalities of 9.5 
day e.a. conceptuses at 48 hours of culture following teratogenic 
treatments during 16-24 hours. Those abnormalities which were found to 
be common to the two SCCA, valproic acid and butyric acid, but different 
from those observed in the few morphologically affected valpromide- 
-treated conceptuses are highlighted. The most outstanding feature 
was the SCCA-induced effect on somite morphology, specifically somites 
13-18, which also reflected the stages of embryonic development during 
the exposure period (see fig. 4.2).
Because of the similarities in teratogenic expression of valproic 
acid and butyric acid, and the contrasting morphological defects caused
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Table 4.10
Growth parameters and morphological abnormalities of 9.5 day e.a. conceptuses at 48 hours of culture 
following 8 hours exposure (16-24 hours of culture) to 2.5ug/ml mevinolinic acid, 1.25mM valproic acid, 
0.75mM butyric acid and 3.0mM valpranide.
( M O L MEVINOLINIC Ii 
ACID ||
I 1
VALPROIC
ACID
1 BUTYRIC
1 ACID 
1
VALPROMIDE
[n=22] I [n=19,9] 11 
1 1-
Cff=6,6] I [n=6,6] 
1
[n=14,13]
GRCWIH PARAMETER
.
!Absolute values
1 1 1 
1 1 1
I 1 I
1 Percent of mean concomitant control
m  i
II i
values
Crcwn-rump length (mm)
.
5.0 (.3)
j i
98(5) l!
1 1
100 (2)
1
I 92 (7) 
1
94 (5)
No. somite pairs 27.2 (.9) I 99 (2) II 
11
101 (2) 1 93 (2) b 
1
97 (2)
Bnbrycoic protein (ug) 238 (42) 101 (11) II
1 1 
t 1
107 (6) 1 94 (24)
1
1
98 (10)
Yolk sac diameter (mm) 5.1 (.3)
■
! i
I 102 (3) II 
1 1
101 (4)
1
98 (4)
1
97 (5)
Yolk sac protein (ug)
’
142 (18) 114 (21) 1!
1 I
107 (11) 115 (7) c
'
103 (9)
.
Morphological score 46.6 (.7)
. . ....
1 1
96 (3) a l!
1 1 
1 1 
1 t
■
96 (.3) a 90 (l)a
'
97 (2) a
ABNORMALITY
1
1
1 1 1
II 1 
II 1
Percent of total embryos with abnormalities
1 II I 
1 II 1
Generally retarded embryo
1
1
4 :
i
1 1 1 
1 1 1
I 32 I! 
1 1 1
o  ;
.
33 57
Retarded otic development
i
9 ! 
1
I II
1 53 I! 
1 1 1
100 I
I
100 14
Retarded optic development
1
9 ! 
1
1 1 1
I 16 11 
1 1 1
100 1 100 36
Yolk sac defects
■
0 ! 
1
1 1 1 
1 0 II
1 II
0
1
0 0
Neural tube defects:
1
1
I
1
1 1 1 
1 1 1 
1 II 
1 II
1
1
1
Slight wave/single kink 45 ! 
1
1 1 1 
1 42 II
1 II
17 I 
1
0 71
•
Crooked
•
0 ! 
1
1 II
1 0 II
1 I 1
67 I 100 0
■
Semite defects:
.
(
1
1
1
1 ( 1 
1 If 
1 1 1 
1 II
1
I
I
Slightly small/irregular 0 I
1 1 1 
0 I! 0 I 0 29
Irregular (13-18) 0 ! 
1
1 1
0 1! 
1 1
100 I 
1
100 0
Fused (13-18)
1
0 ! 
1
1 1
0 II 
1 1 1
67 I 33 0
Growth parameters (mean values, +/- SD) are presented as absolute values (controls) or as the percentage 
of concomitant controls (treated groups). [n=x,y]: x is the number of embryos in the experimental group
and y is the number of concomitant control embryos, c P<0.05, b P<0.01, a P<0.001, control and treated 
significantly different, Student's t test.
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(c) Valpromide, 3.0mM (controls and treated, n=9)
Figure 4.3
Effects of (a) valproic acid, (b) butyric acid and (c) valpromide on the 
incorporation of [3H]acetate into lipid classes of 9.5 day e.a. concep­
tuses during 16-24 hours of culture.
Data are expressed as the percent change (mean ± SEM) from mean control 
'dpm.pg protein-1' values. * P<0.05, ** P<0.01, *** P<0.001, analysis of 
variance. Abbreviations: C, cholesterol; LF, lanosterol+fatty alcohols; 
CE, cholesterol esters; FA, fatty acids; FAE, fatty acid alkyl esters; 
DG, diacylglycerols; TG, triacylglycerols; PL, polar lipids; ToT, total 
lipids.
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by valpromide, it followed that the initial biochemical injury resulting 
in valproic acid-type teratogenicity should differ from that inflicted by 
valpromide.
Therefore, any treatment effects on lipid biosynthesis during the 
same experimental period which were similar in valproic acid and butyric 
acid exposed conceptuses but different from those in valpromide-treated 
conceptuses might give a promising lead in the search for the biochemical 
mechanism of valproic acid teratogenicity.
Figure 4.3 summarizes the effects of these three structurally related 
compounds on the incorporation of [3H]acetate into yolk sac and embryonic 
lipids during the 16-24 hour period. Only two effects were common to 
SCCA and at the same time different from the effects of valpromide.
These effects were restricted to the yolk sac and involved the sterol 
lipid fractions. Following valproic acid and butyric acid treatments, 
incorporation of radiolabel was significantly increased in yolk sac 
sterol (cholesterol) and lanosterol fractions. Valpromide's actions on 
these lipids were directly opposite, the incorporation of [3H]acetate 
into each being significantly reduced. Thus, the actions on yolk sac 
sterol synthesis might be implicated in the teratogenic mechanism of 
valproic acid.
4.4 Studies on the potential metabolism of valproic acid and butyric 
acid by 9.5 day e.a. conceptuses during 16-24 hours of culture
Valproic acid and butyric acid, two SCCA which induce similar dys- 
morphologies in exposed embryos, produced different effects on the 
incorporation of [3H]acetate into embryonic lipids. The possibility that 
differences in embryonic metabolism of these compounds might be 
responsible, was examined in the present study by measuring the incorp­
oration of 14C-SCCA into embryonic and yolk sac lipids.
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Experimental design
The experimental protocol used in section 4.3 was also employed in the 
present study. At 16 hours of culture, 3 conceptuses were transferred 
to each minivial containing 1ml medium (75% serum, 25% MEM) and either 
[2-14C]valproic acid (1.72pCi) or n-[l-14C]butyric acid (0.22pCi). The 
final molar concentrations were 1.25mM valproic acid and 0.75mM butyric 
acid. Following an 8 hour exposure to SCCA, conceptuses were removed to 
ice-cold saline and the embryos and yolk sacs washed in several changes. 
The pooled embryos and pooled yolk sacs from each culture vial were 
processed as described in Chapter 2, section 2.3.5.3 and radioactivity in 
acid-soluble, lipid and acid-insoluble fractions measured by LSC. Lipid 
samples were further analysed by TLC. The amount of SCCA bound to serum 
proteins was determined from aliquots of media.
Results
The results of this SCCA metabolism study are presented in table 
4.11. Data are expressed as pmoles of SCCA measured in each metabolic 
compartment at the end of 8 hours culture and normalized for embryonic 
and yolk sac protein contents, and as the percentage of the total 
measured radioactivity contained in each compartment.
The total dpm taken up into both embryonic and yolk sac tissues 
reflected a greater metabolism of butyric acid, particularly since both 
the medium specific activity and free concentration of [l-14C]butyric 
acid were several times lower than those of [2-14C]valproic acid. 
Butyric acid was essentially unbound while about 65% of valproic acid 
was bound to serum protein at the given molar concentration and medium 
composition. In molar terms incorporation of [l-14C]butyric acid label 
was considerably higher than the incorporation of [2-14C]valproic acid 
label in each isolated fraction in either embryonic or yolk sac tissue.
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Table 4.11
Metabolism of [2-14C]valproic acid and [1~14C] butyric acid by 9.5 day e.a. conceptuses during an 3 hour 
exposure (16-24 hours of culture).
(a) C-SCCA in the culture medium (75% rat serum).
Specific activity J J
11 11
Total media !!
concentration i!
Protein binding
Unbound media 
concentration
[2-14C] VALPROIC ACID
1.37 (.10) uCi/umol
1.72 (.12) uCi/ml
65.2 (4.2) %
0.60 uCi/ml
[i-i4C] BUTYRIC ACID
0.29 (.02) uCi/umol
0.22 (.02) uCi/ml
0 % [3.7 (6.4) %]
0.22 uCi/ml
(b) Uptake and incorporation of 14C-SCCA, pmoles/ug protein/8 hours & [% total uptake].
[2-14C] VALPROIC ACID [1-14C] BUTYRIC ACID
! PRACTICN 
1
YOLK SAC EMBRYO E/YS ii 
1 1
YOLK SAC HffiRYO ! E/YS
1
11
i Add-insoluble
! fraction
11
1
1.9 (.3)
[ 71 (3) ]
3.3 (.2)
[ 76 (6) ]
f 1
1 1 I 1
1.7 * !!
1 1 1 1
1.1 ii
1 1 1 I
71 (9) * 
[ 74 (2) ]
95 (12) *
[ 86 (1) ] *
i 1.3 * 
1
1.2 *
Lipid component 
of insoluble 
fraction
-  —  -  —  —  —
1.0 (.2)
[ 36 (4) ]
2.0 (.1)
[ 46 (3) ]
"* 1 1
1 j
2.0 * ii
1 1 1 1
1.3 * ii
1 1 1 1
38 (4) * 
[ 40 (2) ]
58 (6) *
[ 53 (3) ] *
1.5 * 
1.3 *
Add soluble 
fraction
■■
'
0.8 (.04) 
[ 29 (3) ]
1.0 (.3)
[ 24' (5) ]
1 1 
1 1 1 1
1.3 i!
1 1 1 1
0.8 J!
1 1 1 1
1 1
25 (4) *
[ 26 (2) ]
15 (2) *
[ 14 (1) ] *
0.6 * 
0.5 *
Total uptake 2.7 (.3) 4.3 (.3)
1 1 
! 1 
1 f
1.6 * i{ 
1 1
96 (12) * 110 (14) * 1.1 *
{DPM/tissue! {356 (44)1 {718 (77)} 2.0 * ii
1 1 
1 I 
1 1 —
{2677 (845)J * {3729 (589)} * 1.4 +
ug Protein/tissue 
[no.tissues]
44 (3) 
[3]
56 (7) 
[33
I i
I t 
1 I
1 1 J 1
44 (4) 
[3]
53 (6) 
[3]
Data are expressed as praoles SCCA/ug protein/8 hours and as percentages of the total radioactivity
{DFM/tissue} taken up into the yolk sac or embryo [% total uptake]. Mean values of 9 determinations 
(except for protein binding, n=6) (+/- SD) are presented. + P<0.01, * P<0.001, embryo and yolk sac 
data significantly different or valproic acid and butyric acid data significantly different, Student's 
t test.
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Table 4.12
Incorporation of [2-14 C] valproic acid and [l-14 C] butyric acid into lipid classes of 
9.5 day e.a. conceptuses during 8 hours exposure (16-24 hours of culture).
11
1
[2-14C] VALPROIC ACID 11 11 
• i
[1-14C] BUTYRIC ACID !
«1
i F/N LIPID YOLK SAC EMBRYO
11
11 11
11-
YOLK SAC
i
EMBRYO !
i
ii
i 1 Polar lipids
i
42.9 (6.3) 50.3 (3.9)
i r
I i i i
II i i
11
41.8 (3.2)
i
i
43.3 (2.9) b j
ii
! 2 1,2-Diacylglycerols
i
1.5 (1.8) 1.5 (1.0)
i i
i i i i
i i
2.8 (.8) 2.6 (.8) !
ii
I 3 Sterols & lf3-DG
i
9.0 (3.2) 20.2 (1.9)
i i
11 i i
i i
13.9 (6.2) 26.7 (1.6) a !
ii
! 4+5 Fatty alcohols 
J & lanosterol 
i & fatty acids
i
10.7 (5.3) 7.4 (2.1)
11
i i i i
i i i i 
i i 11
i i
7.6 (1.9)
i
i
6.1 (1.6) j
ii
ii
i 7 Triacylglycerols
i
28.2 (1.6) 13.8 (1.3)
11 
t i 11 
i i
25.6 (3.0) 14.8 (.8) !
ii
! 8 Fatty alkyl 
! esters
i
3.3 (2.7) 5.3 (1.2)
11
i i 11
11 i i
i i
3.9 (.4) 5.1 (.7) !
ii
ii
! 10+ Sterol esters 
! 11 & Squalene
3.9 (2.8) 1.5 (.9)
i i
11 i i
11 i i
i i i i
4.5 (1.4) 1.3 (.3) !
11
11
! Total "fatty acids" 
! (F/N’s 4+5+8)
i
14.0 (4.7) 12.8 (1.8)
i i —
i i 11
11 i i
i i i i
U.5 (2.0)
________ _ 11
1
11.2 (2.0) !
ii
Data are expressed as the percent of total lipids incorporated into individual fractions 
(% total lipids). Mean values of 6 determinations {+/- SD) are presented for both 
14C-SCCA. b P<0.01f a PC0.001, valproic acid and butyric acid data significantly 
different, Student's t test.
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In the embryo, [l-14C]butyric acid incorporation was nearly 30-fold 
higher in the lipid and total acid-insoluble fractions than incorporated 
[2-14C]valproic acid activity, while in these fractions in the yolk sac 
[l-14C]butyric acid activity was ^37-fold higher. The amount of acid- 
-insoluble radiolabel incorporated by the embryo was significantly higher 
than by the yolk sac for each SCCA, although E/YS ratios were higher for 
[2-14C]valproic acid.
The distribution of total [l-14C]butyric acid and total
[2—14C]valproic acid radioactivity between acid-soluble and insoluble 
compartments was quite similar, especially in the yolk sac. The embryo 
did, nevertheless, incorporate significantly more [l-14C]butyric acid 
than C14C]valproic acid into total acid-insoluble, and lipid compart­
ments.
Radioactivity measured in the lipid fractions was analysed further by 
thin-layer chromatography; three-quarters of the total lipid extracts 
were chromatographed. The following amounts of radioactivity in each 
sample (estimated from table 4.11) were applied to the 
chromoplate: [l-14C]butyric acid, ~3200 dpm, yolk sac and s5900 dpm, 
embryo; [2—14C]valproic acid, s380dpm, yolk sac and zlOOO dpm, embryo. 
The percentages of the total applied radioactivities incorporated into 
isolated lipid fractions following TLC are presented in table 4.12. 
Overall there was little difference between the distribution of counts 
from each radiolabelled SCCA. Polar lipids contained most (40-50%) of 
the total lipid-incorporated activity, followed by triacylglycerols and 
the sterol fraction (fraction 3). In embryonic tissue, however, 
[l-14C]butyric acid label was incorporated into polar lipids to a lesser 
extent than was [2—14C]valproic acid, while, in a way apparently related, 
[l-14C]butyric acid was more readily incorporated into fraction 3. 
Incorporation of label into sterol esters was higher in the yolk sac
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than in the embryo, in contrast to the percent incorporation into embry­
onic and yolk sac fraction 3. This relationship added weight to the 
belief that fraction 3 was mainly composed of sterol lipid and contained 
relatively little 1,3-diacylglycerols.
The amount of radioactivity measured in the fatty alkyl ester fraction 
was high (3-5%) as for the combined fractions 4 and 5, presumed to 
contain predominantly free fatty acids. The total pool of assumed 
non-metabolised 14C-SCCA, therefore, accounted for a fairly high pro­
portion (11-14%) of the total activity, and was even apparently slightly 
higher for [2—14C]valproic acid samples.
4.5 Effects of valproic acid and valpromide on the incorporation of 
[3Hi acetate into lipids of 10.2 day e.a. conceptuses during 1-9 
hours of culture
During the course of the previous studies, it became clear that lipid 
metabolism in cultured and freshly explanted conceptuses was different 
(see Chapter 3). In particular, the metabolism of fatty acids and 
acylglycerols was peculiar over this period in cultured conceptuses, but 
not in fresh explants. It therefore became necessary to repeat the 
studies conducted with valproic acid and the control compound, 
valpromide, over this period of culture, using freshly explanted 
conceptuses.
Experimental design Conceptuses of 10.2 days e.a. were incubated in 75% 
rat serum, 25% MEM for a one hour equilibration period and then trans­
ferred to minivials containing 1ml medium and [3H]acetate (125pCi, 
lOOmCi.mmol-1) with or without teratogenic agent. Conceptuses were 
exposed to 1.25mM valproic acid or 3.0mM valpromide for 8 hours. Total 
lipids were subsequently extracted from the pooled embryos and pooled
yolk sacs of each vial and analysed by TLC-LSC.
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4.5.1 Effects of valproic acid
The effects of 1.25mM valproic acid on lipid biosynthesis from 
[3H]acetate in freshly explanted 10.2 day e.a. conceptuses are presented 
in table 4.13. Changes from control incorporation values (dpm.pg 
protein”1) are pictorially summarized in figure 4.4.
Valproic acid effects could be classified as either sterol or fatty 
acid related. The major difference from controls following treatment was 
a highly significant 99% increase in the incorporation of [3H]acetate 
into yolk sac non-esterified sterols. Similarly, measured radioactivity 
in the yolk sac lanosterol fraction was also much higher (80%) after 
valproic acid treatment. Concomitant with these increases in sterol 
synthesis, the amount of label incorporated into yolk sac sterol esters 
was significantly reduced by 48% (both fractions 10 and 11 in the present 
study). This apparent inhibition of sterol esterification, however, did 
not account for the large increase in radioactivity (36 dpm.pg protein-1, 
sl500 dpm.tissue-1) observed in fraction 3. Embryonic levels of sterol 
radioactivity were not altered, although the percent incorporation into 
this fraction was reduced by 15%. Embryonic sterol esters contained 
significantly more counts than corresponding controls.
The amount of label incorporated into fatty acids was increased by 65% 
in both the embryo and yolk sac of conceptuses exposed to valproic acid. 
Possibly related to these observations was an increase in triacylglycerol 
synthesis, although this effect was only significant at the level of 
P<0.1 and was restricted to the embryo.
Finally, neither embryonic nor yolk sac protein contents were signif­
icantly affected by valproic acid exposure during this period.
Table 4.13
Effects of 1.25mM valproic acid on the incorporation of [3H]acetate into lipid classes of 10.2 day e.a. 
conceptuses during 8 hours exposure (1-9 hours of culture).
11
1
YOUC SAC EMBRYO
f1
f
DPM/ug Protein % Total lipids DPM/ug Protein % Total lipids
1
i F/N LIPID 
1
CONTROL VPA CCNIPOL VPA CCNIPOL VPA CONTROL VPA
1
11
! 1 Polar lipids 
1
■
•
294 (23) 320 56.8 (.5) 55.6 844 (39) 890 64.8 (.5) 64.5
1
! 2 Diacylglycerols 16 (1) 20 + 3.1 (.1) 3.5 + 33 (2) 37 2.5 (.1) 2.7
1
! 3 Sterols 
1
37 (5) 73 *** 7.1 (.4) 12.7 *** 254 (15) 229 19.5 (.5) 16.6 **
1
1 4 Fatty alcohols 
& lanosterol
2 (.3) 4 ** 0.4 (.03) 0.7 *** 9 (.8) 10 0.7 (.08) 0.7
5 Fatty acids (FA) 9 (.7) 16 *** 1.8 (.1) 2.8 *** 28 (3) 47 ** 2.2 (.2) 3.4
7 Triacylglycerols 117 (12) 113 22.8 (1.0) 19.4 * 112 (8) 137 + 8.7 (.4) 9.8 *
8 FA alkyl esters 2 (.2) 2 0.4 (.03) 0.4 3 (.4) 4 0.2 (.02) 0.3
10 Sterol esters 21 (1) 11 *** 4.0 (.2) 1^ 9 *** 8 (1) 13 * 0.6 (.09) 0.9 *
11 "10" & Squalene
.
6 (.6) 3 ** 1.2 (.1) 0.6 ** , 
i
*
1 (.3) 3 ** 0.1 (.02) 0.2 *
Total lipids 517 (41) 576 !11303 (60)
ii
1382
ug Protein/tissue 37 (2) 41 !! 52 (3) 51
Data are expressed as DPM/ug protein (rounded to integers) and as the percent of total lipids incorporated 
into individual fractions (% total lipids). Mean values of 5 determinations, control and treated, are 
presented. Hie pooled SIM for each set of control and treated data is presented in brackets. + P<0.1,
* P<0.05, ** P<0.01, *** P<0.001, valproic acid (VPA) data significantly different frcm control data, 
analysis of variance.
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Table 4.14
Effects of 3.0mM valpranide on the incorporation of [3H]acetate into lipid clashes of 10.2 day e.a. 
conceptuses during 8 hours exposure (1-9 hours of culture).
YOLK SAC 1 1 1 1 
1 1
EMBRYO
DPM/ug Protein % Total lipids
1 1
j I DPM/ug Protein % Total lipids
F/N LIPID CCNIROL VPMD CONTROL VPMD i! CONTROL VPMD CONTROL VPMD
1 Polar lipids
.
221 (11) 304 *** 52.5 (.9) 56.3 *
t 1
!! 761 (13) 711 * 61.8 (.6) 62.0
2 Diacylglycerols 12 (.7) 13 2.9 (.1) 2.5 !! 25 (2) 29 2.0 (.2) 2.6 +
3 Sterols 38 (3) 29 * 9.3 (.8) 5.4 ** I! 278 (10)
1 S
213 ** 22.5 (.6) 18.6 **
4 Fatty alcohols 
& lanosterol
2 (.3) 3 + 0.4 (.05) 0.5 !! 6 (.9)
1 1 
1 1
t 1
6 0.5 (.08) 0.5
5 Fatty acids (FA) 10 (.8) 14 ** 2.5 (.1) 2.7 !! 25 (1) 28 2.1 (.1) 2.4 *
7 Triacylglycerols 99 (5) 133 ** 23.3 (.6) 24.6 i! 114 (5) 
1 1
131 * 9.2 (.3) H A  ***
8 FA alkyl esters 3 (.4) 5 ** 0.6 (.09) 0.9 * !! 5 (.4) 
1 1
4 0.4 (.03) 0.4
10 Sterol esters 13 (1) 11 3.0 (.2) 2.0 ** !! 7 (.3) 
1 1
10 *** 0.6 (.02) 0.9 ***
11 "10" & Squalene U  (1) 14 2.8 (.3) 2.6 I! 2 (.4)
1 1 
1 1
3 * 0.2 (.03) 0.3 *
Total lipids 421 (17) 539 *** i11233 (22)
t
1147 *
'
ug Protein/tissue 36 (1) 36 !! 53 (1) 49 +
Data are expressed as DPM/ug protein (rounded to integers) and as the percent of total lipids incorporated 
into individual fractions (% total lipids). Mean values of 6 determinations, control and treated, are 
presented. The pooled SIM for each set of control and treated data is presented in brackets. + P<0.1,
* P<0.05, ** P<0.01, *** P<0.001, valpromide (VPMD) data significantly different from control data, 
analysis of variance.
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4.5.2 Effects of valpromide
The effects of 3.0mM valpromide on lipid synthesis in fresh, early day
11 explants, are presented in table 4.14 and summarized in figure 4.4.
The largest effects induced by valpromide treatment during this 
experimental period involved all three major lipid classes synthesized
from [3H]acetate. Incorporation of label into polar lipids was signif­
icantly increased by 38% in the yolk sac and, conversely, decreased by 7% 
in the embryo. The total amounts of radiolabel measured in the yolk sac 
and embryo reflected these effects on polar lipids; this was not sur­
prising since the activity contained in polar lipids accounted for 50-60% 
of the total. Differential tissue effects did not, however, exist for 
altered sterol and triacylglycerol synthesis. [3H]Acetate incorporation 
into 'free' sterols was significantly decreased by about 24% in both 
tissues, while incorporation into triacylglycerols was significantly 
increased in both the yolk sac (34%) and embryo (15%).
Other treatment related effects included significant increases in the 
amount of radioactivity measured in yolk sac fatty acid fractions (both 
non-esterified acids and alkyl esters) and in embryonic sterol ester 
fractions (fractions 10 and 11).
Data expressed as the '% total lipids' generally reflected these 
observed changes from control values.
4.5.3 Comparison of valproic acid and valpromide effects
The most prominant difference between the effects of these two 
compounds was again on sterol lipid synthesis, particularly in the yolk 
sac (see fig. 4.4). The level of radioactivity measured in the sterol 
fraction of the yolk sac was essentially doubled by exposure to valproic 
acid while valpromide treatment reduced [3H]acetate incorporation into 
this fraction in both this tissue and the embryo. Sterol esterification
VYS Embryo
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(a) Valproic acid, 1.25mM (controls and treated, n=5)
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(b) Valpromide, 3.0mM (controls and treated, n=6)
Figure 4.4
Effects of (a), valproic acid and (b) valpromide on the incorporation of 
[3H]acetate into lipid classes of 10.2 day e.a. conceptuses during 1-9 
hours of culture.
Data are expressed as the percent change (mean ± SEM) from mean control 
'dpm.pg protein-11 values. * P<0.05, ** P<0.01, *** P<0.001, analysis of 
variance. Abbreviations: C, cholesterol; LF, lanosterol+fatty alcohols; 
CE, cholesterol esters; FA, fatty acids; FAE, fatty acid alkyl esters; 
DG, diacylglycerols; TG, triacylglycerols; PL, polar lipids; ToT, total 
lipids.
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in the yolk sac was also different following each treatment.
The observed valproic acid effects on fatty acid (and triacylglycerol) 
synthesis were largely induced by valpromide treatment as well but, 
whereas valproic acid significantly increased incorporation into non- 
-esterified fatty acids of both tissues, valpromide significantly 
increased the incorporation of [3H]acetate into fatty acids in the yolk 
sac and into triacylglycerols in the embryo.
4.5.4 Further analysis of valproic acid’s actions on sterol 
lipid synthesis
Experimental design At the end of culture, digitonin-precipitable 
sterols (DPS) were separated from the total lipid extracts. Both DPS and 
the non-precipitable lipids were analysed further by TLC-LSC.
Results Table 4.15 presents a summary of the results obtained from this 
study. Data are expressed both as 'dpm.pg protein-1' and as '% change 
from control' values.
[3H]Acetate incorporation into yolk sac total DPS was significantly 
increased by 45% with valproic acid treatment, while the amount of 
radioactivity incorporated into embryonic total DPS was not significantly 
altered. Further analysis revealed that cholesterol accounted for the 
majority of total DPS counts in both tissues, and that incorporation into 
this lipid in the yolk sac was increased by valproic acid (66% increase, 
P<0.01). Incorporation of label into yolk sac lanosterol was also 
significantly increased while squalene counts were unchanged.
Thin-layer chromatographic analysis of non-precipitable lipids 
confirmed earlier observations of differential tissue effects on sterol 
ester synthesis by valproic acid exposure. Incorporated radioactivity in 
yolk sac sterol esters was significantly lower than untreated control
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Table 4.15
Effects of 1.25mM valproic acid on the incorporation of [3H]acetate into digitonin-precipitable 
sterols, and sterol esters of 10.2 day e.a. conceptuses during 8 hours exposure (1-9 hours of culture)
LIPID !
! YOLK SAC ! EMBRYO
I DPM/ug Protein % Change 
frcm 
control
{ DPM/ug Protein % Change 
frcm 
controli CONTROL VPA ! CONTROL VPA
Cholesterol !! 34.5 (3.4) 57.3 ** + 66 ! 261.0 (23.0) 240.2 - 8
Lanosterol !{ 0.7 (.2) 1.2 * + 80 ! 2.3 (.4) 2.8 + 21
Squalene !I 11.6 (1.7) 10.8 - 7 ! 10.1 (1.5) 10.1 0
Total DPS !! 53.9 (5.3) 78.0 * + 45 ! 288.3 (26.5) 268.0 - 7
Sterol esters !! 31.7 (1.0) 26.5 ** - 16 ! 9.6 (1.1) 14.6 * + 52
ug Protein/tissue i! 35.1 (.7) 35.3 + 1 i 49.7 (1.7) 45.0 - 9
Data are expressed as DPM/ug protein and as the % change frcm control values. Mean values of 5 
determinations are presented. The pooled SEM for each set of control and treated data is presented 
in brackets. * P<0.05, ** P<0.01, valproic acid (VPA) data significantly different frcm control 
data, analysis of variance.
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levels, while the amount of label contained in embryonic sterol esters 
was increased.
4.5.5 Valproic acid dose-related actions on lipid synthesis
Experimental design This was identical to the protocol described at the 
beginning of section 4.5 except that conceptuses (2 per vial) were 
exposed to 0.5, 1.0, 1.5 and 2.0mM valproic acid.
Results The data obtained from this dose-response study are presented in 
table 4.16; only the most important lipid classes have been included. In 
addition to variance analysis of the data, regression analysis was 
used to provide an indication of the significance which could be ascribed 
to any apparent dose-related actions.
Several dose-related actions of valproic acid treatment were observed 
and (once again) these were restricted to sterol lipids and fatty acids. 
The most marked response was a highly significant dose-related increase 
in the amount of [3H]acetate incorporated into yolk sac non-esterified 
sterols, illustrated in figure 4.5. At the lowest concentration of 
valproic acid exposure the amount of activity measured in this fraction
was only 29% higher than the mean control value and this change was not
statistically significant. Significant increases were, however, measured 
following exposure to higher doses of valproic acid: 78%, 102% and 112%
at 1.0, 1.5 and 2.0mM, respectively. The 99% increase induced by 1.25mM
valproic acid in the earlier study (section 4.5.1) fitted neatly into the
dose-response pattern of the present study.
Incorporation of [3H]acetate into sterol esters also followed appar­
ently significant dose-related patterns in both tissues. In the yolk 
sac, 1.0-2.0mM valproic acid significandy reduced the amount of radio-
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Figure 4.5
Effects of valproic acid (0.5, 1.0, 1.5 and 2.0mM) on the incorporation 
of [3H]acetate into yolk sac cholesterol and cholesterol esters and into 
embryonic cholesterol esters.
Data are expressed as dpm.pg protein-1 and as the percent change from 
mean control values. Mean ± SEM, n=4 control and treated. * P<0.05, ** 
P<0.01, *** P<0.001, analysis of variance.
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activity incorporated into this lipid by 45-47%, which also agreed with 
the 48% decrease observed earlier at the 1.25mM concentration. In 
contrast, embryonic sterol esters contained significantly more radiolabel 
only at the two highest exposure concentrations. The increase observed 
was £59%, again in the same order of magnitude as that for 1.25mM 
valproic acid. In contrast, the amounts of [3H]acetate incorporated into 
embryonic sterols were not significantly altered at any treatment 
concentration.
More [3H]acetate was incorporated into non-esterified fatty acids when 
conceptuses were exposed to increasing concentrations of valproic acid. 
Although a highly significant dose-response was statistically attribut­
able to this effect in both tissues, significant increases only really 
occurred at 1.5 and 2.0mM valproic acid. Maximum increases were 28% and 
50% above yolk sac and embryonic control levels, respectively, lower than 
those measured in the earlier study with 1.25mM valproic acid.
Finally, yolk sac protein contents of conceptuses exposed to valproic 
acid were not altered at any concentration. Embryonic protein contents, 
on the other hand, were significantly lower than untreated controls 
following exposure to valproic acid concentrations of l.OmM or higher in 
this study.
4.6 Effects of valproic acid exposure in vivo on the subsequent 
in vitro incorporation of [3H]acetate into lipids
Experimental design Figure 4.6 illustrates the experimental approach 
used in this study. Pregnant F344/Tru females were dosed by gavage with 
valproic acid (4.0mmoles.kg body weight-1; dissolved in 0.15N saline and 
neutralised with NaOH) early on the 11th day of pregnancy (embryonic age 
approximately 10.3 days). 'Control' pregnant females received an equal
1*75
volume of saline (lml.lOOg body weight-1). After 3 hours, conceptuses 
were explanted and rinsed in MEM before incubating in normal culture 
medium for a half hour equilibration period.
Figure 4.6
Experimental protocol for examining lipid metabolism of 
conceptuses following exposure to valproic acid in utero.
Na valproate Conceptuses
4.0mmoles/kgbdwt. ____ 3 hr____ ^ explanted % hr^ ____ 2 hr ■ t
Oral admin. into culture +[3H]acetate
Treated and control conceptuses were then removed from their respective 
vessels, rinsed in several changes of MEM and finally transferred to 
minivials containing 1ml medium (75% serum, 25% MEM) and [3H]acetate 
(125pCi, lOOmCi.mmol-1); 3 conceptuses were placed in each vial.
Following 2 hours culture, the total lipids were extracted from the 
pooled embryos and pooled yolk sacs in each vial and analysed by TLC-LSC.
Results The effects of this short in vivo valproic acid exposure on the 
subsequent incorporation of [3H]acetate into lipid classes of exposed 
conceptuses are presented in table 4.17 and summarized in figure 4.7.
Again, treatment effects could be generally classified into those 
on sterol lipid and those on fatty acid classes. The biggest induced 
change from untreated controls was a highly significant 90% increase in 
the amount of [3H]acetate incorporated into yolk sac 'free' sterols. 
Similarly, label incorporation was also higher in the lanosterol fraction 
of this tissue (65% increase, P<0.1). The amount of radioactivity 
measured in the main sterol ester fraction (fraction 10) was not, 
however, altered by valproic acid pre-treatment, although counts in 
fraction 11 were reduced. In contrast, embryonic sterol esters contained 
significantly more label than controls while incorporation into 'free' 
sterols remained unchanged following valproic acid exposure. Following
Table 4.17
Effects of 3 hours in vivo exposure of 10.3 day e.a.conceptuses to valproic acid (4.Ctaoles/kg body weight; 
oral administration) on the incorporation of pH] acetate into their lipid classes during a subsequent 2 hour 
culture in the absence of valproic add.
.
YCUC SAC EMBRYO
! DPM/ug Protein % Total lipids
.
DPM/ug Protein % Total lipids
F/N LIPID CCNIRGL ! VPA 
\ ..- -
carocL VPA O C M m VPA CCNIROL VPA
1 Polar lipids 103 (6)
1
1
102 60.1 (1.2) 55.5 * 238 (13) 240 73.4 (.7) 69.4 **
2 Diacylglycerols 6 (.6) 6 3.4 (.2) 3.3 8 (.9) 10 + 2.4 (.2) 2.9 +
3 Sterols 6 (.5) 21 *** 3.6 (.2) 6.2 *** 46 (2) 48 14.2 (.7) 14.0
4 Fatty alcohols 
& lanosterol
0.4 (.1) 0.7 + 0.2 (.05) 0.4 + 2 (.2) 2 0.5 (.07) 0.6
5 Fatty adds (Eft) 3 (.3) 4 ** 1.8 (.1) 2.4 ** 5 (.4) 7 ** 1.6 (.1) 2.1 *
7 Tdacylglycerols 36 (2) 44 * 21.2 (.9) 24.0 * 18 (2) 27 ** 5.7 (.3) 7.8 ***
8 FA alkyl esters 1 (.6) 2 0.7 (.2) 0.8 1 (.4) 1 0.4 (.1) 0.4
10 Sterol esters 11 (.7) 10 6.6 (.4) 5.5 +
■
4 (.4) 7 *** 1.3 (.05) 2.0 ***
11 "10" & Squalene 0:7 (.1) 0.3 + 0.4 (.08) 0.2 + <0.1 <0.3 <0.1 <0.1
Total lipids 171 (9) 184 !! 324 (16)
I
345
ug Protein/tissue 34 (2) 34 !! 47 (2) 44
Data are expressed as DPM/ug protein {most values rounded to integers) and as the percent of total lipids 
incorporated into individual fractions (% total lipids). Mean values of 5 determinations, control, and 6 
determinations, treated, are presented. The pooled SEM for each set of control and treated data is presented 
in brackets. + P<0.1, * P<0.05, ** P<0.01, *** P<0.001, valproic add data significantly different from 
control data, analysis of variance.
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Figure 4.7
Effects of 3 hours culture in vivo of 10.3 day e.a. conceptuses to 
valproic acid (4.0mmoles.kg body weight-1) on the incorporation of 
[3H]acetate into their lipid classes during a subsequent 2 hour culture 
in the absence of valproic acid.
Data are expressed as the percent change (mean ± SEM) from mean control 
'dpm.pg protein-1' values. Controls n=5, treated n=6. * P<0.05, ** 
P<0.01, *** P<0.001, analysis of variance. Abbreviations: C, chole­
sterol; LF, lanosterol+fatty alcohols; CE, cholesterol esters; FA, fatty 
acids; FAE, fatty acid alkyl esters; DG, diacylglycerols; TG, triacyl- 
glycerols; PL, polar lipids; ToT, total lipids.
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in vivo exposure to valproic acid, conceptuses incorporated significantly 
more [3H]acetate into fatty acids and triacylglycerols. Incorporation 
into fatty acids was increased by £36% in either tissue, while triacyl- 
glycerol synthesis was increased by 23% in the yolk sac and by 49% in the 
embryo. The pattern of distribution of the total lipid associated radio­
activity into individual lipids generally reflected these observations, 
although the percent incorporation into polar lipids was lower due to 
increased synthesis of other lipid classes such as sterols and triacyl­
glycerols. The total activity incorporated into the lipid compartment, 
however, remained statistically unchanged from control levels.
Lastly, embryonic and yolk sac protein contents were unaltered by
this short in vivo exposure to valproic acid.
4.7 Summary of the effects of valproic acid and valpromide on 
lipid biosynthesis in conceptuses exposed during different 
experimental conditions 
Table 4.18 summarizes and compares the results pooled from the studies 
described in sections 4.3, 4.5 and 4.6, in which lipid synthesis in
conceptuses exposed to either valproic acid or its primary amide was 
investigated under different experimental conditions. Data are expressed 
as the percent change from control dpm.pg protein-1 values.
In the first study 9.5 day e.a. conceptuses were exposed to
[3H]acetate and valproic acid or valpromide during the 8 hours following 
16 hours preculture, while the second study was designed to examine the 
actions of these agents during an equivalent period of development in 
freshly explanted conceptuses. Finally, the effect of short-term in
vivo exposure of conceptuses to valproic acid on their subsequent lipid 
synthetic activities in culture, was investigated.
As described in the preceding sections, the most prominent effect of
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Table 4.18
Summary of the effects of valproic acid and valpranide on the incorporation of pH] acetate 
into lipid classes of conceptuses exposed under different experimental conditions.
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The table presents a summary of the data obtained frcm the following pH] acetate incorporation 
studies with valproic acid or valpromide treatments: exposure of 9.5 day e.a conceptuses 16-24 
hours of culture (see tables 4.7. & 4.9.), exposure of 10.2 day e.a. conceptuses 1-9 hours of 
culture (see tables 4.10. & 4.11.) and 3 hours in vivo exposure of 10.3 day e.a. conceptuses 
followed by 2 hours culture with label but without teratogen (see table 4.12.).
Data are expressed as the percent change from mean concomitant control "dpm/ug protein" values. 
* P<0.05, ** P<0.01, *** P<0.001, treatment data significantly different frcm control data, 
analysis of variance.
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valproic acid, which was also consistently different from valpromide's 
actions, was the observed increase in yolk sac sterol radioactivity 
(highlighted in table 4.18). In the two studies where a long preculture 
was not employed this increase was £90% over corresponding control 
levels. Valpromide, in contrast, significantly reduced the amount of 
label incorporated into this fraction and also inhibited incorporation 
into embryonic sterols by an equivalent degree.
Effects of these structurally related agents on sterol ester activ­
ities, however, were essentially the same. In the yolk sac, sterol 
esterification was reduced with respect to control levels while, con­
versely, embryonic levels of sterol ester radioactivity were raised by 
each treatment. These effects were generally statistically significant.
The other major observed effect of valproic acid was its action on 
non-esterified fatty acid levels of radioactivity. The amount of
[3H]acetate incorporated into this lipid class was significantly 
increased in both tissues and during each of the three experimental
approaches. Of particular interest, the degree by which control levels 
of fatty acid radioactivity were increased by valproic acid was of the
same order of magnitude in both yolk sac and embryonic tissue in each of
the studies. Levels of triacylglycerol activity were also generally 
increased following valproic acid treatments, more especially in the
embryo. Activity levels in other neutral esters of fatty acids, diacyl­
glycerols and alkyl esters, followed a similar, although not stat­
istically significant trend. However, broadly speaking, the actions of 
valpromide on [3H]acetate incorporation into fatty acids and their esters 
were quite similar. In the yolk sac especially, valpromide-induced
increases in polar lipids, non-esterified fatty acids, fatty alkyl esters 
and triacylglycerols were all significant in at least one study, and
embryonic triacylglycerol levels of incorporated activity were increased
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in both studies.
In conclusion, the only consistently significant action of valproic 
acid on the incorporation of [3H]acetate into lipids of the organo- 
genesis-phase conceptus, and which also differed from the actions of 
valpromide, was the large increase into yolk sac sterols.
4.8 Effects of valproic acid on the incorporation of D-fU-14C]glucose
into lipids of 10.2 day e.a. conceptuses during 1-9 hours of culture
Experimental design The experimental protocol described in section 4.5 
was used to study the potential actions of valproic acid on embryonic 
conversion of glucose to lipids. Following 1 hour 'equilibration', 6-8 
conceptuses (10.2 days e.a.) were transferred to minivials containing 
D-tU-14C]glucose (4.9pCi, 270mCi.mmol-1) in 1ml medium, as described in 
Chapter 3, section 3.7.1. Conceptuses were cultured for 8 hours in the 
presence of label after which total lipids were extracted from pooled 
embryos and pooled yolk sacs of each vial and analysed by TLC-LSC.
Results The results of this study, expressed both as dpm.pg protein-1 
and as the '% total lipids', are presented in table 4.19. Figure 4.8 
illustrates the observed actions of valproic acid treatment on control 
incorporation (dpm.pg protein-1) values.
Despite a very low percentage incorporation into yolk sac sterol 
lipids, both this figure and the actual amount of label incorporated into 
yolk sac sterols was significantly increased by valproic acid treatment 
(50% increase). Concomitantly, the amount and percentage incorporation 
into yolk sac sterol esters was significantly reduced by 1.25mM valproic 
acid.
No other changes from control levels of radioactivity were signif-
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Table 4.19
Effects of 1.25mM valproic add on the incorporation of [U-14C]glucose into lipid classes of 10.2 day e.a. 
conceptuses during 8 hours exposure (1-9 hours of culture).
YCM SAC
F/N LIPID
DPM/ug Protein
1 Polar lipids
2 Diacylglycerols
3 Sterols
4 Fatty alcohols 
& lanosterol
5 Fatty adds (FA)
7 Triacylglycerols
8 FA alkyl esters
10 Sterol esters
11 "10" & Squalene
Total lipids
ug Protein/tissue
% Total lipids
EMBRYO
DPM/ug Protein
ccnirol VPA CONTROL VPA CCNIROL VPA CONTROL VPA
38.4 (1) 35.4 + 58.3 (.7) 56.4 +
.
112.9 (5) 103.6 74.4 (.6) 74.3
1.1 (.1) 1.1 1.7 (.1) 1.7 1.8 (.1) 1.7 1.2 (.08) 1.2
1.0 (.1) 1.5 * 1.6 (.2) 2.4 **
■
11.4 (.4) 10.1 + 7.5 (.1) 7.3
<.01 <.02 <.02 <.03 0.4 (.04) 0.3 0.3 (.03) 0.2
0.5 (.03) 0.4 0.8 (.05)
*
0.7 1.6 (.06) 1.6 1.1 (.06) 1.2
23.0 (1) 22.8 34.7 (.8) 36.3 21.4 (1) 19.9 14.1 (.6) 14.2
0.3 (.05) 0.4 0.4 (.1) 0.6 0.8 (.05) 0.9 0.5 (.02) 0.6 **
1.0 (.04) 0.8 *** 1.6 (.04) 1.2 *** 0.7 (.05) 0.9 + 0.5 (.02) 0.6 ***
0.3 (.07) 0.1 + 0.5 (.08) 0.2 * 0.1 (.01) 0.1 0.1 (.01) 0.1
66.0 (2) 62.8 11151.7 (7) 
1 1
139.6
34 (.6) 37 * !! 49 (2) 43 *
% Total lipids
Data are expressed as DFH/ug protein and as the percent of total lipids incorporated into individual fractions 
(% total lipids). Mean values of 7 determinations, control and treated, are presented. The pooled SEM for 
each set of control and treated data is presented in brackets. + P<0.1, * P<0.05, ** P<0.01, *** P<0.001, 
valproic add (VPA) data significantly different frcm control data, analysis of variance.
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Figure 4.8
Effects of valproic acid (1.25mM) on the incorporation of 
D-tU-14C]glucose into lipid classes of 10.2 day e.a. conceptuses during 
1-9 hours of culture.
Data are expressed as the percent change (mean ± SEM) from mean control 
'dpm.pg protein-1' values. Controls and treated, n=7. * P<0.05, ***
P<0.001, analysis of variance. Abbreviations: C, cholesterol; CE, 
cholesterol esters; FA, fatty' acids; DG, diacylglycerols; TG, triacyl­
glycerols; PL, polar lipids; ToT, total lipids.
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icant. Small changes in embryonic sterol and sterol ester activities 
were apparent, however, and these effects were the opposite of the 
corresponding yolk sac effects described above. Interestingly, the 
amounts of label incorporated into non-esterified fatty acids and 
triacylglycerols remained unaltered following valproic acid treatment.
4.9 Discussion
The preliminary studies presented in this chapter examined the actions 
of teratogenic exposures on the incorporation of [3H]acetate into lipids 
of 9.5 day e.a. rat conceptuses during 48 hours of culture. This initial 
experimental approach to obtaining a 'screen' for investigating terato­
genic actions on lipid biosynthesis seemed to be a logical first choice 
since this 2 day culture period is the standard protocol routinely used 
for assessing the teratogenic capacities of chemical agents in rat whole 
embryo culture.
Before attempting to study the potential actions of valproic acid 
in this system, two metabolic inhibitors of known mechanistic actions 
were employed to assess the suitability of the 48 hour period as a 
'screen'. These were mevinolinic acid, a specific competitive inhibitor 
of HMG-CoA reductase, and TMD which specifically inhibits oxidosqualene 
cyclase, also by competitive action. Both agents, therefore, inhibited 
the cholesterol-synthetic pathway, mevinolin at the rate-limiting step, 
and TMD at a distal stage in the pathway. Similarly, both agents were 
known to be teratogens, and evidence suggested that their mechanisms of 
teratogenic action were through their specific enzyme-inhibitions. 
Minsker et al (1983) were able to demonstrate suppression of mevinolinic 
acid teratogenicity in vivo by mevalonate supplementation in pregnant 
rats. Similarly, studies in this laboratory by Jin ejt al. (1985) using 
the 48 hour rat embryo culture technique showed that the incidence and
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severity of mevinolinic acid-induced terata were significantly reduced by 
mevalonate, but not by cholesterol supplementation of the culture 
medium. Jin's work also showed that the incidence of abnormalities 
induced in embryos cultured in the presence of TMD was not affected by 
mevalonate supplementation but was prevented by the addition of 
cholesterol/corn oil to the medium. However, the effects of these agents 
on embryonic lipid synthesis, measured by [3H]acetate incorporation, were 
not quite as expected. Large decreases in sterol lipid associated 
radioactivity were not observed while the amounts of label incorporated 
into several other lipid classes, notably triacylglycerols, fatty alkyl 
esters and polar lipids were considerably altered, especially by mevin­
olinic acid treatment. The fact that in neither of these studies was it 
possible to say which of these effects was primarily induced, suggested 
that this experimental approach was in fact not suitable for determining 
initial biochemical sites of action, and that a shorter experimental 
period might hold more promise.
Nevertheless, the reduced incorporation of [3H]acetate into sterol 
lipids indicated that cholesterol biosynthesis was active in the develop­
ing rodent conceptus. However, radioactivity measured in sterol lipid 
fractions of treated conceptuses was not tremendously lower than control 
levels by the end of the 48 hour period. Thus, compensatory enzyme 
synthesis might be operating. Accumulation of intermediary metabolites 
directly proximal to the sites of inhibition, as evident in the TMD 
study, appeared to compete more readily for the active sites on the 
enzymes. Inhibition of cholesterol synthesis would necessarily result in 
reduced cholesterol esterification, as observed with mevinolinic acid. 
TMD did not appear to affect the levels of label incorporated into sterol 
esters, but in fact this observation was confounded by the increased 
amounts of squalene in both embryo and yolk sac. This tended to rule out
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the possibility that the yolk sac was deficient of the enzyme oxido- 
squalene cyclase, a theory which might have explained the apparently 
slight action of TMD on sterol lipids in this tissue unlike the signif­
icant dose-related inhibition seen in embryos.
These studies and those of Jin et al. (1985) suggested that the
primary action of these agents in the conceptus was likely to be inhib­
ition of cholesterol biosynthetic enzymes. The reduced percent incorp­
oration into sterol lipids was certainly highly significant, although 
this was also partly due to increased amounts of radioactivity incorp­
orated into triacylglycerols and other lipids. These 'side-effects' 
differed to an extent following exposure to the two inhibitors and the
possibility that these other effects might be responsible for the
structural anomalies ultimately expressed by these agents at 48 hours of
culture could not be ruled out.
Although the data from these long-term cultures ’masked’ the initial 
biochemical sites of action from being defined they did provide infor­
mation about the embryos responses to what were likely to have been 
specific actions on lipid biosynthesis. In this respect it did appear to 
be worth studying valproic acid with this approach, especially if
conceptuses were exposed to increasing teratogenic concentrations to
help identify the most (if any) significantly affected pathways. Several 
effects were observed following valproic acid treatment, even at the
relatively low dose of 0.6mM. Radioactivity incorporated into embryonic 
sterol and triacylglycerol fractions was increased in an apparently 
dose-related fashion, while yolk sac sterols, and polar lipids in both 
tissues, also contained higher levels than controls. Overall, lipid 
associated radioactivity was significantly increased by valproic acid 
treatments although these actions did not closely agree with the true 
dose-response observed for measured protein contents. The severe growth
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retardation observed with l.OmM valproic acid at the end of 48 hours and 
the profile of associated abnormalities were very similar to other 
published data from this laboratory (Brown et al., 1987).
This general increase in lipid biosynthesis, induced in response to 
valproic acid treatment over the standard 48 hour culture period, could 
be due to intrinsic actions on lipid enzyme systems, interference with 
mechanisms of exogenous lipid uptake, or may reflect actions on other, 
perhaps non-lipid pathways. It was hoped that the subsequent short-term 
cultures would shed more light on the mechanism behind these actions by 
identifying the pathway, or pathways, initially affected. The actions of 
mevinolinic acid during an 8 hour exposure (16-24 hours of culture) were 
encouraging in this respect as sterol lipid synthesis was inhibited by 
90% in both embryonic and yolk sac tissues. This highly significant 
effect confirmed the hitherto only suspected specific inhibitory action 
of mevinolinic acid in the developing conceptus. It also indicated that 
this second experimental approach was likely to prove more successful as 
a 'screen' for identifying initial actions on lipid pathways, or at least 
the initial response(s) to a related biochemical action.
As described earlier (Chapter 1, section 1.6) this 8 hour period 
of culture is suitable for examining the actions of valproic acid and 
some other SCCA. Exposure to valproic acid over 16-24 hours of culture 
produces somite abnormalities observable at 48 hours and resembling those 
produced following valproic acid treatments in vivo which result in 
rib and vertebral defects at term. Since these structural defects are 
produced as a result of insult(s) initiated during the exposure period, 
it follows that initial biochemical changes that lead to malformation 
should be detectable by the end of this treatment period. Indeed, 
unlike the earlier biochemical investigations with this experimental 
protocol (Coakley et: al., 1986), valproic acid produced highly signif­
icant changes in the incorporation of [3H]acetate into lipid fractions. 
However, unlike the specific effects of mevinolinic acid which were 
similar in both tissues, valproic acid's actions could not be pinpointed 
to any one major effect, with changes occurring in fatty acids, embryonic 
triacylglycerols and yolk sac sterol lipids. The comparisons with 
butyric acid, and valpromide were, therefore, important in attempting to 
highlight which effects, if any, induced by valproic acid exposure, might 
be implicated in its teratogenic mechanism. Butyric acid is the most 
potent SCCA in embryo culture (in terms of added media concentrations), 
and produces malformations like those of valproic acid. Valpromide, on 
the other hand, produced only slight and very different abnormalities 
when conceptuses were exposed during 16-24 hours of culture, and the 
concentration used in these studies (3.0mM) was the lowest effective 
treatment over this period (other valpromide treatment data not 
presented). Exposure of conceptuses to 2.0mM valpromide during an entire 
48 hour culture only retarded embryonic and yolk sac growth to an extent 
equivalent to that seen with 0.75mM valproic acid exposure over 48 hours, 
again with a different profile and lower incidence of produced abnorm­
alities (data not presented). Given the additional fact that valpromide 
remains essentially non-ionized in the physiological pH range and does 
not consequently bind to serum proteins (protein binding <10%, Nau & 
Scott, 1986; unlike 1.25mM valproic acid which was about 65% bound under 
the experimental culture conditions) the free concentration of valpromide 
surrounding the conceptus during the 8 hours was calculated to be 
6.8-fold higher than the free media concentration of valproic acid. 
Similarly, the free media concentration of butyric acid was also 1.7-fold 
higher than valproic acid, showing that valproic acid was in fact the 
more potent SCCA.
Comparisons of these treatments highlighted a common effect of
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valproic acid and butyric acid on yolk sac sterol lipids; a significant 
increase in the amount of incorporated label in this lipid class which 
contrasted with the actions of valpromide. Valproic acid also increased 
the levels of activity into fatty acid and embryonic triacylglycerol 
fractions. These latter actions might be explained in terms of increased 
synthesis or reduced oxidation of fatty acids. However, earlier work in 
this laboratory (Brown et al., 1985; Coakley ejt al., 1986) suggests that 
it is unlikely that valproic acid inhibits fatty acid p-oxidation, at 
least in the same way that it does in adult hepatocytes by depletion of 
cellular acetyl-CoA. Also, in Chapter 3, oleic acid incorporation data 
suggested that very little or any oxidation of long-chain fatty acids 
occurred in these 10.5 day e.a. conceptuses. In any case, valpromide also 
increased levels of embryonic triacylglycerols and, although levels of 
non-esterified fatty acids were unchanged, valpromide did increase the 
amount of label measured in yolk sac fatty acid alkyl esters. Thus, 
these effects on fatty acids did not appear to be restricted to valproic 
acid.
With the exception of the commonly-induced apparent increase in yolk 
sac sterol synthesis, considerable differences were observed between the 
actions of valproic and butyric acids, particularly on [3H]acetate 
incorporation into embryonic lipids. Differences in metabolism seemed a 
likely candidate for an explanation. Previous work in this laboratory 
had shown that the naturally occurring butyric acid is extensively 
metabolised in 11.5 day e.a. Lac:P conceptuses unlike valproic acid which 
is not incorporated to any significant extent (Brown, 1987). Similar 
studies with 10.2 day F344/Tru conceptuses also showed that butyric acid 
is much more readily metabolised than valproic acid. The small amount of 
impurities in the valproic acid label could conceivably have 
accounted for the small amount of radioactivity incorporated. In
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addition, about half the total measured butyric acid label incorporated 
into these conceptuses was present in the lipid fraction. Further 
analysis of this fraction revealed fairly high levels of fatty acids 
(either non-esterified or alkyl esters) although activity was substan­
tially incorporated into polar lipids, triacylglycerols and sterols, in a 
way similar to that observed for acetate. In adult systems metabolism of 
butyric acid proceeds via acylation of its carboxyl group. Not only did 
this study indicate that 10.5 day conceptuses were capable of this 
conversion, but because activity was found in the sterol fraction, 
oxidation of the formed butyryl-CoA to acetyl-CoA was also implied. 
Thus, metabolism of butyric acid, especially to more complex lipids, 
might well account for its different actions from valproic acid on 
acetate metabolism. The mechanism(s) responsible for valproic acid's 
teratogenicity did not appear to be correlated with embryonic metabolism 
of SCCA.
Following the observation that preculture of conceptuses in 75% serum 
appears to influence the incorporation of [3H]acetate into lipid frac­
tions (see Chapter 3), the valproic acid and valpromide studies were 
repeated with conceptuses which were freshly explanted at an age equiv­
alent to 9.5 days plus 16 hours, i.e. 10.2 days e.a.. Again, an 8 hour 
experimental period was employed and conceptuses were exposed to 
[3H]acetate and teratogenic concentrations identical to the previous 
experimental design. In general, the actions of both valproic acid and 
valpromide were similar to those observed in precultured conceptuses. 
However, the previously highlighted common action of valproic and butyric 
acids, i.e the increase in yolk sac sterol synthesis, was now 2-fold 
control levels following 1.25mM valproic acid treatment. Similarly, the 
levels of radioactivity in fatty acids were also raised above controls by 
a greater margin than previously observed. Larger treatment effects were
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not restricted to valproic acid; valpromide actions also appeared to be 
more potent when fresh explants were exposed to this agent. This 
phenomenon of enhanced treatment-induced changes, therefore, amplified 
the differences between the actions of valproic acid and its amide.
The dose-response study confirmed that valproic acid's action on 
yolk sac sterol synthesis was especially important. At the lowest dose 
studied (0.5mM) the amount of radioactivity measured in this fraction was 
not significantly altered from control levels, while the highest dose 
(2.0mM) increased the activity in this fraction by 112%. Over this 8 
hour exposure period, 0.5mM valproic acid was without effect on embryonic 
morphology examined at 32 hours of culture, while increasing concen­
trations of the drug produced abnormalities in a dose-related manner 
(full details not presented). At l.OmM and 1.5mM concentrations, somite 
irregularities and fusion were again the the most prominent malformations 
observed, while the relatively high concentration of 2.0mM valproic acid 
produced conceptuses with retarded embryonic growth and yolk sac 
defects.
Further analysis of the sterol lipids precipitated as their digi- 
tonides, confirmed that the observed increase was an increase in yolk sac 
cholesterol biosynthesis. Concomitant with this highly significant 
dose-dependent increase in yolk sac cholesterol synthesis, yolk sac 
sterol ester formation was decreased in a dose-related fashion. This 
relationship had been observed in both previous valproic acid studies and 
provided a basis for the postulation that metabolic 'up-regulation' of 
cholesterol synthesis was perhaps being operated in response to del­
eterious actions on exogenous cholesterol uptake processes. The apparent 
dose-related increase in fatty acid levels did not, however, appear to 
fit into this theory. Thus, two separate actions of valproic acid might 
be considered responsible for, or associated with, its exhibited terato­
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genicity.
Up to this point all studies examining the potential actions of 
valproic acid on lipid biosynthesis had been conducted in cultured
conceptuses with simultaneous exposure to the drug and [3H]acetate. 
Although these investigations had employed different experimental 
approaches it was not yet certain if the apparently specific increases on 
fatty acid and yolk sac sterol syntheses were actions restricted to
valproic acid exposure in culture; i.e., were these biochemical responses 
were also induced in vivo? It was also not known if the observed actions 
of valproic acid in culture were due to effects only on exogenously 
derived acetate; did valproic acid have similar effects on the endogenous 
acetate (acetyl-CoA) pool?
The first of these questions was answered by a study which demon­
strated that the specific actions of valproic acid were, indeed, induced 
as a result of in vivo exposure. These in vivo actions of valproic acid 
were measured subsequent to just 3 hours exposure. Pharmacokinetic data 
show that oral (or subcutaneous) administration of sodium valproate to 
pregnant mice results in rapid absorption into the blood stream and peak 
plasma and embryonic concentrations are reached within 10-30 minutes (Nau 
et al., 1981; Nau, 1986a). Due to a short half-life and high plasma
clearance rate in the mouse, plasma levels decrease sharply, and >90% of
the drug is eliminated after 3-4 hours (Nau et al., 1981). By comparing
the incidence of malformations in embryos exposed via these admin­
istration procedures with those produced following exposure to steady- 
-state maternal plasma concentrations of valproic acid (obtained using 
subcutaneous implanted osmotic minipumps) Nau was able to show that the 
peak concentration, rather than the total exposure (AUC), was the 
relevant factor determining the teratogenicity of this drug (Nau, 1985). 
Therefore, by the end of the 3 hours following oral administration of a
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teratogenic dose of valproic acid in the present study peak embryonic 
concentrations of the drug would have been reached and initial bio­
chemical actions should in theory be detectable. After explantation, 
exposed conceptuses were rinsed in several changes of MEM and equilib­
rated in normal medium for 30 minutes. Most of the little remaining 
valproic acid present in the conceptuses would have diffused out into the 
surrounding medium during this period (Brown, 1987). Conceptuses were 
then transferred to fresh medium and cultured in the presence of 
[3H]acetate for 2 hours. In addition to the earlier observed actions on 
fatty acids and yolk sac sterols, the amount of radioactivity incorp­
orated into triacylglycerols was also increased in both tissues. 
Increased triacylglycerol activity had only previously been observed in 
the embryonic compartment.
Having established that valproic acid causes similar actions on 
[3H]acetate incorporation into lipids both in culture and in vivo, the 
question concerning exogenous vs. endogenous acetate metabolism was 
investigated. Endogenous acetate is present as acetyl-CoA in biological 
systems and is produced via several metabolic pathways: fatty acid
(J-oxidation, glycolysis, and metabolism of tricarboxylic acid cycle 
intermediates such as the products of oxidative amino acid degradation. 
Studies with radiolabelled oleic acid showed that fatty acids are 
predominantly esterified to polar lipids, acylglycerols, and sterol 
esters, while levels of fatty acid oxidation providing the embryo with 
acetyl-CoA appear to be very low during early organogenesis. However, 
radiolabelled glucose, despite its greater metabolism to lactate, might 
provide a suitable substrate for labelled endogenous acetyl-CoA. 
Although incorporation of radiolabelled glucose derived acetyl-CoA into 
lipids would be confounded by the high levels of radioactive glycerol
incorporated via G3P/DHAP, small amounts of radioactivity were present in
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the sterol and sterol ester fractions. Moreover, simultaneous exposure 
to valproic acid resulted in significantly increased yolk sac sterol and 
reduced yolk sac sterol ester levels of incorporated label. This showed 
that valproic acid was producing a real action on acetyl-CoA anabolism 
rather than a more obscure effect solely on the exogenous, initially 
non-acylated acetate.
Summary Valproic acid induced specific changes in the incorporation 
of [3H]acetate into yolk sac and embryonic lipids of the organogenesis- 
-phase embryo. These changes could be classified as two main actions, 
one increasing cholesterol synthesis and concomitantly reducing levels of 
synthesized sterol esters in the yolk sac, the other causing increased 
levels of radioactivity in fatty acid and triacylglycerol fractions. 
These actions of valproic acid were observed during several different 
experimental teratogenic exposure conditions, including in vivo 
exposure. Valproic acid's actions on yolk sac sterols were of particular 
interest for the following reasons: similar actions were observed 
following treatment with butyric acid; the actions of valpromide on this 
lipid were consistently different (even opposite) to those of valproic 
acid; increasing culture medium concentrations of valproic acid induced 
highly significant dose-related increases in yolk sac sterol synthesis 
and decreases in sterol esters; and similar actions on the incorporation 
of D-fU-14C]glucose label into yolk sac sterols and sterol esters were 
observed.
The consistent specificity of these actions suggested select actions 
on lipid metabolism of the developing conceptus, rather than a general 
toxic insult or non-specific actions on acetate metabolism. Together 
with the previous negative findings in this laboratory (Coakley et al., 
1986) these actions therefore represented a promising lead in the search
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for the initial teratogenic insult of valproic acid. The following 
chapter describes and discusses the results obtained from studies 
designed to investigate the actions of valproic acid on yolk sac sterol 
metabolism in more detail.
Chapter 5
CHOLESTEROL METABOLISM: FURTHER STUDIES 
WITH VALPROIC ACID
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5.1 Introduction
From the studies described in the previous chapter it appeared that 
the most important of valproic acid's actions on lipid biosynthesis was 
the increase in yolk sac cholesterol synthesis. This action was per­
sistent following exposure in culture and in vivo and was shown to be 
dose-dependent.
The studies described in this chapter attempted to determine if 
this effect was causally related to the production of malformations 
observed after valproic acid treatments. Were the increased levels of 
synthesized sterol directly responsible or did they represent a 
biochemical response to the initial insult? Most extrahepatic tissues 
acquire the majority of their required cholesterol via plasma lipoprotein 
uptake, especially LDL (see Chapter 1, section 1.1.3). Under these 
conditions sterol synthesis is suppressed. However, when exogenous 
supplies of cholesterol do not satisfy cellular requirements the activity 
of the rate-limiting enzyme in cholesterol synthesis, HMG-CoA reductase, 
is induced and de novo sterol synthesis increased. Thus, if the chol­
esterol content in the yolk sac is regulated in a similar way to adult 
extrahepatic tissues and derives most of its cholesterol from maternal 
sources, it follows that inhibition of cholesterol uptake by valproic 
acid would increase the rate of sterol synthesis and could also have a 
major impact on embryonic development.
The following studies were designed to investigate this hypothesis and 
began by examining whether or not yolk sac and embryonic cholesterol 
contents were significantly reduced during exposure to valproic acid.
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5.2 Effects of valproic acid and valpromide treatments on cholesterol 
contents of cultured conceptuses
5.2.1 Effects of 48 hours exposure to valproic acid
Experimental design Conceptuses were cultured from 9.5 days e.a. in 4ml 
medium (75%serum/25% MEM) for 48 hours in the presence or absence of 
0.75mM valproic acid. Three conceptuses were cultured per bottle. The 
free and total cholesterol contents of individual embryos and yolk sacs 
were subsequently determined.
Results Cholesterol contents of 9.5 day e.a. conceptuses following 48 
hours culture in the presence and absence of 0.75mM valproic acid are 
shown in table 5.1. Both yolk sacs and embryos of untreated concep­
tuses contained about 13nmoles total cholesterol. This was mostly free 
cholesterol in the embryo proper while nearly one quarter of the total 
yolk sac cholesterol was esterified. Although the ratio of free to 
esterified cholesterol was unaltered by valproic acid treatment, total 
cholesterol contents of exposed conceptuses were reduced by 30-40%. 
Tissue protein contents were also reduced by treatment but this did not 
totally account for the decrease in cholesterol contents, which were 
still significantly lower when normalised to pmoles.pg protein-1. 
Expressed in this manner, embryonic cholesterol levels were 10% lower 
than controls. Yolk sac free and total cholesterol levels were lower by 
about 20% while cholesterol esters were 41% lower. In contrast, embry­
onic cholesterol esters remained unchanged.
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Table 5.1
Effects of 0.75irM valproic acid on the cholesterol contents of 9.5 day e.a. 
conceptuses at 48 hours of culture following 48 hours exposure.
! YOLK SAC !i HffiRYO |
i i
! CHOLESTEROL j! CONTROL ! VPA !
i i i
! CONTROL
i
VPA {
i
! Free : pnoles j
i i i
i 9915 (342) i 6975 *** j
i i i
i 12888 (472)
i
i
7504 *** 1
1 pnoles/ug j! 65 (3) ! 53 *** {! 51 (2)
i
46 ** S
i
S % total Si 76 (2) i 79 i
i i i
1 98 (.5) 97 j
ii
I Esters : pnoles !i 3165 (132) { 1874 *** i
i i i
! 236 (40)
i
212 i
i
i pnoles/ug ij 21 (1) i 14 *** i
i i i
i 1 (.2)
i
1 !
i
! % total jI 24 (2) ! 21 I
i i i
! 2 (.5)
i
3 !
ii
i
! Total : pnoles 1j 13080 (414) I 8849 *** IS 13124 (464)
i
7716 *** !
i
i praoles/ug !i 86 (3) i 67 *** !
i i i
! 52 (2)
i
47 * i
i
j ug Protein/tissue {
i i i
j 153 (4) S 132 *** !! 251 (7)
i
164 *** !
Cholesterol (free, esters and total) contents are expressed as pnoles/tissue and 
pnoles/ug protein. Free and esterified contents are also expressed as the 
percentage of total cholesterol (% total). Means of 20 determinations (control) 
and 23 determinations (treated) are presented. The pooled SEM for each set of 
control and treated data are given in brackets. * P<0.05, ** P<0.01,
*** P<0.001, valproic acid (VPA) data significantly different from control data, 
analysis of variance.
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5.2.2 Effects of valproic acid and valpromide exposures during 16-24
hours of culture
Experimental design Conceptuses (9.5 days e.a.), cultured in bottles 
containing 4ml medium (75% serum,25% MEM), were exposed to 1.25mM 
valproic acid or 3.0mM valpromide during 16-24 hours of culture. Seven 
conceptuses were cultured in each bottle. At 24 hours the free and total 
cholesterol contents of the pooled embryos and pooled yolk sacs from each 
bottle were determined.
Results The effects of just 8 hours exposure to valproic acid and 
valpromide on the cholesterol contents of day 11 conceptuses are illus­
trated in figures 5.1 and 5.2 respectively, while table 5.2 presents the 
data normalized for protein content.
At 24 hours of culture untreated embryos contained about 1.8nmoles 
total cholesterol of which *97.5% was non-esterified. By comparison, 
yolk sac tissue contained about 2.6nmoles total cholesterol with only 77% 
in the free form. Both valproic acid and valpromide treatments induced 
significant reductions in yolk sac cholesterol contents (12%), affecting 
both free and esterified levels, while embryonic levels measured at 24 
hours of culture were not significantly altered. However, net chol­
esterol accumulation over the 8 hour exposure period was significantly 
lower in treated embryos (figures 5.1 and 5.2). Cholesterol levels of 
control conceptuses increased by 1.8-fold in the yolk sac and doubled in 
the embryo during 16-24 hours of culture. Thus, the small treatment 
effects measured at the end of this period reflected much larger changes 
in net accumulation of cholesterol. In fact, both valproic acid and 
valpromide reduced total cholesterol accumulation by about 25% in the 
embryo, while valpromide appeared to have a greater effect on the yolk
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Table 5.2
Effects of (a) 1.25roM valproic acid and (b) 3.0mM valpranide on the cholesterol 
contents of 9.5 day e.a. conceptuses at 24 hours of culture following 8 hours 
exposure (16-24 hours of culture).
(a) Effects of valproic acid (VPA)
CHOLESTEROL
Free : pmoles/ug
% total
Esters : pmoles/ug
% total
Total : pmoles/ug
ug Protein/tissue
YOLK SAC
CONTROL VPA
48.5 (.9) 43.0 **
76.9 (.6) 77.8
14.6 (.7) 12.3 *
23.1 (.6) 22.2
63.1 (1.5) 55.3 **
40.3 (.8) 42.4
EMBRYO
CONTROL VPA
34.7 (1.3) 32.3
97.5 (.4) 97.7
0.9 (.1) 0.7
2.5 (.4) 2.3
35.6 (1.3) 33.0
53.6 (.6) 51.0
(b) Effects of valpranide (VPMD)
CHOLESTEROL
Free : pmoles/ug
% total
Esters : pmoles/ug
% total
Total : pmoles/ug
ug Protein/tissue
YOLK SAC
CONTROL VPMD
53.1 (1.2) 48.3 *
76.7 (.9) 79.6 +
16.1 (.8) 12.5 **
23.3 (.9) 20.4 +
69.2 (1.6) 60.8 **
38.4 (1.0) 38.1
EMBRYO
CONTROL VPMD
33.3 (.8) 32.8
97.8 (.9) 95.8
0.7 (.3) 1.4
2.2 (.2) 4.2
34.0 (.8) 34.2
52.0 (2.2) 45.2 +
Cholesterol (free, esters and total) contents are expressed as pmoles/ug protein. 
Free and esterified contents are also expressed as the percentage of total 
cholesterol (% total). Means of 6 determinations are presented for both control 
treated data and the pooled SEM for each set of data are given in brackets.
* P<0.05, ** P<0.01, *** P<0.001, valproic acid (VPA) data significantly 
different fran control data, analysis of variance.
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sac than valproic acid.
5.3 Effect of cholesterol supplementation of the culture medium on 
valproic acid actions 
The results obtained from the previous study provided support for 
the theory that reduced cholesterol availability to the conceptus 
might be responsible for the increase in yolk sac sterol synthesis 
induced by valproic acid. Was it therefore possible to counter the
teratogenic expression and/or abolish the measured biochemical effects of 
this drug by growing treated conceptuses in the presence of excess 
cholesterol?
5.3.1 Potential protection from teratogenicity
Experimental design The effects of cholesterol supplementation of the 
culture medium on the development of conceptuses exposed to valproic acid 
was studied using two different experimental approaches.
(i) 9.5 day e.a. conceptuses were cultured in bottles containing 4ml 
medium (75% serum,25% MEM) supplemented with 500pg cholesterol.ml~1, or 
2.5% v/v of the solvent vehicle corn oil (controls), with or without
0.5mM valproic acid for the full 48 hours.
(ii) 9.5 day e.a. conceptuses were cultured in 4ml medium supple­
mented with Img cholesterol.ml-1, or 5.0% v/v of corn oil (controls), for 
the first 24 hours only. Valproic acid (1.25mM) was added at 16 hours of 
culture and, following 8 hours exposure, conceptuses were transferred to 
fresh, normal medium.
Growth and morphological development was assessed at 48 hours of 
culture.
Results The results of studies (i) and (ii) are presented in tables 5.3 
and 5.4, respectively. In both studies the amount of cholesterol added 
to the medium was the highest possible for that period of culture and was 
limited by its solubility in corn oil (20mg.ml-1) and by the toxicity 
of the solvent vehicle. Pilot studies showed that media corn oil 
concentrations of 2.5% and 5.0% were the maximum tolerated by conceptuses 
during 48 and 24 hours of culture respectively (data not presented). 
Despite this limiting factor, the addition of 0.5mg cholesterol per ml 
medium more than doubled the usual medium total cholesterol concentration 
and an extra lmg.ml-1 increased it 3.8-fold (serum total cholesterol 
levels were 47.2 ± 3.5 mg.100ml-1). Few malformations were observed in
conceptuses exposed to cholesterol or its solvent vehicle at these 
levels, especially those treated for the first 24 hours only. Embryonic 
development was generally good and embryos cultured in cholesterol-rich 
medium appeared large compared with those routinely cultured for 48 hours 
in normal medium ('cholesterol-treated1 conceptuses were significantly 
larger than corn oil controls). Exposure to 2.5% corn oil over 48 hours 
resulted in some embryos having slightly large looking heads but they 
were otherwise morphologically normal.
However, neither supplementation protocol prevented or even partially 
protected against the teratogenic expression of valproic acid treatment. 
Even when conceptuses were cultured for 16 hours in cholesterol-rich 
medium prior to drug exposure the characteristic irregular and/or fused 
somite morphologies and amongst other defects were unaffected. In fact 
embryos treated with valproic acid during this 8 hour period in the 
presence of excess cholesterol appeared more retarded than treated 
embryos grown in unsupplemented medium.
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Table 5.3
Growth parameters and morphological abnormalities of 9.5 day e.a. conceptuses at 48 hours of 
culture following 48 hours exposure to 0.5mM valproic acid in media supplemented with 
cholesterol (0.5mg/ml) or its solvent vehicle com oil (2.5% v/v).
11
1
t1
1
11
t1
11
1
CORN OIL 
(2.5% v/v) 
CONTROLS
[nf=7]
11 11 
11 11 
11 11
11 11 
11 11 
11 11
11 11 
11
CHOLESTEROL
(0.5mg/ml)
[h=8]
!‘VALPROIC ACID 
! (0.5mM)
1
1
[n=10]
! VALPROIC ACID i 
! (0.5mM) ! 
I +CH0LESTEROL ! 
S (0.5mg/ml) !
i [n=8] I
1
1
! GRCWIH PARAMETER 
| -
1 1 
1 1 ( I
Absolute values!!
1 1 1 1
Percent of mean control values !
!
i Crown-rung) length (ran) 
1
4.9 (.2)
11 11 
11 11 
11
98 (5) 92 (9) c 90 (5) b !
I
! Head length (mm)
I
2.7 (.1)
11 
11 11
11
100 (6) 89 (7) a 87 (7) a !
1
i No. Semite pairs
II
I
26.7 (1.0)
11 
11 11 
11 11
11
102 (2) 99 (2) 
[CC,n=2]
99 (4) !
1
i Enbryonic protein (ug)
1I
235 (30)
11 
11 11 
11 11
101 (8) 80 (21) d 75 (12) b !
1
! Yolk sac diameter (mn) 5.1 (.2)
11 11
11 11
11
100 (4) 94 (7) c 92 (4) b !
1
Yolk sac protein (ug)
......
128 (28)
11
11 11
ii
i
107 (18) 97 (24) 98 (28) !
•
ABNORMALITY
.
1
11
Percent of total embryos
1 1 1 1
with abnormalit:ies I
Yolk sac defects 28
i i 
11 11 
i
13 30 63 !
.
Abnormal embryonic shape
■
43"
i
11 11 
11
25* 40" 50" !
Retarded otic development 
[open otics]
0
11 
t 1 1 1
f I 1 1
1 1
25 100
[10]
100 !
Retarded optic development 0
1 1 
1 1 1 1 
1 1
0 100 100 ' !
.
Irregular & fused samites 0
1 1 
t 1 1 ! 
1 1
0 90 88 !
Turning defects 
Neural tube defects:
0
1 1
1 1 1 I
1 1 1 1 
1 1 1 1
1 I
0 10 38
Slight wave/single kink 57
1 1 
1 1 1 1 
I t
38 20 12 !
1
Crooked
11
0
1 1 
1 1 1 1
1 t I t
0 80 88 !
Growth parameters (mean values, +/- SD) are presented as absolute values (com oil controls) or 
or as the percentage of controls (treated groups), d P<0.1, c P<0.05, b P<0.01, a P<0.001, 
com oil controls and treated significantly different, Student's t test. CC, could not count. 
Slight enlargement of brain region. " Long/thin embryonic profile.
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Table 5.4
Grcwth parameters and morphological abnormalities of 9.5 day e.a. conceptuses at 48 hours of 
culture following 8 hours exposure to 1.25mM valproic acid (16-24 hours of culture) and grown 
im media supplemented with cholesterol (lmg/ml) or its solvent vehicle com oil (5% v/v) from 
0-24 hours of culture.
CORN OIL 
(5% v/v) 
CCNIROLS
[n=6]
1!
11
I1
11
11
1I
1 1 I 1
i f
CHCSjESTEKXj
(lmg/ml)
[n=6]
VALPROIC ACID 
(1.25mM)
[n=6]
1I
I VALPROIC ACID 
! (1.25mM) 
i 4CH0LE5TEROL 
! (lmg/ml)
! fe=6]
! GRCWIH PARAMETER
I 1 
1 1 1 I
{Absolute valves!!
t 1 I 1
i
i
Percent of mean control
11
values
i Crown-rump length (no) 4.7 (.3)
I 1 I 1 
I 1 1 1 
1 1
107 (7) d 101 (1) 92 (4) c
! No. scmite pairs 27.2 (.8)
1 1 
t 1 1 1 103 (2) 97 (1) c 97 (0)
[*CC,n=l] 1 t 1 1 
1 i
[CC,n=2]
! Hnbryonic protein (ug)
I
231 (33)
1 1 
I 1 1 <
1 * 1 !
117 (9) c 99 (12) 89 (3) d
! Yolk sac diameter (mm) 4.9 (.4)
1 1 1 1 
1 1 1 1 
1 1
106 (3) 99 (1) 96 (2)
1
! Yolk sac protein (ug) 
1
143 (19)
1 1
1 1 1 1 
1 1 1 1 
1 1
118 (18) d 105 (2) 84 (2) c
|1
j ABNORMALITY
1
11
Percent of total embryos
11
with abnormalil:ies
11
! Yolk sac defects 0
1 I 1 1 
1 1 1 1 
1
0 0 0
1
! Abnormal embryos 
1
'17
1
11
1
0 100 100
1 Retarded otic development 
1
0
1
I1
I
17 50 100
1
! Retarded optic development 
1
0
1
11
1
0 50 100
! Turning defects 17
1
11
1 1
0 0 0
! Scmite defects: 
1
1 1 
11 I 
1 1
! Irregular (13-18) 0
1 1 
1 t 1 1 
1 t
0 100 100
! Fused (13-18) 0
1 1 
1 1 1 1 
1 1
0 67 83
! Neural tube defects:
I
1 1 
1 1 1 1 
1 1
! Slight wave/single kink 0
1 1 
1 1 1 1
1 1
0 33 33
1
! Crooked
11
0
1 1 
1 1 1 1
1 1 1 1
0 50 67
Growth parameters (mean values, +/- SD) are presented as absolute values (com oil controls) or 
or as the percentage of controls (treated groups). d P<0.1, c P<0.05, com oil controls 
and treated significantly different, Student’s t test. CC, could not count. * Due to turning 
failure in one embryo.
208
5.3.2 Potential reversal of altered lipid biosynthesis
Experimental design The effects of cholesterol supplementation of the 
culture medium on valproic acid's actions on lipid biosynthesis were 
studied using a protocol based on experimental design (ii), section 
5.3.1. Conceptuses (9.5 days e.a.) were cultured in medium supplemented 
with lmg cholesterol.ml"1, or 5.0% v/v of corn oil (controls), for the 
first 24 hours only. Culture was in bottles containing 4ml supplemented 
medium for the initial 16 hours after which conceptuses were transferred 
to minivials containing 1ml of supplemented medium, 1.25mM valproic acid 
and [3H]acetate (125pCi, lOOmCi.mmol-1). Following an 8 hour exposure 
conceptuses were removed to ice-cold saline, and total lipids extracted 
from the pooled embryos and pooled yolk sacs of each vial for analysis by 
TLC-LSC.
Results Table 5.5 presents the results of this study expressed as dpm.pg 
protein-1 and as the percentage change from control levels induced by 
valproic acid treatment (where these changes were significant). Stat­
istical analyses of valproic acids actions on lipid biosynthesis were 
made for conceptuses cultured in medium containing corn oil alone and for 
those cultured in medium supplemented with cholesterol. Conceptuses were 
exposed to these four treatments (corn oil ± valproic acid and corn 
oil/cholesterol ± valproic acid) simultaneously within an experiment. 
For comparison, the first three columns of data include the results 
obtained in the earlier study where the actions of valproic acid were 
examined in normal media, using the same experimental protocol (Chapter 
4, section 4.3.2).
The most important observation arising from the present study was the 
failure of cholesterol supplementation of the culture medium to reverse
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Table 5.5
Influence of media supplementation with cholesterol (lmg/ml) and its solvent vehicle com oil (5% v/v) cn 
'normal' and valproic acid (1.25mM) altered incorporation of [3H]acetate into lipid classes of 9.5 day e.a. 
conceptuses during 16-24 hours of culture.
! Media supplements: 1 1 1 1 None CCRN OIL |! CORN OIL + CHOLESTEROL
1 1 1
i! CCNIROL 
! i [n=ll]
-f 1
i VALPROIC ACID 
[n=ll]
.1
CCNIRQL
[n=5]
! VALPROIC ACID
! [n=5]
- *
11
ii ccnirol 
[n=5]
I VALPROIC ACID 
! Cn=5]
-i
YOLK SAC
— 1 1
!! Dpn/ug Pr
_l 1
“1
■otein % change Dpn/ug Pi
•1
■otein % change Dpn/ug Pi
■i—  ■■■■
■otein % change
1 Polar lipids ! 1 142 (7)
1 I
152 196 (12) 226 237 (11) 247
2 Diacylglycerols i! 10 (1)
I 1
11 19 (3) 31 + 61 * 11 (1) 15 + 36 *
3 Sterols ii 38 (2) 
1 1
55 + 44 *** 341 (40) 481 + 41 * 39 (3) 61 + 58 *
4 Fatty alcohols 
+ lanosterol
! 1 6 (.5)
1 1 1 1
1 1
8 + 29 * ! 4 (1)
-
5 0.3 (.4) 1
5 Fatty acids !! 11 (1) 
1 1
15 + 41 ** 20 (2) 31 + 57 ** 15 (2) 16
7 Triacylglycerols i! 58 (3) 
1 1
64 94 (8) 142 + 51 ** 139 (13) 175
8 Fatty alkyl 
esters
I! 3 (.4) 
1 1 1 1 
1 1
3 4 (.6) 4 6 (1) 4
10 Sterol esters 
+11
i! 13 (.5)
1 1 1 1 
1 1
10 - 24 ** 27 (3) 49 + 84 ** 46 (2) 46
Total lipids !! 285 (12)
1 t
322 + 13 * 718 (62) 990 + 38 * 504 (29) 579
ug Protein/tissue 
[no.tissues]
!! 48 (2) 
1! [3]
52
[3]
!! 41 (3) 
ii [2]
40
[2]
I! 37 (2) 
!! [2]
38
[2]
EMBRYO
■
1 Polar lipids 360 (7) 351
-
592 (54) 557 523 (58) 563
2 Diacylglycerols 16 (1) 17 31 (3) 38 22 (3) 29
3 Sterols 192 (6) 188 492 (21) 610 + 24 ** 284 (16) 339 + 19 *
4 Fatty alcohols 
+ lanosterol
19 (2) 22 15 (2) 14 ■ 7 (1) 7
5 Fatty acids 19 (2)' 27 + 39 ** 40 (5) 47 17 (1) 28 + 64 ***
7 Triacylglycerols 84 (5) 105 + 24 ** 130 (12) 180 + 39 * • 106 (13) 159 + 50 *
8 Fatty alkyl 
esters
5 (.7) 6 . 7 (.7) 9 7 (1) 8
10 Sterol esters
11
9 (.7) 9 9 (.2) 17 + 89 *** 15 (2) 25 + 63 *
Total lipids 710 (18) 734 i{1329 (85)
ll
1488 i! 992 (18)
ll
1172
ug Protein/tissue 
[no.tissues]
66 (2) 
[3]
65
[3]
!! 59 (4) 
ii [2]
51
[2]
ii 54 (3) 
1! [2]
49
[2]
Data is expressed as dpn/ug protein or as the percentage change from control values. The pooled SHI for each 
set of treated and control data are presented in brackets. * P<0.05, ** P<0.01, *** P<0.001, valproic acid data 
data significantly different from control data. A Media supplementation was from 0-24 hours of culture. 
Uhsupplemented media data taken from table 4.7, chapter 4.
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valproic acid's major actions on lipid biosynthesis, namely increased 
yolk sac sterol synthesis and increased acetate incorporation into 
embryonic triacylglycerols. Indeed, additional changes were recorded
following valproic acid treatments in supplemented medium, i.e. increased 
acetate incorporation into embryonic sterols and into yolk sac
diacylglycerols. The former probably reflects the higher rates of
sterol synthesis in conceptuses cultured in supplemented, as opposed to 
normal, medium. Addition of corn oil alone specifically increased
incorporation of [3H]acetate into yolk sac sterols by nearly 900%. 
Sterols accounted for about half the total activity incorporated into 
lipids of these yolk sacs compared with just 12 percent incorporation 
under normal culture conditions. Embryonic sterols were also apparently 
increased by corn oil treatment but to a much smaller extent. This might 
have been due to transport of newly synthesized sterols from the yolk sac 
rather than a specific effect on embryonic rates of sterol synthesis per 
se. Adding cholesterol to the solvent vehicle reduced the corn oil- 
-induced increase in yolk sac sterol synthesis to control levels 
(i.e. that observed in conceptuses cultured in normal medium). 
Similarly, embryonic sterol associated radioactivity was also reduced.
Thus, although added medium cholesterol was apparently taken up by 
the yolk sac and profoundly influenced the rate of sterol synthesis in 
this tissue at least, presumably by 'down-regulation' of HMG-CoA reduct­
ase, it had no impact on the biochemical actions of valproic acid on this 
lipid class.
5.4 Potential actions of valproic acid on cholesterol uptake
Although cholesterol supplementation of the culture medium was unable 
to protect against the teratogenicity of valproic acid, or abolish its 
actions on lipid metabolism, the possibility that processes concerned
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with cholesterol uptake might be infuenced by this drug remained unres­
olved.
Experimental design Uptake of exogenous cholesterol by day 11 concep­
tuses and the possible influence of valproic acid on this or these 
process(es) was investigated by two experimental methods.
{i) Conceptuses were explanted at 10.6 days e.a. and, following 1
hours pre-incubation in 50% serum,50% MEM, were cultured for 2 hours in 
200pl serum-free medium containing 75% MEM and 25% [3H]cholesterol-LDL 
(20pg protein) with or without 1.25mM valproic acid. Total cholesterol 
in the medium was 30.75pg.ml-1 and 1.45pCi.ml-1 (18.24mCi.mmol-1).
(ii) Conceptuses were explanted at 10.2 days e.a. and, following 1
hours pre-incubation in 100% serum, were cultured for 4 or 8 hours in 
210pl containing 95% [3H]cholesterol-serum and 5% MEM with or without 
1.25mM valproic acid. Total cholesterol in the medium was 450pg.ml-1 and 
3.05pCi.ml-1 (2.62mCi.mmol-1).
In both (i) and (ii) incubations were carried out in 2.5ml centrifuge 
tubes with 2 conceptuses in each. At the end of the cultures the pooled
embryos and pooled yolk sacs of each tube were homogenised and chol­
esterol uptake measured by LSC of homogenate aliquots.
Results Figure 5.3 illustrates the time-courses observed for uptake of 
LDL and total serum cholesterol. Unfortunately, serum-free media are 
unable to support normal embryonic development for more than a few hours; 
day 11 conceptuses appear to be particularly sensitive to these con­
ditions. However, the rate of [3H]cholesterol-LDL uptake by concep­
tuses cultured in MEM (containing lOOpg LDL protein.ml-1) was linear 
for the first two hours (0.35nmoles.conceptus-1.hour-1) and this period 
was therefore chosen for subsequent studies. Uptake of total serum
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[3H]cholesterol by the yolk sac was rapid during the first two hours 
(O.SBnmoles.conceptus”1.hour-1) after which the rate appeared to reach a 
new, lower steady-state. The rate of cholesterol transport to the embryo 
proper was fairly steady (0.07nmoles.conceptus_1.hour-1) throughout the 8 
hour incubation. In fact, E/YS ratios increased slightly with time. In 
both studies the amount of labelled cholesterol measured in the embryo at 
2 hours was about 10% of the total taken up into the whole conceptus and 
had reached >20% by the end of the 8 hours studied.
Table 5.6 shows that valproic acid had no significant effect on the 
uptake of either LDL-cholesterol or total serum cholesterol. Total 
uptake of [3H]cholesterol-LDL over two hours appeared to be increased, 
although this was accounted for when normalized for protein contents. 
Although conceptuses were exposed to valproic acid for a shorter duration 
than in previous experiments, it was probable that an effect on such a 
specific process as LDL uptake would have been detectable if this was the 
primary cause of the changes in lipid metabolism observed after the 8 
hour exposure. The fact that conceptuses were also exposed to a higher 
free concentration of valproic acid in this study (due to reduced protein 
binding) seemed to reinforce this claim. Unaltered total serum chol­
esterol measured after 8 hours exposure (as well as 4 hours, data not 
presented) indicated that other possible mechanisms of cholesterol uptake 
by the conceptuses, e.g. via VLDL or HDL uptake, or by fluid-phase 
endocytosis, were also unaffected by valproic acid.
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Table 5.6
Effect of 1.25mM valproic acid on the uptake of exogenous cholesterol by freshly 
explanted day 11 conceptuses during short periods of culture.
1 II 1 11
2 Uptake of: Ii
i 11 i 11
1 By: !! 
! During: j 2
2 In: 2 2
i 11
[3 H] CHOLESTEROL-LDL
10.6 day conceptuses 
1-3 hours of culture 
Serum free media
[3H] CHOLESTEROL-SERUM
10.2 day conceptuses 
1-9 hours of culture 
75% serum, 25% MEM
i 11
i 11 • it
i M i 11
i ii i 11
i 11
CCMROL
[s=9]
VPA
[n=10]
CCfTTROL
[n=6]
VPA
[n=6]
1 11
2 YOLK SAC 2 2
i 111 11
2 total pinoles uptake 2 {
i 11
567 (32)
...
641 2767 (180) 2754
1 11
2 pmoles/ug protein {}
11 11 
• i
21 (2) 21 83 (6) 86
11
EMBRYO 2 2
11 11
total prooles uptake 2 2 
11
67 (5) 70 779 (82) 714
11
pmoles/ug protein 2 2
11 11 
■ i
1.5 (.1) 1.4 14 (1) 13
11
WHOLE CCNCEPIUS 2 2
11 11
total pmoles uptake 2 2 
11
634 (35) 711 3546 (172) 3468
11
pmoles/ug protein 2 2
11 11
11
9 (1) 9 39 (2) 41
11
ug Protein/yolk sac 2 2 28 (3) 2 30 33 (2) 2 32
ug Protein/embryo 2 2 44 (3) { 51 + 57 (3) 2 53
Data are expressed as pinoles or pmoles/ug protein taken up by the yolk sac and 
into the embryo or by the conceptus as a whole. The pooled SIM for each set of 
control and treated data are given in brackets. + P<0.1, valproic acid (VPA) 
data significantly different frco control data, analysis of variance.
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5.5 Net cholesterol accumulation in vitro and in vivo
5.5.1 Cholesterol contents of cultured conceptuses and fresh explants at 
different stages of development
Experimental design Free and total cholesterol contents of embryos and 
yolk sacs were determined in cultured conceptuses after 16, 24 and 48 
hours of culture and in freshly explanted conceptuses at equivalent in 
vivo ages (10.3, 10.6 and 11.6 days e.a.).
The numbers of tissues pooled for each individual determination (free 
and total cholesterol) were: 10-14 at 16 hours, 8-11 at 10.3 days, 4-8 at 
24 hours and 10.6 days, and single tissues at 48 hours and 11.6 days.
Results The cholesterol contents of cultured and freshly explanted (in 
vivo) conceptuses at equivalent developmental ages are illustrated in
figure 5.4. Cholesterol levels are expressed as pinoles.pg protein-1 and 
the tissue protein contents (pg) are given at the foot of each histogram 
bar. As observed in previous studies (section 5.2), the total amount of 
cholesterol contained in yolk sac tissue was generally greater than 
embryonic levels; only 48 hour cultured conceptuses contained equal 
amounts of total cholesterol in both tissues in the present study.
At each age, cultured conceptuses (both embryo and yolk sac) contained 
significantly less total cholesterol than fresh explants. Over the 32 
hour period studied, cultured conceptuses accumulated about 24nmoles 
total cholesterol, divided equally between the embryo and its sur­
rounding yolk sac. By comparison, total cholesterol accumulation in vivo 
was nearly 35nmoles, the yolk sac accounting for 60% of this gain. In
these yolk sacs the total cholesterol accumulation was in excess of
yolk sac growth. However, the amount of free cholesterol per pg protein
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was unchanged over this developmental period, the extra cholesterol being 
stored as esters. Thus, the ratio of esterified to free yolk sac 
cholesterol significantly increased with time in vivo (0.8 to 1.3;
i.e. the percentage of total cholesterol as esters increased from 
43-57%). Similarly, this ratio increased in yolk sacs of cultured
conceptuses, although only 18% increasing to 25% of the total cholesterol
was esterified. However, the amount of free cholesterol measured in yolk 
sacs of cultured and equivalent age in vivo conceptuses was generally not 
significantly different.
The amount of cholesterol stored as esters in the embryo proper was 
relatively low. Only about 2% was esterified in cultured embryos while
the amount esterified in fresh explants decreased with age from 10% to 4%
of the total cholesterol contents. Compared with embryos at 16 and 24 
hours of culture, equivalent age in vivo embryos contained significantly 
more cholesterol. However, this difference decreased with age and by 48 
hours of culture embryonic cholesterol levels were not significantly 
lower than those in vivo. These observations appeared to reflect the 
high rate of membrane synthesis required for the exponential growth of 
embryos, less cholesterol being available for storage.
5.5.2 The contributions of de novo synthesized and exogenously derived 
cholesterol to net cholesterol accumulation in the developing 
conceptus
The data presented in the above section allow the determination of 
net cholesterol accumulation in day 11 conceptuses over a defined period 
of development in culture and in vivo. From the data in section 5.4 it 
is possible to estimate how much of this is derived from external 
sources. In this section the amount of total cholesterol synthesised de 
novo from acetate was determined directly and the relative contributions
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of this and exogenously derived cholesterol to the net accumulation were 
calculated.
Experimental design Cholesterol synthesis was determined in 9.5 day 
e.a. conceptuses during 16-24 hours of culture using [2-14C]acetate 
(51.4pCi.ml medium-1, 51mCi.mmol-1). The protocol was identical to that 
described in Chapter 3, section 3.3.1. Serum contained 1.39 ± O.lpmoles 
acetate.ml-1 (n=8; range 1.7-2.0pmoles.ml-1) and, since MEM has no 
acetate, the final specific activity of [2-14C]acetate in the medium was 
21.4mCi.mmol-1.
Calculation of the amount of cholesterol synthesized The amounts of 
newly synthesized cholesterol present in the yolk sac and embryo at the 
end of the experimental period were determined from the total dpm 
measured in the sterol and sterol ester fractions following TLC. These 
were converted to curies of radioactivity and divided by the specific 
activity to give a value in moles of acetate incorporated. All 27 
carbons of cholesterol are derived from 18 moles of acetate. However, 
because only 15 of the 18 labelled methyl carbons of acetate reach the 
final cholesterol molecule (Cornforth et al., 1957; Bloch, 1965) the
figure was multiplied by 1.2 to give the total moles of acetate incorp­
orated. Finally the number of moles of cholesterol were calculated by 
dividing through by 18.
Results Table 5.7 presents the data (net accumulation, uptake and
synthesis) compiled from various sections of this Chapter. The table 
allows a gross comparison of cholesterol metabolism during equivalent 
periods of development in day 11 conceptuses in culture and in vivo.
During 16-24 hours of culture de novo synthesis accounted for just
219
Table 5.7
Contributions of exogenously derived and de novo synthesized cholesterol to net 
cholesterol accumulation in day 11 rat conceptuses.
(a) During 16-24 hours of culture (9.5 day e.a. conceptuses).
1 j i TOLK SAC
i 11
EMBRYO i iWHOLE CCNCEPTOSJ 
11---------- 1
! (i) Net pmoles cholesterol 
accumulation (5.5.1)
11 
11
!{ 1031
11 11 11
886
i i---------- 1
ii : 
i i 1917 i
II 1 II 1
1 1 1
I (ii) Pmoles de novo synthesized 
cholesterol
11
11 11
ii 4.2
11 11 
ii
24.0
1 1 1
1 1 1 1 1 1
ii 28.2 {
11 i ■ i i 
ii i
% of net accumulation i! 0.4 2.7
i i
ii 1.5 i
(b) During 1-9 hours of culture (10.2 day e.a. conceptuses).
i ! i YOLK SAC
• ii
EMBRYO WHOLE CONCEPTUS!
r ■ —  -.. ■ . .. - ■ ii
i (i) Net pmoles cholesterol i i 
i accumulation (5.5.1) i! 2216
i 11 i 11
• 11
1321 3537 !
r -.. ' — ..—  11
{ (ii) Pmoles total serum cholesterol i{ 
i uptake (5.4) ii 2767
i 11 i 11
i 11
779 3546 i
i
... .... - ||
! (iii) Pmoles LDL cholesterol {i 
i uptake (5.4) !! 2356*
i 11 i it
i ii
664* 3020* i
i ■ —  ■ ii
' (iv) Pmoles de novo synthesized i i 
i cholesterol ii 3.3*
i m i 11 
i ii
17.4* 20.7* i
i 11
! % of net accumulation }j 0.1* 1.3* 0.6* i
(c) During an equivalent 8 hour period in vivo (10.2-10.6 days e.a.).
i i i YOUC SAC
i ii
EMBRYO i {WHOLE CGNCEPTUS!
11 ii
i (i) Net pmoles cholesterol 
i accumulation (5.5.1)
ii
11
I j
ii 2901
II 11
1223
11 i
i i i 
!! 4124 i
11 i 11 i
Data are expressed as proles total cholesterol accumulated or synthesized during 
an 8 hour period of development. Contributions made by de novo synthesis are 
also expressed as percentages. * Estimated values? see text (section 5.5.2) 
for method of calculation.
1.5% of the total cholesterol accumulated. The amount of newly synth­
esized cholesterol was greater in the embryo proper but some of this may 
have been due to synthesis in the yolk sac and subsequent transport­
ation. Although the amount of cholesterol synthesized in 10.2 day 
e.a. conceptuses during 1-9 hours of culture was not directly measured, 
an estimation was possible from the incorporation of [3H]acetate into 
sterol fractions over this period relative to 16-24 hours of culture (see 
Chapter 3, tables 3.2 and 3.9). As discussed in Chapter 3 the rate of 
sterol synthesis in these fresh explants was lower than in equivalent age 
cultured conceptuses. It seems that the higher cholesterol contents and 
apparently greater ability to take up and/or utilize exogenous (medium) 
cholesterol in these conceptuses suppresses HMG-CoA reductase 
activity; thus the estimated contribution of endogenously synthesized 
cholesterol to the total accumulated was less than 1%. This observation 
was supported by the total measured uptake of serum cholesterol being 
equivalent to the net accumulation in these conceptuses during the 8 
hours studied. LDL-cholesterol uptake by fresh explants over this period 
was estimated from the 2 hour data (section 5.4). The rate of uptake 
(pmoles.pg protein-1.hour-1) was multiplied by 4 and by the tissue 
protein contents at the end of the 9 hours culture period to give the 
highest possible estimate of cholesterol uptake via LDL. The final 
estimate was smaller than both the net accumulation and uptake of 
total serum cholesterol over the same period. This was either due to 
impaired LDL uptake by conceptuses cultured in non-physiological medium 
or, since the rate of uptake was linear under these conditions during the 
first two hours (see figure 5.3), suggested that small quantities of 
cholesterol were derived from components in whole medium other than LDL.
Finally table 5.7 shows the amount of cholesterol accumulated during 
an equivalent period in vivo. As this is considerably more than that
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observed in cultured conceptuses it is likely that synthesis of chol­
esterol would be further suppressed in the conceptus in utero.
5.6 Discussion
The measurement of cholesterol contents of control and treated concep­
tuses was the logical first approach to investigating the proposed 
hypothesis for valproic acid's observed actions on yolk sac sterol 
synthesis. Reduced cholesterol contents following exposure to the 
drug would tend to support the observed 'compensatory' synthesis and 
lend weight to the argument that the initial site of valproic acid's 
action was directed towards cholesterol uptake mechanisms. After 48 
hours exposure to 0.75mM valproic acid total cholesterol contents of 
both yolk sacs and embryos were considerably reduced and this was not 
accounted for by the retarded growth of these tissues. In fact, it is 
quite possible that the reduced cholesterol levels themselves were 
responsible for embryonic growth retardation since less material would be 
available for the high rates of membrane synthesis required. In add­
ition, possible non-physiological structures of newly synthesized 
membranes under these conditions might offer an explanation for the 
abnormal embryonic development. More important to the hypothesis was the 
decrease in net cholesterol accumulation induced by valproic acid during 
16-24 hours of culture, since it was after this period that the bio­
chemical 'response' was also detectable.
These first experiments were, therefore, encouraging and showed that 
an examination of the mechanism(s) of cholesterol uptake by the yolk sac 
would be worthwhile. However, two observations immediately suggested 
that the reduced cholesterol contents per se were not specifically 
responsible for the production of the characteristic structural deform­
ities associated with valproic acid teratogenicity. Firstly, valpromide,
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the control compound, also reduced cholesterol accumulation over this 
period. Secondly, attempts to protect the conceptus against the terato­
genic actions of valproic acid by culturing in cholesterol-rich medium 
were unsuccessful.
Although lipoproteins in the medium would presumably contain maximum 
'loads' of cholesterol, the added 'free' cholesterol was nevertheless 
taken up by the conceptus, as demonstrated by the suppression of in­
creased sterol synthesis induced by corn oil. The mechanism of uptake of 
the 'free' cholesterol is uncertain, although it could be mediated via 
molecular or 'soluble' absorption in corn oil micelles (in a similar 
manner to lipid absorption in the adult digestive tract), or simply by 
pinocytosis. Although the cholesterol contents of conceptuses were not 
determined following culture in cholesterol supplemented medium ± 
valproic acid, these conditions failed to abolish the drug's actions on 
the incorporation of [3H]acetate into yolk sac sterols and other lipids. 
In fact, significantly greater amounts of newly synthesized sterol were 
measured in the embryo proper. This may simply have reflected transport 
of sterols from the yolk sac and/or could have been a true action on 
sterol biosynthesis in this tissue under these medium conditions. Thus, 
it was still possible that the reduced cholesterol accumulation induced 
by valproic acid, and presumably responsible for these biochemical 
actions, was due to inhibition of normal processes of cholesterol uptake, 
e.g. receptor-mediated uptake of lipoproteins.
This process had not previously been demonstrated in the mammalian 
yolk sac, although the amounts of cholesterol accumulated during a 
defined period of development suggested that most was derived from 
exogenous supplies. Indeed, measurement of absolute rates of sterol 
synthesis using [2-14C]acetate proved that de novo synthesis contributed 
very little (<2%) to the total cholesterol requirements of the embryo
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or its surrounding yolk sac. These observations were confirmed by 
measured rates of uptake of [3H]cholesterol-labelled total serum or 
purified LDL. Uptake of total serum cholesterol over an 8 hour period 
(1-9 hours of culture of 10.2 day e.a. conceptuses) equalled the total 
cholesterol accumulation during this time. The amount of cholesterol 
derived specifically from LDL during this period was estimated from the 
rate of uptake over a 2 hour incubation in serum-free medium and showed 
that the majority of accumulated cholesterol could be derived from 
this source. Unless this was an underestimate, these observations 
implied that a small amount cholesterol was also obtained from other 
exogenous sources, e.g. VLDL, HDL or chylomicrons. The contributions, if 
any, of these lipoprotein classes to net cholesterol accumulation by 
conceptuses and, probably more importantly, their infuence on LDL uptake 
in physiological conditions, remain to be investigated. In any event, 
valproic acid failed to have any effect on either total serum cholesterol 
uptake during an 8 hour exposure or on LDL-cholesterol uptake, specif­
ically, during a 2 hour incubation. Subsequent studies in this labor­
atory using 12SI-labelled LDL have confirmed this latter observation in 
day 12 rat conceptuses (McCarthy, unpublished).
Although these studies failed to identify the mechanism responsible 
for the reduced cholesterol contents of valproic acid-exposed con­
ceptuses, they stongly suggested that inhibition of exogenous cholesterol 
uptake, in particular receptor-mediated uptake, was not implicated. In 
addition, they provided useful information about uptake and metabolic 
regulation of cholesterol by the organogenesis-phase conceptus. The fact 
that LDL could provide most of the conceptuses required cholesterol was 
significant in itself. This showed that receptor-mediated uptake 
processes were likely to be operational in the yolk sac at this stage of 
embryonic development and, together with the low sterol synthetic
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activities, suggested that the yolk sac behaved like other extra-hepatic 
tissues in the adult with respect to regulation of cholesterol content. 
Regulation of HMG-CoA reductase activity by exogenously derived chol­
esterol was particularly evident in this tissue. This was not surprising 
since the yolk sac bathes in its environment, protecting the embryo 
proper, and is therefore directly responsible for cholesterol uptake and 
also, probably, for subsequent re-esterification of free cholesterol 
liberated by lysosomal degradation of LDL, prior to ’repackaging1 for 
transportation to the embryo. While sterol biosynthesis was already low 
in culture, the higher cholesterol contents measured in fresh explants 
appeared to suppress the activity of this pathway even more (see Chapter 
3, sections 3.5 and 3.6). The best example of metabolic regulation of 
HMG-CoA reductase activity, however, was demonstrated by the corn oil ± 
cholesterol supplementation studies. The presence of corn oil in the 
medium induced a 9-fold stimulation of yolk sac sterol biosynthesis, 
which was largely reversed by the addition of cholesterol. The mechanism 
by which corn oil acts could be explained in a similar way to that 
originally hypothesised for valproic acid. Studies following up this 
observation confirmed that uptake of 12SI-labelled LDL was inhibited in 
day 12 conceptuses by corn oil concentrations as low as 0.1% (McCarthy, 
unpublished). Similar concentrations of paraffin oil also inhibited 
uptake and micellular absorption of LDL, effectively 'mopping-up' 
lipoproteins, has been postulated for this apparently non-specific effect 
(McCarthy, unpublished). However, if this is true, then two questions 
are raised. Firstly, since plasma lipoproteins appear to supply the 
conceptus with most of its cholesterol, why is embryonic development not 
severely affected during 48 hours of culture in the presence of corn 
oil? Determination of cholesterol contents of these conceptuses might 
help to answer this. Secondly, how is the added 'free' cholesterol in
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supplementation experiments taken up? It could be that lipoprotein- 
-micelle complexes aggregate to form large lipid 'globules’ where as 
added cholesterol is still absorbed in smaller micelles.
Inhibition of lipoprotein uptake by corn oil provided further evidence 
that valproic acid was not acting by this mechanism, especially since the 
corn oil-stimulated sterol synthesis was further stimulated by exposure 
to the drug (additive stimulation xl2 ). Similarly, the unusually high 
levels of newly synthesized sterol measured were several times higher 
than those observed following valproic acid treatment alone, confirming 
that increased levels of de novo synthesized cholesterol were also not 
directly responsible for the teratogenic expression of valproic acid.
Finally, despite the conceptus obtaining nearly all its cholesterol 
from the serum, de novo sterol synthesis accounted for a high percentage 
of the total acetate utilized for lipid biosynthesis. In contrast to the 
high cholesterol content in the yolk sac, more newly synthesized free 
sterol was measured in the embryo proper. It is possible that a certain 
amount of compartmentalization exists, exogenous cholesterol being 
largely incorporated into membranes and synthesized cholesterol being the 
major precursor for synthesis of steroid hormones.
Summary The organogenesis-phase conceptus acquires most of its required 
cholesterol from external (maternal) sources, apparently via 
receptor-mediated uptake of plasma lipoproteins by the yolk sac. 
Although much of this exogenously derived cholesterol is utilized 
or stored as esters in the yolk sac, it is also transported to the embryo 
proper. The mechanism of yolk sac to embryo transportation, however, 
was not studied. Regulation of HMG-CoA reductase activity has been 
demonstrated, particularly in the yolk sac, although sterol biosynthesis 
is largely suppressed under ’normal’ physiological conditions.
The mechanism by which valproic acid reduces cholesterol levels in 
exposed conceptuses remains unresolved. However, it appears that this 
action and the apparently related increased levels of newly synthesized 
sterols are not directly responsible for the valproic acid terato­
genicity.
Chapter 6 
GENERAL DISCUSSION
6.1 Studies of embryonic lipid metabolism
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6.1.1 Lipid synthesis
The incorporation studies described in Chapter 3 demonstrated the 
existence of some major lipid synthetic pathways in the organogenesis- 
-phase rodent conceptus. Acetate, the simple two-carbon lipid 'building 
block1, was activated to acetyl-CoA, making it available for a wide range 
of biosynthetic reactions. This precursor was incorporated into all 
major lipid classes, suggesting that de novo synthesis of lipids in the 
conceptus is important for development. Studies with oleic acid demon­
strated that serum non-esterified fatty acids might provide the conceptus 
with an important source of lipid, and indicated the presence of acyl-CoA 
synthetase, responsible for activation of long-chain fatty acids. The 
predominant incorporation of glucose into polar lipids and triacyl- 
glycerols showed that this major embryonic fuel molecule was a potential 
source of glycerol for the synthesis of complex lipids, while relatively 
little glucose was utilized for de novo synthesis of fatty acids and 
sterols. Each of these lipid precursors are present in the maternal 
circulation and, therefore, present potential sources for lipid synthesis 
to the embryo in utero.
The high incorporation of [3H]acetate into phospholipids and chole­
sterol reflected the extensive membrane synthesis in progress during 
organogenesis. The percent incorporation into these lipids in the embryo 
was very similar to lipid profiles of hepatic plasma membranes (phospho­
lipids about 57% and total cholesterol about 22% of the total lipid 
weight; van Hoeven & Emmelot, 1972). Considerably more phosphatidyl­
choline was synthesized than other phospholipids during the early post­
implantation period, showing similarities with preimplantation mouse 
embryos (Flynn & Hillman, 1978 and 1980) and immature pig oocytes (Homa
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et al., 1986). However, short incubations with acetate label at diff­
erent stages of development suggested that de novo synthesis of phospho­
lipids was reduced, especially in the yolk sac, as development proceed­
ed. In contrast, the amount of cholesterol synthesized was higher in 
later stage embryos. These observation were similar in both precultured 
and freshly explanted conceptuses.
Unlike the embryo proper, the yolk sac incorporated considerable 
amounts of acetate and fatty acid into triacylglycerols and sterol 
esters. Similarly, the percentage of glucose incorporated into yolk sac 
triacylglycerols was higher than the embryo. These observations,
together with the more intense iodine staining of these lipids in yolk 
sac samples, the larger amounts of esterified cholesterol quantified in 
the yolk sac than the embryo, and previous observations of a 'fatty' yolk 
sac (Takeuchi, 1980), suggested that lipid storage was an important yolk 
sac function. As triacylglycerols are highly efficient fuel storage 
molecules, one role of the yolk sac might be to store supplies of fuel 
molecules in reserve for oxidative energy metabolism, soon to commence, 
or possible periods of stress such as maternal starvation during later 
development. This role is supported by observations that glycogen, the 
storage form of glucose, is also stored in the yolk sac (Ellington, 
personal communication). In addition, high levels of cholesterol and 
free fatty acids can be toxic to cells, and the yolk sac could thus
be protecting the embryo from this potential hazard by esterifying excess 
lipid material. However, the reason for an apparent inhibition or
reduction in triacylglycerol synthesis around 16 hours of culture, or
slightly earlier in vivo, remains unclear.
In contrast to the yolk sac, the particularly low cholesterol ester 
content of the embryo proper indicated a greater requirement for free 
cholesterol, and reflected the different activities of microsomal
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cholesterol regulating enzymes in the two tissues.
Finally, while mitochondrial respiration is established on day 11 
in the rat (Tanimura & Shepard, 1970b; Mackler, 1971; Horton et al., 
1985), levels of fatty acid p-oxidation were apparently low during the 8 
hour exposure periods studied. Evidence for this observation comes from 
two sources. Firstly, preliminary studies with 14C-labelled palmitate 
indicate only very low oxidative metabolism, as measured by the formation 
of 14C02. Secondly, while acetate was incorporated into sterol lipids to 
a larger extent in the embryo and a lesser extent in the yolk sac, oleic 
acid activity incorporated into these sterol fractions was low, but 
highest in the yolk sac. This suggested that the activity derived from 
oleic acid in these fractions was predominantly present as diacyl- 
glycerol. While small amounts of two-carbon units from low levels of 
oleic acid oxidation would probably be diluted within the cytosol, 
incorporation into sterols would presumably be detected after a period as 
long as 8 hours.
6.1.2 Cholesterol metabolism
Although embryonic sterols were one of the major lipid classes 
synthesized from acetate, the organogenesis-phase conceptus acquires most 
of its cholesterol (about 98%) from exogenous (maternal) sources. 
Preimplantation mouse embryos appear to differ in this respect, and meet 
their sterol demands via de novo synthesis (Pratt, 1982). The component 
in serum which supplies cholesterol to the implanted conceptus appears to 
be LDL. This plasma lipoprotein could provide most of the net chole­
sterol accumulated by the whole conceptus over a specified time.
The major mechanism of LDL-cholesterol ingestion by extrahepatic 
cells (most studies have used cultured human fibroblasts) is suggested to 
be via specific cell-surface receptor-mediated uptake (Goldstein & Brown,
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1974), while 'low-affinity', pinocytotic uptake (Goldstein & Brown, 1974) 
and molecular transfer at the cell membrane (Bailey, 1965) are also 
implicated. Brown & Goldstein (1976) suggested that only receptor 
mediated LDL-cholesterol uptake results in net accumulation and esterifi- 
cation of cholesterol, although a recent study (Slotte et al., 1984) 
showed that LDL-cholesterol was processed intracellularly in 
LDL-receptor-negative fibroblasts. These mutant fibroblasts also 
accumulated and processed non-lipoprotein (vesicle) cholesterol (Slotte 
et al., 1984; Slotte, 1987). The present studies did not elucidate which 
of these mechanisms was responsible for LDL-cholesterol uptake by the 
yolk sac. Previous studies have demonstrated both receptor-mediated 
uptake (transferrin, IgG) and bulk-phase pinocytosis uptake mechanisms by 
the yolk sac (Huxham & Beck, 1981; McArdle & Priscott, 1984; Williams ejt 
al., 1975a).
The most plausible mechanism appears to be receptor-mediated uptake 
since recent studies in this laboratory have shown that suramin (a newly 
found inhibitor of LDL-receptor interactions; Schneider et al., 1982) 
reduced uptake of 12SI-labelled LDL by the yolk sac by 50% at a concen­
tration of 0.3mM (McCarthy, unpublished). Similar concentrations of 
suramin were previously shown to inhibit LDL binding to purified bovine 
adrenal receptors (ImM suranim was completely inhibitory; Schneider et 
al., 1982). Although Freeman & Lloyd (1985) have shown that suramin was 
dysmorphogenic in vitro and inhibited yolk sac pinocytotic and proteo­
lytic functions, ten-fold higher concentrations (5mg.ml_1, equivalent to 
3.5mM; MWt=1429) were required to produce these effects. Thus, if this 
reasoning is correct, this would suggest that inhibition of LDL receptor- 
-mediated uptake into the yolk sac would not, itself, produce malform­
ations, and indicates that other mechanisms of cholesterol uptake may 
operate under these circumstances.
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This indeed appears to be the case since subsequent work in this 
laboratory showed that corn oil inhibited 12SI-LDL uptake by the yolk 
sac, apparently by a non-specific mechanism (McCarthy, unpublished), but 
did not produce abnormalities over a 48 hour exposure to cultured rat 
conceptuses. Also, the addition of cholesterol reversed corn-oil-stim­
ulated cholesterol biosynthesis in the yolk sac. This observation
proved that 'free' cholesterol (perhaps as liposomes or low molecular
weight micelles formed during sonication of the corn oil ± cholesterol 
into serum) could be taken up by non-receptor mediated pathways, and was 
carried into the cytosol where it was able to regulate the activity of 
HMG-CoA reductase. The ability of exogenously derived non-lipoprotein 
cholesterol to reduce HMG-CoA reductase activity has previously been 
observed in mutant human fibroblasts (Brown et al., 1974). Although, 
therefore, under normal conditions, LDL-derived cholesterol appears to be 
the major source of embryonic cholesterol, other potential sources
exist. HDL predominates in the serum of adult rats, but contributes less 
to total serum cholesterol levels than does LDL (Johansson, 1983). 
Furthermore, specific HDL receptors have been identified on rat hepato- 
cytes (Rifici & Eder, 1984).
While the activity of HMG-CoA reductase is largely suppressed in 
the organogenic conceptus, the corn oil/cholesterol studies demonstrated 
that this activity was regulated by the free cellular cholesterol 
content. Similarly, the higher amounts of cholesterol accumulated by 
conceptuses in utero suppressed de novo synthesis of sterols further than 
observed in cultured conceptuses. However, sterol synthesis in the 
embryo was always greater than in the yolk sac. Extensive membrane 
synthesis in the embyro might cause exogenous supplies of cholesterol to 
be utilized for this purpose. Thus, cellular cholesterol concentrations 
would be relatively low, HMG-CoA reductase activity higher than the
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yolk sac, and little esterification of cholesterol would occur.
Although the mechanism of cholesterol transport to the embryo has 
yet to be elucidated, apolipoproteins are synthesized by the yolk sac 
endoderm (Meehan et al., 1984; Shi & Heath, 1984), and may be ’packaged' 
with cholesterol for transport to the embryo in the vitelline circu­
lation.
6.2 Valproic acid actions on embryonic lipid metabolism
Initial experiments with specific lipid biosynthesis inhibitors 
on the incorporation of [3H]acetate, and during a routine 48 hour 
culture, appeared only to provide information on secondary biochemical 
effects, while the initial insult(s) could not readily be determined. In 
particular, the exponential growth of the embryo during this period meant 
that a high proportion of the total incorporated radioactivity would 
have accumulated during the latter hours of culture only, therefore 
masking the early changes. Thus, the next approach to developing an 
informative protocol by which valproic acid and other SCCA could be 
'screened' for possible actions, was to adopt a shorter incubation period 
during which malformations could be produced without requiring very high 
concentrations of SCCA. The 16-24 hour exposure period used previously 
(Coakley et al., 1986) provided a suitable protocol, and a pilot study 
using mevinolinic demonstrated the sensitivity of this new approach.
Experiments subsequently conducted with valproic acid and two struct­
urally related compounds, butyric acid and valpromide, yielded promising 
results for further study. A biochemical action induced by valproic acid 
had been observed in the organogenesis-phase conceptus for the first 
time. However, in the course of these studies it became apparent that 
lipid metabolism in the cultured conceptus differed from that in vivo, 
this difference became greater with a longer time in culture. It became
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necessary to adapt the 16-24 hour protocol, therefore, and experiments 
were repeated with freshly explanted conceptuses.
The main conclusions drawn from these preliminary experiments were as 
follows: (i) valproic acid caused significant increases in [3H]acetate- 
-derived activity in free fatty acid/triacylglycerol and yolk sac sterol 
fractions, while activity in yolk sac sterol esters was reduced, (ii)
valpromide produced similar increases in fatty acid/triacylglycerol
fractions, but decreased acetate incorporation into sterols, (iii)
actions common to valproic acid and butyric acid but not induced by
valpromide were restricted to yolk sac sterol and sterol ester
fractions. Moreover, the different actions of valproic acid and 
valpromide on sterol lipids were accentuated during the 'repeat' experi­
ments using freshly explanted conceptuses, and (iv) metabolism of
valproic acid was apparently not implicated.
Subsequent experiments confirmed that valproic acid was, in fact, 
inducing cholesterol biosynthesis in the yolk sac and concomitantly 
suppressing cholesterol esterification, and that these actions were 
dose-dependent. The increases in fatty acids were also apparently 
dose-related. In particular, a non-teratogenic dose of valproic acid
(0.5mM) did not produce significant deviations. In addition, valproic 
acid had a similar effect on yolk sac cholesterol synthesized from 
an endogenous pool of acetate, derived from D-[U-14C]glucose. Further­
more, yolk sac cholesterol biosynthesis was 2-fold higher than controls 
following 3 hours in vivo exposure to valproic acid. Thus, the consis­
tent and specific actions of valproic acid suggested a promising lead in 
the search for the initial teratogenic insult.
However, the hypothesis formulated to explain these actions, 
i.e. potential inhibition of cholesterol uptake, was disproved by 
subsequent studies. All attempts to measure an effect on uptake of
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exogenous cholesterol were negative. Evidence supporting these findings 
was provided by the corn oil studies. Even 0.1% corn oil in the culture 
medium completely abolished LDL binding, and uptake at the yolk sac 
endoderm (McCarthy, unpublished), while the higher concentration used in 
the present studies resulted in a 9-fold stimulation of yolk sac chol­
esterol biosynthesis. This observation, itself, strongly suggested that 
neither inhibition of lipoprotein-cholesterol uptake, nor high levels of 
newly synthesized cholesterol, could explain valproic acid's teratogenic 
action, since corn oil produced only a few, subtle dysmorphologies in 
exposed embryos which were unlike the characteristic abnormalities 
produced by valproic acid. Furthermore, the similar actions of corn oil 
and valproic acid on yolk sac cholesterol synthesis was additive when 
both were present in the media, while cholesterol supplementation under 
these conditions resulted in suppression of the corn oil-stimulated 
HMG-CoA reductase activity, but not of the valproic acid-stimulated
activity. Thus, uptake of non-lipoprotein derived cholesterol was also 
not affected by valproic acid; this might have been suspected since
valproic acid has previously been shown not to inhibit yolk sac pino-
cytosis (Coakley ejt al., 1986).
The mechanism underlying the reduced cholesterol contents induced
by valproic acid treatment, therefore, remains to be investigated. 
Increased degradation of membrane cholesterol appears to be the most 
plausible explanation at the present time. However, since valpromide 
produced similar effects on cholesterol contents, it would appear that 
this action was not responsible for the valproic acid teratogenicity.
In addition to valproic acid's effects on cholesterol, persistent 
increases in the levels of labelled free fatty acids were observed, while 
triacylglycerols were also increased following exposure of conceptuses in 
utero. These effects might reflect inhibition of p-oxidation, and it
would be interesting to analyse the individual fatty acids to see if 
they were long-chain, or possibly shorter like the C6 -C10 dicarboxylic 
acids found in patients treated with valproic acid (Mortensen et al., 
1980). However, previously discussed data suggests that p-oxidation 
activity is minimal during the period studied, and even if these effects 
do reflect inhibition of low levels of fatty acid oxidation, this action 
is unlikely to be implicated in valproic acid's mechanism of teratogenic 
action since abnormalities may be induced during earlier exposures when 
oxidative metabolism is not in operation. High levels of free fatty 
acids are also observed following membrane damage. Thus, lipid peroxi­
dation or perhaps stimulation of non-specific lipases (e.g., of lyso­
somal origin) are potential candidates for future investigation. These 
actions might also offer attractive mechanisms for the observed decrease 
in cholesterol content induced by valproic acid. It would, therefore, be 
important to measure phospholipid levels, and to determine the relative 
molar concentrations of cholesterol and phospholipids, fundamentally 
important for the preservation of membrane integrity. Although lipid 
peroxidation is a suggested mechanism of valproic acid hepatotoxicity 
(Buchi et al., 1984) it is difficult to understand how this would be 
initiated, especially in the cultured embryo where metabolism of valproic 
acid either does not occur, or is negligible. It is also difficult to 
understand how such non-specific toxic events would produce the 
relatively specific malformations induced by valproic acid during a short 
exposure, and why incorporation of acetate into polar lipids would remain 
unaffected.
It is not known why the organogenesis-stage conceptus is apparently 
unable, or has a low capacity, to metabolize valproic acid, while butyric 
acid is extensively incorporated into lipids. Brown et. al. (1985) found 
no evidence for the formation of valproyl-CoA, however, suggesting that
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valproic acid was not available for incorporation via (S-oxidation. 
However, the enzyme responsible for the activation of branched-chain 
C4-C11 fatty acids is presumably medium-chain fatty acid thiokinase (EC 
6.2.1.2), also known as butyryl-CoA synthetase and, therefore, required 
for activation of butyrate also. It is plausible that this enzyme is 
not present in the embryo and butyric acid is ’activated' by one of the 
other acyl-CoA synthetases. Alternatively, butyric acid could be 
converted to D-3-hydroxybutyrate via microsomal oxidation, and then enter 
fatty acid synthesis directly, or be converted to acetyl-CoA via aceto- 
acetate.
6.3 Concluding remarks
Little is known about the metabolism of lipids by the mammalian 
embryo. Lipid pathways during the organogenesis period of development 
are particularly poorly understood because the majority of research 
conducted in this area of metabolism has concentrated on the
preimplantation and late foetal/peri-natal stages. The studies presented 
in this thesis begin to close the gap in this knowledge, but clearly 
there are many interesting and important questions to answer. In
particular, while the embryo is able to synthesize all major lipid
classes de novo, the oleic acid incorporation data and cholesterol uptake 
studies suggest that the raw materials for membrane biosynthesis are 
predominantly acquired from maternal transfer, mediated by the visceral 
yolk sac during this period of development. Thus, interference with the 
uptake of lipids and their transport to the embryo would be potential 
targets for teratogenic action, in addition to the biosynthetic pathways 
responsible for rebuilding these important molecules once they reach 
their destination and are deposited as hydrolysates in the cytosol.
Although mitochondrial activities are known to increase during organo­
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genesis, it would also be important, and interesting, to establish 
specifically when fatty acid oxidation becomes operational.
A concise understanding of the lipid biochemistry, and of metabolism 
in general, of the mammalian embryo during this critical period of its 
development would, indeed, be of significant importance to the teratol- 
ogist. Such information would help to identify pathways which are 
particularly susceptible to chemical interference, therefore aiding 
the discovery and comprehension of fundamental mechanisms of 
teratogenicity. Together with the library of data being collected from 
other approaches to understanding the science of abnormal development, 
this new found knowledge would hopefully allow the prediction of 
teratogenic outcome and, therefore, contribute to the prevention of human 
birth defects, the ultimate goal of teratology.
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